Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,40679,105,3.86 [1.22-12.23],0.021733092334743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,39538,103,1.22 [0.86-1.73],0.2555550693230811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,46483,124,0.87 [0.65-1.16],0.3375296804465949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,39283,102,2.96 [2.08-4.21],1.7134936506637915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABHD14B,Protein ABHD14B,46193,123,0.85 [0.64-1.12],0.2470419609002399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,46483,124,1.39 [1.12-1.73],0.0024741936351694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABO,Histo-blood group ABO system transferase,40646,105,1.07 [0.94-1.22],0.3192500308702628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,39283,102,1.27 [0.97-1.67],0.079554287751883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",45615,120,1.64 [1.39-1.93],4.787922592291903e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39882,107,1.17 [0.93-1.47],0.1712401471936649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40628,107,1.08 [0.89-1.31],0.4551792014440917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,46256,124,0.54 [0.30-0.96],0.0368637427652414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,40646,105,2.92 [1.59-5.35],0.0005183781883831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,45838,124,1.87 [1.50-2.34],3.6280445566353874e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,39729,105,1.22 [0.72-2.08],0.4588412401652048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOT13,Acyl-coenzyme A thioesterase 13,40451,106,1.15 [0.98-1.34],0.0899230941382113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,46694,125,1.10 [0.83-1.45],0.5103716954435045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39446,103,0.63 [0.40-1.00],0.048451398508407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,46891,128,2.88 [2.13-3.89],7.504689207218237e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP6,Lysophosphatidic acid phosphatase type 6,47029,128,1.02 [0.82-1.27],0.8591112902599323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,40433,105,1.25 [0.84-1.88],0.2741963419375787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,39446,103,1.26 [1.05-1.53],0.0156792292743392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39283,102,1.21 [0.75-1.95],0.4313611662231869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",45838,124,2.21 [1.83-2.67],1.3548336717330802e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,39283,102,1.64 [1.28-2.08],6.759316565702853e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN4,Alpha-actinin-4,45833,124,1.13 [0.73-1.76],0.5759062568765709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,46258,124,6.80 [4.95-9.35],2.7564297449054244e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,46694,125,1.91 [1.53-2.38],8.344806375970616e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39283,102,2.13 [1.62-2.81],8.541176115711388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACYP1,Acylphosphatase-1,39577,104,0.96 [0.72-1.27],0.7737187607820006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA,Adenosine deaminase,47210,127,1.14 [0.75-1.73],0.5348196006323345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,46431,124,6.29 [4.90-8.07],3.1497180253023576e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39446,103,1.94 [0.86-4.41],0.1115819869404609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,45838,124,1.97 [1.18-3.26],0.0089244830543556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,46337,124,1.76 [1.15-2.68],0.0092078216483052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,47210,127,1.96 [1.21-3.17],0.0062325827678772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,47039,128,2.77 [1.92-4.00],5.6740633650179735e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40451,106,4.70 [3.40-6.50],8.414995659179207e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39446,103,2.43 [1.79-3.31],1.5741846844600653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,47267,128,1.76 [0.93-3.36],0.0847611975190683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,46483,124,2.74 [1.92-3.91],2.6860688062710512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,45838,124,1.16 [0.74-1.85],0.5162179189541235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39446,103,2.00 [1.33-3.02],0.0009547057311437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,46850,129,0.63 [0.45-0.88],0.0075677065745032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,40614,105,6.51 [4.80-8.84],2.769314286405118e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL4,ADAMTS-like protein 4,39538,103,1.41 [0.64-3.07],0.392440922723289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,40628,107,1.65 [1.10-2.47],0.0156621200996219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,45615,120,0.77 [0.42-1.39],0.3844922998105028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,39729,105,0.91 [0.70-1.17],0.462675992405439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,46258,124,3.33 [2.13-5.21],1.3638209714264457e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,39729,105,2.67 [1.77-4.05],3.274469772605767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,40451,106,2.10 [1.57-2.82],6.218760458445979e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,46900,124,7.64 [4.95-11.80],4.543842996358484e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,47034,127,4.33 [3.40-5.50],8.387573729207301e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,40628,107,2.71 [1.39-5.27],0.0033228675521362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,46483,124,2.31 [2.03-2.63],9.333356486667236e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,46694,125,0.40 [0.31-0.51],1.4065629738123297e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRV1,Adhesion G-protein coupled receptor V1,39312,102,0.99 [0.75-1.30],0.927381360338066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH1B,All-trans-retinol dehydrogenase,39729,105,1.07 [0.85-1.35],0.5843699184571203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,45838,124,1.12 [0.93-1.37],0.2371328768886402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,40679,105,0.66 [0.50-0.87],0.0030252758304894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,47097,128,30.78 [16.91-56.04],3.646023820412472e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADRA2A,Alpha-2A adrenergic receptor,39283,102,0.89 [0.65-1.20],0.4370174244927661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFAP1,Actin filament-associated protein 1,39729,105,1.15 [0.93-1.42],0.1917681435019471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFM,Afamin,40679,105,0.63 [0.26-1.56],0.3205145443195342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,46184,124,0.58 [0.44-0.75],5.064908203471218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGBL2,Cytosolic carboxypeptidase 2,39312,102,0.94 [0.76-1.16],0.5784469433412229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGER,Advanced glycosylation end product-specific receptor,46590,123,1.10 [0.75-1.62],0.6105594163547735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,45260,123,2.01 [1.76-2.29],3.189200419827461e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,45538,120,1.56 [1.26-1.95],6.740562773102053e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,46900,124,3.95 [3.23-4.84],1.770982298178391e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,47210,127,2.58 [1.99-3.36],1.6433033421137622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,40646,105,1.90 [1.00-3.60],0.0498829839824839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,46694,125,1.64 [1.36-1.97],1.870832203925515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHCY,Adenosylhomocysteinase,46694,125,1.14 [0.91-1.44],0.254671046974994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,39538,103,1.49 [0.86-2.55],0.1518064245385898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,39538,103,2.05 [1.20-3.48],0.0081917269552783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40433,105,0.90 [0.66-1.21],0.477818002972221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSG,Alpha-2-HS-glycoprotein,40646,105,1.17 [0.58-2.35],0.664721436889238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,46621,127,0.80 [0.66-0.96],0.0172650107792149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIDA,"Axin interactor, dorsalization-associated protein",39492,104,1.12 [0.92-1.37],0.2698597795264741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1,Allograft inflammatory factor 1,45615,120,1.17 [0.86-1.60],0.3149499750791225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,39538,103,1.33 [1.02-1.74],0.0378846970469054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",46405,124,1.30 [1.13-1.49],0.0002907812045629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,46694,125,0.61 [0.47-0.80],0.0002457018913641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK2,"Adenylate kinase 2, mitochondrial",40529,106,1.12 [0.94-1.34],0.2001390815882704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKAP12,A-kinase anchor protein 12,39729,105,0.74 [0.29-1.91],0.5384606574307431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,45615,120,1.22 [0.98-1.50],0.070093982181852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,39492,104,1.55 [1.26-1.91],2.924938416873456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1C4,Aldo-keto reductase family 1 member C4,45838,124,1.25 [0.97-1.61],0.0879200255588376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39446,103,1.46 [1.17-1.83],0.0008010998231279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT1S1,Proline-rich AKT1 substrate 1,45638,124,1.06 [0.83-1.35],0.6300543573301716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT2,RAC-beta serine/threonine-protein kinase,40550,105,1.02 [0.88-1.18],0.8205612097724344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT3,RAC-gamma serine/threonine-protein kinase,45406,119,1.06 [0.80-1.41],0.686568991742282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,47267,128,12.99 [6.97-24.23],7.25539022931015e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH1A1,Retinal dehydrogenase 1,46698,127,0.96 [0.72-1.26],0.7546966142547704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40433,105,0.97 [0.65-1.43],0.8747757432600687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",46552,123,1.32 [1.11-1.57],0.0014848771308855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40550,105,1.72 [1.25-2.38],0.0009350620133461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,39882,107,1.45 [1.06-2.00],0.0217074707716545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPI,Intestinal-type alkaline phosphatase,39446,103,1.15 [0.99-1.33],0.07580997064793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",46483,124,1.25 [1.08-1.45],0.0023861265706434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBN,Ameloblastin,45833,124,0.82 [0.45-1.48],0.504238022387409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,47028,128,25.64 [14.56-45.15],2.67958595202354e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40614,105,1.21 [0.59-2.46],0.601858003377219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMFR,E3 ubiquitin-protein ligase AMFR,45638,124,1.15 [0.92-1.44],0.212393577897936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO1,Amphoterin-induced protein 1,39492,104,1.05 [0.73-1.53],0.7795145664598142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,46483,124,5.38 [3.05-9.51],6.583819710997586e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMN,Protein amnionless,45833,124,1.12 [0.81-1.55],0.4819007288007574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOT,Angiomotin,39729,105,1.51 [0.95-2.38],0.0788786924071468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOTL2,Angiomotin-like protein 2,40286,105,1.28 [0.91-1.80],0.1633236666148086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMPD3,AMP deaminase 3,40529,106,0.82 [0.64-1.07],0.1395553055834988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,38074,98,0.85 [0.57-1.26],0.4158399149155428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,44899,121,0.69 [0.49-0.96],0.0284230742679782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,43523,116,0.60 [0.43-0.85],0.0039857392090143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,46575,125,2.56 [1.77-3.70],6.725281168636901e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT1,Angiopoietin-1,46527,124,1.08 [0.89-1.31],0.4292985597411604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,47097,128,5.57 [4.07-7.64],1.0872288556707303e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,46024,125,4.66 [2.76-7.86],7.862715874901394e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,46746,123,2.04 [1.39-2.99],0.0002396841611913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,46731,125,0.59 [0.37-0.92],0.0207878413342117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,46823,124,5.19 [3.70-7.29],1.884306989010535e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,47097,128,3.47 [2.63-4.59],2.423050037061432e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANK2,Ankyrin-2,39283,102,0.85 [0.62-1.16],0.308543797726253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39446,103,1.20 [0.95-1.50],0.1196295541955488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRA2,Ankyrin repeat family A protein 2,39172,104,0.89 [0.62-1.27],0.519141262640288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,45615,120,0.72 [0.52-1.00],0.0466033615087873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39538,103,1.00 [0.61-1.66],0.993010185440954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANPEP,Aminopeptidase N,46817,125,1.61 [0.93-2.76],0.0864269444413228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,39500,105,1.34 [0.92-1.95],0.1304011632030062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,45638,124,1.50 [1.28-1.75],3.73664450333707e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA11,Annexin A11,46551,123,1.00 [0.78-1.27],0.9734235731768914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,38935,103,1.26 [0.99-1.59],0.0576271187799644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA3,Annexin A3,47039,128,0.99 [0.79-1.24],0.9174893448126608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA4,Annexin A4,46479,125,0.92 [0.74-1.15],0.4630399630029673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,45485,123,2.32 [1.52-3.56],0.0001040587859829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],45833,124,0.66 [0.45-0.95],0.0256253832023033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,46888,125,11.86 [7.95-17.71],1.0120476451933348e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,40433,105,1.30 [1.04-1.62],0.0191648303334602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,39492,104,1.29 [0.92-1.82],0.1390069794703227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,40451,106,1.34 [1.08-1.68],0.0095121189866682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,40529,106,1.43 [1.03-1.97],0.0310511262025768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,46483,124,1.29 [0.94-1.77],0.108903869493198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,40320,105,0.46 [0.27-0.79],0.0044231955010718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,46950,128,0.88 [0.67-1.17],0.3882903119611604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,46694,125,0.49 [0.36-0.68],1.3948078132638366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,40679,105,0.47 [0.32-0.69],0.0001542928997745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,40646,105,1.27 [0.88-1.83],0.2044908842292526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,40679,105,3.44 [2.73-4.33],8.475119795829328e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOB,Apolipoprotein B-100,40646,105,1.01 [0.46-2.21],0.9808114583189383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,39538,103,0.55 [0.37-0.83],0.0037608934516788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,40604,105,0.49 [0.37-0.65],9.4659521840646e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,38841,103,0.60 [0.45-0.79],0.0002248745249007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOE,Apolipoprotein E,40679,105,0.78 [0.56-1.08],0.1354236570807322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,40646,105,0.40 [0.30-0.55],1.1595777403980056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOH,Beta-2-glycoprotein 1,46698,127,1.01 [0.67-1.52],0.9779817195752188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,40646,105,0.55 [0.37-0.81],0.0029796768691059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,46810,125,0.31 [0.23-0.43],1.4669012828648814e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APP,Amyloid-beta precursor protein,46625,126,1.12 [0.89-1.42],0.3222952409330261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APPL2,DCC-interacting protein 13-beta,39729,105,1.07 [0.90-1.27],0.425996353402876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APRT,Adenine phosphoribosyltransferase,46257,124,1.19 [0.84-1.68],0.3247388867913403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARAF,Serine/threonine-protein kinase A-Raf,39882,107,1.12 [0.86-1.46],0.4081894527207096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,46483,124,4.59 [3.79-5.56],3.794844061776064e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARF6,ADP-ribosylation factor 6,40451,106,1.05 [0.89-1.25],0.5613223147604472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARFIP1,Arfaptin-1,40550,105,1.11 [0.86-1.43],0.4370584749297035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,46427,126,0.55 [0.41-0.75],0.0001494643570865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG2,"Arginase-2, mitochondrial",40433,105,1.13 [0.76-1.69],0.5503727277362507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,45615,120,0.65 [0.46-0.92],0.0163394317233853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP25,Rho GTPase-activating protein 25,45615,120,1.06 [0.83-1.37],0.626881159064822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP30,Rho GTPase-activating protein 30,39882,107,1.10 [0.70-1.73],0.6711662462665229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP45,Rho GTPase-activating protein 45,39729,105,1.18 [0.94-1.47],0.1537271971275912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP5,Rho GTPase-activating protein 5,39172,104,1.09 [0.87-1.37],0.4336580006588638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,40529,106,1.19 [0.97-1.47],0.0962760801717805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,40550,105,1.22 [1.01-1.48],0.0371128116241483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,46626,123,1.14 [0.98-1.33],0.0942473792585409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,39312,102,1.46 [1.19-1.79],0.0002785923727451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID3A,AT-rich interactive domain-containing protein 3A,39312,102,0.95 [0.61-1.49],0.8380262698366681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,45638,124,0.54 [0.33-0.90],0.0184252341439553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL13B,ADP-ribosylation factor-like protein 13B,39283,102,1.06 [0.82-1.37],0.6686241016028776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39283,102,0.89 [0.55-1.44],0.6403519707200527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,39312,102,1.02 [0.74-1.41],0.8886007887548291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,45833,124,1.21 [0.79-1.85],0.3889105563979939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39283,102,0.72 [0.46-1.13],0.1536564622780586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSA,Arylsulfatase A,46698,127,1.22 [0.89-1.68],0.2181241013620807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSB,Arylsulfatase B,46483,124,1.13 [0.86-1.49],0.3837536759627873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,46888,125,1.98 [1.31-2.99],0.0012300256228638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART5,Ecto-ADP-ribosyltransferase 5,39312,102,1.12 [0.86-1.46],0.3924442420146203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARTN,Artemin,45833,124,1.07 [0.78-1.48],0.6743775712340673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,40229,105,1.61 [1.26-2.05],0.0001411080370399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH2,Neutral ceramidase,46337,124,1.39 [1.00-1.93],0.0500213528910573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,46337,124,7.06 [5.34-9.32],4.1765944585458445e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,40646,105,6.52 [3.67-11.61],1.734319231253926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,40628,107,1.79 [1.13-2.84],0.0127327712805393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPSCR1,Tether containing UBX domain for GLUT4,40550,105,1.02 [0.77-1.34],0.9033030631295924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39538,103,1.00 [0.83-1.22],0.965285931787958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASS1,Argininosuccinate synthase,39283,102,1.03 [0.81-1.32],0.7838293255837863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,45638,124,1.10 [0.89-1.36],0.3908595001374952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39172,104,0.70 [0.38-1.29],0.2527540854049734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,40451,106,1.30 [1.05-1.61],0.0142766299305984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG4A,Cysteine protease ATG4A,45615,120,0.84 [0.64-1.11],0.2263252566091817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,46850,129,1.36 [1.08-1.71],0.0081066659595817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39283,102,1.37 [1.07-1.74],0.0109067091156748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39283,102,1.52 [0.94-2.46],0.0873824450817638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39283,102,1.07 [0.66-1.73],0.7887826657158465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B4,Protein ATP1B4,39172,104,1.03 [0.66-1.60],0.887799977473271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39283,102,0.74 [0.49-1.11],0.1426823088346173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39283,102,0.73 [0.46-1.16],0.1802795868477114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5IF1,"ATPase inhibitor, mitochondrial",46900,124,1.13 [0.97-1.30],0.1084097008894906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5PO,"ATP synthase subunit O, mitochondrial",45638,124,0.84 [0.56-1.27],0.4056797640591898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,45615,120,1.84 [1.43-2.36],1.7798189273824443e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1D,V-type proton ATPase subunit D,46483,124,0.77 [0.41-1.46],0.4277714238531006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,45562,123,1.01 [0.79-1.29],0.9348039882748628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G1,V-type proton ATPase subunit G 1,39538,103,1.03 [0.80-1.33],0.8211708216672807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G2,V-type proton ATPase subunit G 2,39283,102,1.06 [0.87-1.29],0.5561589704362173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,40451,106,1.79 [1.49-2.15],3.2339503196872184e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",40679,105,5.39 [1.94-14.94],0.001215544700244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN10,Ataxin-10,45638,124,1.01 [0.81-1.26],0.9105295526090588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2,Ataxin-2,39312,102,1.00 [0.84-1.19],0.9681575711144664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,40550,105,1.21 [0.86-1.70],0.2848809521559096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN3,Ataxin-3,40529,106,0.87 [0.65-1.16],0.3272477308100555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXIN1,Axin-1,46626,123,1.14 [0.97-1.35],0.1149707296582295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,46888,125,4.08 [2.44-6.81],8.393901681114093e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZI2,5-azacytidine-induced protein 2,40550,105,1.35 [0.99-1.85],0.0576334645769285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZU1,Azurocidin,45257,121,0.95 [0.77-1.19],0.6761563512322744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,40679,105,2.00 [1.72-2.32],5.479199834709823e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39283,102,1.13 [0.45-2.87],0.7936198336988173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39538,103,8.82 [5.68-13.72],3.913955064795973e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",46900,124,8.58 [5.54-13.28],6.054543265832248e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",46698,127,1.37 [0.72-2.59],0.3397244592214679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BABAM1,BRISC and BRCA1-A complex member 1,39446,103,1.45 [0.84-2.49],0.1818870442094413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,46626,123,1.30 [1.06-1.60],0.0133879159759554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG3,BAG family molecular chaperone regulator 3,46258,124,1.04 [0.70-1.55],0.8508681103064591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,39446,103,1.59 [1.15-2.19],0.0052290540585038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG6,Large proline-rich protein BAG6,45838,124,1.22 [0.79-1.90],0.3677516162616873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,45615,120,1.83 [1.53-2.19],2.491846688184929e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,45615,120,3.65 [2.80-4.76],1.6324633357594969e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BANK1,B-cell scaffold protein with ankyrin repeats,46626,123,1.14 [0.98-1.34],0.0944648908208818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAP18,Chromatin complexes subunit BAP18,40529,106,1.14 [0.89-1.47],0.3002905921619179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BATF,Basic leucine zipper transcriptional factor ATF-like,39492,104,1.11 [0.91-1.36],0.3084908608393827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAX,Apoptosis regulator BAX,45560,124,1.17 [0.99-1.40],0.0686387771484525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,46698,127,3.26 [2.17-4.90],1.2925686764754892e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,46337,124,0.37 [0.29-0.48],4.990643357057713e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40628,107,1.70 [1.00-2.88],0.0503344772264291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39312,102,0.53 [0.32-0.87],0.0120928332804721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCHE,Cholinesterase,39889,104,0.75 [0.38-1.50],0.4197757077600051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,40451,106,1.52 [1.21-1.90],0.0002885949803601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L1,Bcl-2-like protein 1,40529,106,1.09 [0.90-1.31],0.3865068010643817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",46626,123,2.54 [1.63-3.96],3.98564555702783e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,39446,103,1.33 [1.00-1.76],0.0460788461273081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39172,104,1.01 [0.75-1.36],0.9427583492629475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40433,105,0.57 [0.34-0.97],0.0386366596117561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,46626,123,1.23 [1.03-1.46],0.0194221423046767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BDNF,Brain-derived neurotrophic factor,40614,105,1.06 [0.85-1.33],0.6067621723595852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,39538,103,1.33 [0.99-1.77],0.0545182491365601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BEX3,Protein BEX3,39172,104,1.09 [0.76-1.58],0.6291172481833718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,40614,105,0.68 [0.55-0.84],0.0002831228572809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGN,Biglycan,45538,120,1.05 [0.91-1.20],0.5133070889020581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHLHE40,Class E basic helix-loop-helix protein 40,39312,102,0.95 [0.73-1.25],0.7284418500794819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39283,102,1.10 [0.53-2.30],0.7902508328193407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BID,BH3-interacting domain death agonist,46626,123,0.98 [0.77-1.25],0.8565198796116271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIN2,Bridging integrator 2,46698,127,1.03 [0.87-1.22],0.7376139131471741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,45615,120,1.18 [0.92-1.50],0.1860874084881453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,47267,128,0.58 [0.37-0.92],0.0207885008273081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLNK,B-cell linker protein,39446,103,1.00 [0.62-1.63],0.9908454967253608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39312,102,0.92 [0.70-1.20],0.5339298400558079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40529,106,1.35 [0.89-2.05],0.159509174371298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,46698,127,0.74 [0.57-0.95],0.0176530182234453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,39729,105,3.58 [1.82-7.02],0.0002111261264797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,46258,124,1.39 [1.02-1.88],0.0368280345200812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,45762,124,1.59 [1.09-2.32],0.0166040695204826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,39729,105,7.45 [5.21-10.64],3.306547417174873e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40628,107,1.34 [0.81-2.20],0.2533178879679664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39446,103,2.21 [1.60-3.06],1.6638565431787505e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,45838,124,6.97 [3.92-12.41],3.929371893761431e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,39312,102,1.32 [0.98-1.79],0.0647541405517446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,39538,103,0.66 [0.47-0.95],0.0238866013128364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,38117,100,0.83 [0.69-0.99],0.0406245152024167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,46588,125,0.79 [0.62-1.00],0.049791824453097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB2,BPI fold-containing family B member 2,40549,107,1.11 [0.86-1.43],0.4240748238020171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRAP,BRCA1-associated protein,40084,105,1.11 [0.93-1.32],0.2566288673143939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD1,Bromodomain-containing protein 1,39882,107,1.20 [0.68-2.12],0.5368588630134533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD2,Bromodomain-containing protein 2,39312,102,0.80 [0.43-1.48],0.4779921676728147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD3,Bromodomain-containing protein 3,39283,102,1.00 [0.67-1.50],0.995255925372032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRDT,Bromodomain testis-specific protein,39283,102,1.14 [0.69-1.91],0.6025745399952127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,45638,124,1.01 [0.71-1.42],0.9688064044261272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRME1,Break repair meiotic recombinase recruitment factor 1,39312,102,1.01 [0.65-1.57],0.9725848479147088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,40550,105,1.58 [1.06-2.35],0.0256706216742606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,47133,127,8.14 [4.57-14.49],1.0466684555763076e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSND,Barttin,39172,104,1.05 [0.61-1.83],0.8505733898283259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,47117,128,2.87 [1.69-4.88],9.952624595861854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,47117,128,1.62 [1.30-2.02],1.7609437278323296e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTC,Probetacellulin,45615,120,1.06 [0.85-1.31],0.6265954722248723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,40679,105,3.37 [1.31-8.64],0.011451291308183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTLA,B- and T-lymphocyte attenuator,39172,104,1.12 [0.92-1.35],0.2512985419510669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN1A1,Butyrophilin subfamily 1 member A1,40355,105,1.02 [0.64-1.62],0.9337152072970396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,46900,124,6.98 [4.99-9.77],9.53963268525568e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,46626,123,2.22 [1.79-2.76],4.3348191960439723e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTNL10,Butyrophilin-like protein 10,39172,104,1.11 [0.71-1.74],0.6415651076232578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C19orf12,Protein C19orf12,45638,124,1.18 [0.96-1.44],0.1205226954360498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,39283,102,1.57 [1.00-2.46],0.0496153640560218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,46978,126,4.99 [2.84-8.76],2.1052480192053653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40550,105,0.85 [0.61-1.19],0.3500795844354999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,39446,103,0.60 [0.38-0.94],0.024760799105626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,46888,125,3.03 [2.38-3.86],2.344394266990342e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39729,105,1.89 [1.13-3.16],0.0149216514688943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40550,105,1.58 [1.01-2.47],0.0460003301090444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39656,105,1.07 [0.72-1.58],0.7474380175550863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1R,Complement C1r subcomponent,40679,105,0.74 [0.24-2.25],0.5899232661282447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,40609,105,5.97 [2.26-15.79],0.0003201595064959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1S,Complement C1s subcomponent,40679,105,0.97 [0.40-2.39],0.951204223655366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,46810,125,7.18 [3.40-15.19],2.471911242932267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,45562,123,1.54 [1.18-2.02],0.0016853929480075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2orf69,UPF0565 protein C2orf69,39492,104,1.17 [0.90-1.53],0.2498936358261677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C3,Complement C3,38601,102,1.09 [0.71-1.68],0.6887710256870432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C4BPB,C4b-binding protein beta chain,46850,129,0.81 [0.54-1.20],0.2894769140385488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,40679,105,3.21 [1.07-9.62],0.0372572942458118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,39701,103,12.09 [8.34-17.52],1.4363331256049084e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7orf50,Uncharacterized protein C7orf50,40529,106,0.85 [0.35-2.09],0.7289385185596297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C8B,Complement component C8 beta chain,40679,105,1.43 [0.77-2.65],0.2523571916376497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9,Complement component C9,40646,105,0.81 [0.59-1.11],0.1895538885351252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,40451,106,0.75 [0.59-0.95],0.0179539905978603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,45645,122,0.58 [0.43-0.76],0.0001112366747477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,45615,120,1.73 [1.26-2.39],0.0007557519939362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,46483,124,4.64 [3.70-5.81],9.061252771950735e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA13,Carbonic anhydrase 13,46178,122,1.03 [0.89-1.20],0.6850085744421366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA14,Carbonic anhydrase 14,47097,128,1.11 [0.73-1.69],0.63107210507974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,46543,127,0.69 [0.54-0.88],0.0027549684105143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,47189,127,1.35 [1.06-1.73],0.0152280312539647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,47267,128,1.48 [0.77-2.83],0.2378728292048016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",45838,124,1.44 [1.24-1.67],2.0368502328889054e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,46560,127,0.52 [0.40-0.66],2.0160085039777585e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA7,Carbonic anhydrase 7,39882,107,1.26 [0.85-1.88],0.2557979249588415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA8,Carbonic anhydrase-related protein,39446,103,1.56 [0.93-2.62],0.0908182890500646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,47097,128,2.43 [1.87-3.16],2.983952952113179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CABP2,Calcium-binding protein 2,39492,104,1.22 [0.93-1.61],0.152460542227315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39312,102,0.68 [0.35-1.30],0.2407405713193703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39283,102,0.83 [0.56-1.23],0.3558670014366855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39312,102,0.78 [0.55-1.13],0.189517913438912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40550,105,1.27 [1.03-1.58],0.0276033147230301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACYBP,Calcyclin-binding protein,39655,104,1.15 [0.96-1.39],0.129227461159912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CADPS,Calcium-dependent secretion activator 1,39492,104,0.89 [0.54-1.46],0.6385531705186753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,46483,124,1.57 [1.12-2.19],0.0082833842048715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,45638,124,1.01 [0.58-1.76],0.9706803531940916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,46261,123,1.77 [1.49-2.10],9.762671870659759e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,40529,106,1.75 [1.27-2.41],0.0005841005562129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,46954,128,1.12 [0.96-1.31],0.1360048327203764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39538,103,1.27 [1.00-1.63],0.0518198406195719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALY,Neuron-specific vesicular protein calcyon,39283,102,0.74 [0.42-1.28],0.2808425891673289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,45615,120,1.47 [1.06-2.04],0.0217901603219244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39492,104,1.24 [0.91-1.70],0.1718474668620558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40550,105,1.15 [0.97-1.37],0.1027622002414597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,46556,125,8.68 [4.26-17.68],2.5868052552038795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,46355,127,1.40 [1.09-1.80],0.0092406669791227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPN3,Calpain-3,40433,105,1.17 [0.74-1.85],0.5059595530541621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPS,Calcyphosin,40529,106,1.09 [0.92-1.28],0.3054614551442627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,45638,124,0.50 [0.36-0.71],7.543347595686249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,39492,104,1.43 [0.96-2.12],0.0751174936958716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP1,Caspase-1,45638,124,1.01 [0.80-1.26],0.9422317194646193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP10,Caspase-10,45638,124,1.03 [0.82-1.29],0.8288107456080456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP2,Caspase-2,46626,123,1.21 [0.97-1.51],0.0959477326949827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP3,Caspase-3,47267,128,1.07 [0.89-1.27],0.4859266016628731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP4,Caspase-4,39882,107,1.01 [0.90-1.12],0.9076578665614972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP7,Caspase-7,40529,106,1.13 [0.91-1.41],0.252809023106526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,46960,128,0.72 [0.55-0.94],0.0175603290573956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP9,Caspase-9,39446,103,0.89 [0.65-1.22],0.4666400631757382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASQ2,Calsequestrin-2,39283,102,1.21 [0.87-1.69],0.2612849536910095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,40042,102,0.59 [0.41-0.87],0.0075006121742105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,46621,125,1.62 [1.33-1.97],2.015502144523894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN1,Cerebellin-1,39312,102,0.93 [0.75-1.17],0.5493158635448355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,47097,128,0.80 [0.51-1.25],0.3241393128726823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBS,Cystathionine beta-synthase,39538,103,1.30 [0.92-1.82],0.1322763441617825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBX2,Chromobox protein homolog 2,39283,102,1.22 [0.85-1.76],0.2780504513050025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,46337,124,1.09 [0.88-1.35],0.445309499011487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCAR2,Cell cycle and apoptosis regulator protein 2,40529,106,0.92 [0.62-1.36],0.6708108065601673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC134,Coiled-coil domain-containing protein 134,40433,105,1.29 [0.94-1.79],0.1194266996821691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC28A,Coiled-coil domain-containing protein 28A,39492,104,1.22 [0.64-2.30],0.5452788731117852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC50,Coiled-coil domain-containing protein 50,40550,105,1.16 [0.94-1.43],0.1691289934651007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,46694,125,2.69 [1.91-3.78],1.3878888380520637e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39538,103,1.22 [0.91-1.62],0.1782242325355943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,47210,127,3.55 [2.34-5.39],2.654459345306535e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL13,C-C motif chemokine 13,47136,127,1.08 [0.86-1.35],0.533433316598283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,46575,125,1.92 [1.48-2.50],1.0155165294595556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,47267,128,4.12 [3.12-5.45],1.652791559330117e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,47267,128,2.61 [1.92-3.54],9.62648476363658e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL17,C-C motif chemokine 17,46590,123,1.13 [0.95-1.34],0.1765294628078942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,46047,124,1.21 [1.01-1.45],0.0415094919123569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,47117,128,1.15 [1.03-1.27],0.0101025983093466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL2,C-C motif chemokine 2,46258,124,1.00 [0.75-1.35],0.9770159176745756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,47210,127,1.55 [1.37-1.75],1.1794106584207417e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,46900,124,2.18 [1.80-2.64],3.129418638705856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,46214,123,1.58 [1.20-2.08],0.001203520596008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,46900,124,1.80 [1.24-2.61],0.0019263132039259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL24,C-C motif chemokine 24,46823,124,1.16 [0.96-1.39],0.1237922048414867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,47210,127,2.70 [1.99-3.65],1.2791530778826535e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL26,C-C motif chemokine 26,46626,123,0.92 [0.76-1.11],0.3730361687340606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL27,C-C motif chemokine 27,46694,125,1.02 [0.79-1.32],0.8846564991037644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,46477,123,1.46 [1.15-1.86],0.0020453868235659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,46626,123,1.42 [1.23-1.65],2.0845083521939383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL4,C-C motif chemokine 4,46745,124,1.17 [0.95-1.43],0.1344770021094272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL5,C-C motif chemokine 5,46888,125,1.11 [0.95-1.29],0.1931717692192314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,46626,123,1.70 [1.44-2.01],3.060039388109754e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL8,C-C motif chemokine 8,47028,128,1.26 [0.97-1.62],0.0807930028351976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,46405,124,1.42 [1.13-1.79],0.0028269238624734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN2,CCN family member 2,46669,124,1.10 [0.83-1.46],0.5212613436755649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,47196,128,3.50 [2.59-4.74],4.051331507319435e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,47097,128,3.35 [2.49-4.51],1.5555119686925797e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,46698,127,3.31 [2.31-4.74],6.392550784150883e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCND2,G1/S-specific cyclin-D2,39882,107,1.01 [0.61-1.66],0.9719133083003456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCNE1,G1/S-specific cyclin-E1,39446,103,1.07 [0.88-1.30],0.5051977567529331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,46337,124,0.41 [0.29-0.59],1.937491976501768e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCT5,T-complex protein 1 subunit epsilon,45615,120,0.91 [0.63-1.32],0.6295088639128926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,40451,106,1.70 [1.11-2.63],0.0156613391545699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,46698,127,4.12 [2.60-6.52],1.632045376571848e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,45736,125,3.25 [2.39-4.43],7.498895840945535e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,47210,127,3.12 [2.43-4.01],3.993878084574971e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,46888,125,2.75 [2.01-3.76],1.9305853559824084e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,46698,127,1.76 [1.46-2.13],4.85291198352942e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164L2,CD164 sialomucin-like 2 protein,39492,104,0.97 [0.57-1.64],0.9013498062661852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD177,CD177 antigen,46624,127,1.13 [0.99-1.28],0.0704809834386475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,46850,129,0.49 [0.34-0.71],0.0001574420830718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,39283,102,1.61 [1.22-2.12],0.0006885835905518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,46626,123,2.31 [1.43-3.72],0.0006156218121409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,46474,122,1.61 [1.03-2.50],0.0353175945549783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,45679,121,3.52 [2.40-5.16],1.338431560706963e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD209,CD209 antigen,46811,126,1.11 [0.74-1.67],0.608447622908983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,47210,127,1.82 [1.35-2.46],9.9898398548864e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,39446,103,1.77 [1.17-2.68],0.0070459280681059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,47210,127,4.57 [2.85-7.33],2.722119391504789e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,40614,105,0.55 [0.34-0.88],0.0117811953878387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,46850,129,4.32 [3.55-5.26],2.4272903399433352e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,46337,124,3.79 [2.89-4.96],3.7140224623955613e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,46670,123,11.16 [7.85-15.86],3.317356283533556e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,45615,120,2.80 [2.29-3.41],5.121848574648335e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2AP,CD2-associated protein,46694,125,1.06 [0.84-1.34],0.6249074769147412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,39729,105,6.46 [4.01-10.43],2.009274390458337e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,47117,128,4.21 [3.05-5.81],2.184481533643953e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,46946,127,4.13 [3.12-5.47],3.6589309164074896e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,47097,128,2.01 [1.50-2.70],3.657173139719557e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,46698,127,1.54 [1.01-2.34],0.0445709812418926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,46483,124,5.77 [4.50-7.39],1.5835880408540182e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD33,Myeloid cell surface antigen CD33,46850,129,1.21 [0.99-1.48],0.065215163830898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,46967,127,0.35 [0.18-0.67],0.001412074377756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,39446,103,1.96 [1.35-2.83],0.0003597354732446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,46483,124,5.06 [3.39-7.55],2.284157089346856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3D,T-cell surface glycoprotein CD3 delta chain,39312,102,0.94 [0.52-1.70],0.8466705758973628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39882,107,0.88 [0.50-1.55],0.6560332543685243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,39446,103,1.05 [0.86-1.29],0.6297148045427883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,46551,123,1.42 [0.87-2.31],0.1613786813003671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,46668,124,2.25 [1.73-2.93],1.252182353203624e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40LG,CD40 ligand,47210,127,1.03 [0.85-1.25],0.758650897883521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,46428,125,4.20 [2.97-5.95],5.51392774432506e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,46823,124,6.28 [4.38-8.99],1.155326184639097e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,47028,128,2.35 [1.97-2.81],1.872850211106139e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,45075,119,3.71 [2.70-5.10],7.485935424649421e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD58,Lymphocyte function-associated antigen 3,46594,123,0.71 [0.29-1.74],0.4510183820694632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,45016,122,6.12 [4.43-8.47],7.941478825815839e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,40456,105,1.50 [1.02-2.21],0.0381799726430733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD6,T-cell differentiation antigen CD6,47133,127,1.10 [0.82-1.48],0.5380009942467792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,46258,124,1.76 [1.28-2.44],0.000602665764278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD69,Early activation antigen CD69,46466,125,1.14 [0.96-1.37],0.1405589593640132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,39374,102,2.67 [2.02-3.52],3.814204293516689e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,46626,123,2.42 [1.82-3.21],9.80449182302916e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,39729,105,2.48 [1.84-3.35],2.343434819520022e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,47117,128,7.04 [5.08-9.74],6.122640835514551e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,47210,127,3.04 [2.50-3.70],4.2771936427676965e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,40628,107,4.56 [3.36-6.19],1.7223952865181611e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,39882,107,1.43 [1.02-2.00],0.0402689509042289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,46626,123,4.41 [3.34-5.83],2.2213955326867937e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD84,SLAM family member 5,46626,123,1.33 [0.80-2.19],0.2694661175652941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD86,T-lymphocyte activation antigen CD86,40451,106,1.11 [0.59-2.09],0.736693641841366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,47117,128,1.99 [1.55-2.55],5.1271742542341486e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,44916,119,2.86 [1.78-4.59],1.479826723004158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,46698,127,6.68 [3.81-11.73],3.5539569656007544e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,46698,127,3.44 [1.89-6.28],5.622879028666308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDA,Cytidine deaminase,40549,107,0.87 [0.58-1.32],0.5157139384032694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDAN1,Codanin-1,40529,106,0.93 [0.43-2.01],0.8586297205324946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC123,Cell division cycle protein 123 homolog,39172,104,1.10 [0.84-1.44],0.4948793365054812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC25A,M-phase inducer phosphatase 1,39172,104,0.86 [0.51-1.46],0.5765220082913878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,40376,106,1.25 [0.97-1.62],0.0905661804503019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,45615,120,1.31 [1.03-1.67],0.0250561640352253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC37,Hsp90 co-chaperone Cdc37,46850,129,1.02 [0.85-1.22],0.8265320085141392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40451,106,1.22 [1.03-1.45],0.0212186754502817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,46337,124,2.69 [2.17-3.32],6.209739883992403e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,45157,120,2.62 [2.18-3.13],1.826558122987095e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,47041,127,1.66 [1.39-1.98],1.536599841153002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,46694,125,2.12 [1.75-2.57],3.364658970372695e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,46694,125,5.60 [3.66-8.58],2.299060907437496e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH22,Cadherin-22,39882,107,1.08 [0.57-2.06],0.813243585337224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH23,Cadherin-23,40529,106,0.98 [0.47-2.04],0.9606847470183464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,47117,128,2.79 [1.95-3.98],1.7040231680119315e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH4,Cadherin-4,39312,102,0.99 [0.66-1.47],0.9472782068641544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,47267,128,1.75 [1.06-2.88],0.0274231449490416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,46694,125,3.01 [2.22-4.07],1.375600497186241e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR1,Cadherin-related family member 1,45638,124,0.74 [0.50-1.10],0.1335712895809478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,46483,124,1.36 [1.05-1.75],0.0180626368817127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR5,Cadherin-related family member 5,46694,125,0.85 [0.57-1.27],0.4276480840417623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK1,Cyclin-dependent kinase 1,39172,104,1.31 [0.79-2.18],0.2995192660757518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40550,105,1.11 [0.84-1.47],0.4461510088515709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKL5,Cyclin-dependent kinase-like 5,39312,102,0.86 [0.58-1.28],0.4571486639729416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,46483,124,1.27 [1.10-1.48],0.0013103227643717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,46483,124,1.00 [0.84-1.18],0.9976645118622822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,46483,124,1.90 [1.40-2.59],4.23896943067798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,46745,123,1.95 [1.06-3.57],0.0318561376649555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,47070,127,1.86 [1.32-2.62],0.0003566107758521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,46780,129,2.97 [1.52-5.81],0.0015039958563112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40451,106,0.81 [0.64-1.02],0.0729357867545627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39882,107,1.21 [0.97-1.50],0.0857065977656169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40451,106,2.23 [1.56-3.20],1.325624956233588e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39882,107,1.16 [0.82-1.64],0.3874779232931873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,46626,123,1.30 [1.09-1.54],0.0031850889440075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,45615,120,0.90 [0.63-1.28],0.5426798326279387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,45017,118,1.73 [1.39-2.16],1.2375488824504029e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40614,105,1.89 [1.50-2.38],4.852684171319902e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,45838,124,1.83 [1.40-2.40],1.296336222668096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPA,CCAAT/enhancer-binding protein alpha,39446,103,1.39 [0.90-2.14],0.1381833019441535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPB,CCAAT/enhancer-binding protein beta,45838,124,1.14 [0.77-1.69],0.5096469126402834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,40614,105,0.82 [0.61-1.09],0.1708800343869551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,47188,128,0.82 [0.63-1.07],0.1372753106241209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39729,105,2.01 [1.09-3.69],0.0247972073555977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,39446,103,1.72 [1.27-2.32],0.0004040878642744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,39312,102,1.08 [0.82-1.44],0.5711809864437435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPF,Centromere protein F,39882,107,0.92 [0.66-1.28],0.6022210336237575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,39882,107,1.26 [1.01-1.56],0.0366307076074448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP112,Centrosomal protein of 112 kDa,39283,102,1.27 [0.89-1.79],0.1835490501746678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP152,Centrosomal protein of 152 kDa,39172,104,1.27 [0.87-1.85],0.2203524403274714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP164,Centrosomal protein of 164 kDa,45833,124,1.03 [0.82-1.30],0.7769563704682053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP170,Centrosomal protein of 170 kDa,39538,103,1.23 [0.99-1.53],0.0648173417667244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP20,Centrosomal protein 20,45615,120,1.20 [0.98-1.48],0.082511069314242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP290,Centrosomal protein of 290 kDa,39882,107,1.07 [0.76-1.51],0.7082510673852833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP350,Centrosome-associated protein 350,39172,104,0.99 [0.60-1.62],0.9666628072692502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,45471,122,1.12 [0.89-1.41],0.3386811356654031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP85,Centrosomal protein of 85 kDa,45615,120,1.21 [0.95-1.54],0.1272859711174028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CERT,Ceramide transfer protein,45638,124,1.01 [0.78-1.31],0.9304162282513936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,46806,124,1.27 [1.08-1.50],0.0038904419814154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,46483,124,1.69 [1.33-2.15],2.0846287607584467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES3,Carboxylesterase 3,46483,124,0.91 [0.72-1.15],0.4175475907595587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN2,Centrin-2,45638,124,1.11 [0.89-1.38],0.3676315516273887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN3,Centrin-3,40451,106,1.15 [0.92-1.45],0.2214152381302699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,39942,105,2.86 [1.57-5.20],0.0005853287203816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,45615,120,2.21 [1.75-2.78],2.0298527823631093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,40679,105,4.08 [2.57-6.48],2.610993786729857e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,38313,101,3.13 [1.35-7.28],0.0079238341430323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,40383,103,1.45 [0.99-2.12],0.0535901273628433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,40600,105,0.72 [0.57-0.92],0.0078016504640264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR5,Complement factor H-related protein 5,40123,105,0.80 [0.52-1.24],0.3232627705880921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,40679,105,5.39 [2.09-13.92],0.0005056646334277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFP,Properdin,40679,105,0.45 [0.18-1.11],0.0833017196581783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,46698,127,1.88 [1.53-2.30],1.212229219712304e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40646,105,0.99 [0.61-1.62],0.9812327707596076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGN,Cingulin,39492,104,0.87 [0.54-1.42],0.588123281493572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,46694,125,3.94 [2.83-5.49],4.519577291194125e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,45615,120,0.92 [0.69-1.21],0.5308673283905665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,39729,105,0.51 [0.42-0.64],8.194090045233885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40529,106,3.08 [2.58-3.67],6.219769466294398e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,40433,105,2.87 [2.15-3.82],5.289789895329107e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHEK2,Serine/threonine-protein kinase Chk2,45838,124,0.72 [0.43-1.20],0.2076546723284864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,40614,105,1.79 [1.57-2.04],1.3914203628289257e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,46967,127,2.56 [1.85-3.53],1.189161067397408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,45685,121,1.98 [1.71-2.29],1.3702705529416942e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHIT1,Chitotriosidase-1,46882,125,1.03 [0.92-1.14],0.6077216773904959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHL1,Neural cell adhesion molecule L1-like protein,46817,124,1.14 [0.67-1.93],0.6283857330932401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHM,Rab proteins geranylgeranyltransferase component A 1,39492,104,1.07 [0.79-1.44],0.6793043127503651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP1A,Charged multivesicular body protein 1a,46337,124,0.98 [0.80-1.20],0.8577475184147513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP6,Charged multivesicular body protein 6,40628,107,1.19 [0.87-1.63],0.2750820174005756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHP1,Calcineurin B homologous protein 1,39312,102,1.00 [0.76-1.31],0.997493917040829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,46823,124,5.15 [3.34-7.93],1.0229280300192205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL2,Chordin-like protein 2,46694,125,1.17 [0.85-1.60],0.3333913031687121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRM1,Muscarinic acetylcholine receptor M1,39492,104,1.05 [0.63-1.74],0.8516514334045513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIAPIN1,Anamorsin,46850,129,1.09 [0.85-1.40],0.4750248264716536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,40614,105,3.52 [2.80-4.43],3.243642627621925e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CINP,Cyclin-dependent kinase 2-interacting protein,39882,107,0.94 [0.62-1.44],0.7871676300624475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIRBP,Cold-inducible RNA-binding protein,40451,106,1.09 [0.90-1.33],0.3680805481187439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIT,Citron Rho-interacting kinase,39492,104,1.16 [0.78-1.71],0.4602609723066565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,46978,127,4.89 [3.90-6.14],8.404840143141878e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,40614,105,1.58 [1.16-2.15],0.0039807890165648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",46517,124,1.60 [1.25-2.05],0.0001920573329285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLASP1,CLIP-associating protein 1,39172,104,1.08 [0.84-1.40],0.5406375294860838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLC,Galectin-10,46624,125,1.04 [0.82-1.31],0.762873864209361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,46337,124,2.70 [1.74-4.20],1.0528132785279786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC11A,C-type lectin domain family 11 member A,46622,126,1.01 [0.73-1.41],0.9354321515308592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,39446,103,3.03 [1.75-5.24],7.793585381613919e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,46698,127,4.09 [2.75-6.09],3.718933465516456e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,45838,124,3.46 [2.35-5.10],3.4399166772525576e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1B,C-type lectin domain family 1 member B,47117,128,1.16 [0.99-1.36],0.0669328109470624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC2L,C-type lectin domain family 2 member L,39492,104,1.13 [0.79-1.60],0.5069683439041903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,39735,105,0.33 [0.20-0.55],2.013302723012984e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,46626,123,0.36 [0.25-0.53],1.4494055818158521e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,46626,123,0.68 [0.49-0.94],0.0207295735213864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,46626,123,2.01 [1.60-2.52],1.2758842113839975e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,46626,123,1.32 [0.82-2.14],0.2578005443567056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4M,C-type lectin domain family 4 member M,40542,105,0.75 [0.51-1.11],0.1537067744927076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,46538,125,3.82 [2.48-5.87],1.0741673069442747e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,45615,120,2.67 [2.02-3.52],5.514065306843622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,47210,127,2.24 [1.61-3.13],2.034649322837968e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,39492,104,1.92 [1.51-2.45],1.346839793283906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIC5,Chloride intracellular channel protein 5,39492,104,1.13 [0.66-1.93],0.6462456814438631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLINT1,Clathrin interactor 1,39172,104,0.88 [0.57-1.36],0.574744868795629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIP2,CAP-Gly domain-containing linker protein 2,46626,123,1.13 [0.98-1.30],0.0921611264327654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,47097,128,8.19 [5.10-13.16],3.260865112389615e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLNS1A,Methylosome subunit pICln,39492,104,0.60 [0.33-1.08],0.0899513299156427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",46261,123,1.16 [0.99-1.37],0.0663265221777091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPS,Colipase,46621,127,0.86 [0.69-1.07],0.1717801614244103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSPN,Claspin,45562,123,0.92 [0.55-1.52],0.7416334602547465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN1,Calsyntenin-1,45638,124,1.05 [0.77-1.45],0.744018432718309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,47210,127,2.99 [2.34-3.81],8.637475722460147e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,40529,106,2.83 [1.78-4.50],1.039135501336566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLTA,Clathrin light chain A,45838,124,0.94 [0.66-1.34],0.7331790572852213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLU,Clusterin,40679,105,1.15 [0.66-2.01],0.624352790249127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,46620,125,0.42 [0.30-0.60],2.172467625411096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMC1,COX assembly mitochondrial protein homolog,40628,107,1.12 [0.93-1.36],0.2381403326872813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMIP,C-Maf-inducing protein,40433,105,1.15 [0.93-1.42],0.1978351276410248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,46888,125,0.98 [0.71-1.37],0.9242993340430516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39312,102,0.95 [0.64-1.41],0.8115037793332068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39467,103,1.05 [0.83-1.33],0.7091559764643164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY2,Protein canopy homolog 2,45838,124,1.01 [0.78-1.31],0.9447906671404148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY4,Protein canopy homolog 4,46483,124,1.17 [0.95-1.45],0.1474507894772979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,46694,125,1.15 [1.00-1.33],0.0465036522580743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTF,Ciliary neurotrophic factor,39312,102,0.74 [0.42-1.30],0.2951355918610523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN1,Contactin-1,47267,128,1.22 [0.68-2.18],0.5027688696528009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,47097,128,2.14 [1.53-2.99],8.700106391913264e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,46698,127,2.56 [1.47-4.45],0.0008455985172917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,46698,127,3.90 [2.09-7.29],1.949069348308644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,46822,126,0.37 [0.24-0.57],8.184822142269484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,46626,123,2.30 [1.71-3.08],2.8749796806807343e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP4,Contactin-associated protein-like 4,39492,104,1.03 [0.86-1.23],0.7560090984696431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,40628,107,1.49 [1.02-2.17],0.038974546211693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,40614,105,1.07 [0.54-2.08],0.8538782376388997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,46891,127,17.94 [10.52-30.58],2.770814705698849e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,47267,128,0.44 [0.22-0.89],0.0212659421263361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL24A1,Collagen alpha-1(XXIV) chain,40451,106,1.15 [0.82-1.62],0.407190150165024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL28A1,Collagen alpha-1(XXVIII) chain,39492,104,1.01 [0.80-1.28],0.9238020502332532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL2A1,Collagen alpha-1(II) chain,39538,103,1.01 [0.80-1.27],0.9445912900053384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,40614,105,3.96 [2.12-7.39],1.6280088979229814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,46694,125,4.37 [3.15-6.06],9.229225122317784e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A4,Collagen alpha-4(IV) chain,39819,107,0.94 [0.66-1.33],0.7171203850390753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,39729,105,2.90 [2.11-3.97],4.437037522493543e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,47267,128,5.12 [3.94-6.66],2.396938739713512e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A1,Collagen alpha-1(IX) chain,46626,123,0.95 [0.68-1.34],0.7834629497324209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A2,Collagen alpha-2(IX) chain,39882,107,1.01 [0.69-1.47],0.9585633365797852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,46670,123,9.66 [6.63-14.08],4.2205674742699365e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD1,COMM domain-containing protein 1,39538,103,1.08 [0.79-1.48],0.6219803858158783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD9,COMM domain-containing protein 9,40433,105,1.01 [0.64-1.61],0.9585294900684328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMP,Cartilage oligomeric matrix protein,46202,121,0.84 [0.52-1.35],0.4681051408551387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMT,Catechol O-methyltransferase,45335,121,1.00 [0.82-1.22],0.9904749582930362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPB2,Coatomer subunit beta',39283,102,1.27 [0.85-1.90],0.2439080918475641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPE,Coatomer subunit epsilon,45638,124,0.81 [0.55-1.19],0.2832001876955433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39538,103,1.10 [0.70-1.72],0.6800601852490102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO1A,Coronin-1A,45747,123,1.08 [0.92-1.28],0.3478325502945976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,39312,102,1.69 [1.20-2.37],0.0023937903814628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",46483,124,1.29 [1.05-1.58],0.0149769520680398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,40628,107,2.25 [1.43-3.56],0.0004765333137337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,47267,128,0.89 [0.69-1.14],0.3478740460108905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,46961,127,2.06 [1.68-2.54],9.147716231610136e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA4,Carboxypeptidase A4,38951,102,0.70 [0.45-1.09],0.1163477613577026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,47267,128,0.94 [0.73-1.22],0.6565146453531655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB2,Carboxypeptidase B2,40604,105,1.16 [0.52-2.63],0.715300924969205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,46739,126,0.60 [0.42-0.84],0.0034727172894353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPLX2,Complexin-2,39172,104,1.04 [0.58-1.87],0.8968319395035241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,46893,127,5.75 [4.03-8.21],6.663665865452723e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39446,103,1.19 [0.60-2.35],0.6275823022416038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,47117,128,0.77 [0.60-0.98],0.0368272052968709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,40536,105,1.56 [0.93-2.62],0.0933866805929329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPTP,Ceramide-1-phosphate transfer protein,39283,102,0.81 [0.49-1.35],0.426880122377243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,47019,128,2.01 [1.36-2.98],0.0004971048517753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM1,Probable carboxypeptidase X1,46850,129,1.16 [0.94-1.44],0.1739310420198698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,40628,107,4.57 [3.29-6.35],1.2637177829126113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,40490,105,2.90 [2.14-3.94],8.344435673583283e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,46888,125,2.42 [1.78-3.29],1.7961560932702082e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,45615,120,1.20 [1.01-1.44],0.0438558487405838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRADD,Death domain-containing protein CRADD,46261,123,0.96 [0.78-1.19],0.7025621463661834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREB3,Cyclic AMP-responsive element-binding protein 3,39172,104,0.94 [0.67-1.33],0.7457606693853307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREBZF,CREB/ATF bZIP transcription factor,39172,104,1.24 [0.62-2.46],0.543170822099023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,46096,129,0.75 [0.50-1.12],0.1593460085070218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,39729,105,5.59 [3.53-8.87],2.539926365692515e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,46823,124,2.16 [1.65-2.82],1.8392208357661522e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,45538,119,0.63 [0.51-0.76],4.519157442468347e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,46670,123,8.44 [4.90-14.55],1.5725106753999186e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHR1,Corticotropin-releasing factor receptor 1,45838,124,0.89 [0.67-1.18],0.4143330739802187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,46900,124,11.22 [5.98-21.05],5.0201726812663125e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,46337,124,2.17 [1.78-2.64],1.4289367605734137e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,47097,128,0.69 [0.54-0.88],0.0032936470180276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP3,Cysteine-rich secretory protein 3,40267,102,0.53 [0.27-1.04],0.0644184877390226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRKL,Crk-like protein,46747,124,1.07 [0.92-1.25],0.3858795414138805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,46900,124,3.67 [2.00-6.73],2.7106867814382662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRNN,Cornulin,45364,124,0.82 [0.65-1.04],0.1027467830313587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,47267,128,0.50 [0.31-0.80],0.0045251701791744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,46337,124,2.06 [1.52-2.80],3.779807867535272e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAP,Cartilage-associated protein,39492,104,1.05 [0.73-1.53],0.7777621593556965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRX,Cone-rod homeobox protein,45838,124,0.92 [0.78-1.09],0.3530998241112498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,40628,107,1.42 [1.09-1.85],0.0104008383460563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB2,Beta-crystallin B2,40529,106,1.07 [0.87-1.31],0.5234585715807893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYGD,Gamma-crystallin D,40529,106,0.91 [0.75-1.10],0.3216608332262607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYM,Ketimine reductase mu-crystallin,39312,102,1.00 [0.77-1.29],0.9877814967890652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYZL1,Quinone oxidoreductase-like protein 1,39538,103,0.97 [0.79-1.20],0.7824690192977786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSDE1,Cold shock domain-containing protein E1,39283,102,1.14 [0.99-1.33],0.073433552355073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,46900,124,11.01 [6.95-17.43],1.6151784013520003e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,40646,105,2.87 [2.05-4.02],8.720304377559162e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2,Granulocyte-macrophage colony-stimulating factor,39283,102,1.49 [0.99-2.24],0.057409779343414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,46337,124,1.58 [1.28-1.96],2.7932077600891268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RB,Cytokine receptor common subunit beta,39446,103,0.86 [0.56-1.34],0.5145671127274989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3,Granulocyte colony-stimulating factor,45833,124,0.99 [0.70-1.39],0.9550392483673048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,39446,103,1.80 [1.10-2.95],0.0190891542621223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSH1,Chorionic somatomammotropin hormone 1,40646,105,0.63 [0.33-1.21],0.1682096755903112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK1D,Casein kinase I isoform delta,39446,103,1.16 [0.88-1.52],0.2854443765992194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK2A1,Casein kinase II subunit alpha,40550,105,0.97 [0.64-1.45],0.8663087519364054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,40614,105,2.26 [1.29-3.95],0.0042952135895259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG5,Chondroitin sulfate proteoglycan 5,39312,102,0.78 [0.51-1.20],0.2611912910109268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,39283,102,1.43 [1.26-1.63],7.038293776703668e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST1,Cystatin-SN,35240,87,1.09 [0.89-1.34],0.4044197337743167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,46819,125,6.73 [4.79-9.45],3.042775054633414e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,45806,123,1.49 [1.12-1.99],0.0056567960480738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,45471,123,1.47 [1.07-2.01],0.0162379580093176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,46745,124,1.34 [1.19-1.50],1.0188598904355525e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,46044,121,2.34 [1.73-3.17],4.09037859706804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,39808,107,0.96 [0.65-1.40],0.8186658718213904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,40064,102,3.43 [1.68-6.98],0.0006823635711505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTF1,Cardiotrophin-1,45838,124,0.98 [0.81-1.17],0.7988901054253983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,40614,105,3.94 [2.49-6.23],4.250716157109641e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTLA4,Cytotoxic T-lymphocyte protein 4,40614,105,1.34 [0.73-2.45],0.3505964625819168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTNNA1,Catenin alpha-1,39312,102,0.77 [0.41-1.43],0.4052991407034044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,46698,127,0.75 [0.56-0.99],0.0410308508584267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,46668,123,0.61 [0.48-0.77],4.692814372431126e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,40529,106,0.58 [0.45-0.75],2.4501129237422025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,46745,127,1.60 [1.21-2.11],0.0009048400167096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSC,Dipeptidyl peptidase 1,46587,123,1.31 [0.92-1.84],0.130112857753639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,43631,114,2.83 [2.28-3.51],4.15748238369954e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,39729,105,2.09 [1.48-2.95],2.6513607820582364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSF,Cathepsin F,46850,129,1.26 [0.85-1.86],0.2429655146728905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,45677,124,1.32 [1.07-1.63],0.0092589393600231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,46694,125,7.87 [4.60-13.46],5.2260896453705485e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,47210,127,4.34 [3.06-6.16],1.741932459737473e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,36692,100,13.08 [6.78-25.24],1.7593233476915663e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,46945,127,0.78 [0.53-1.14],0.1992719146062077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,46737,125,6.36 [4.11-9.83],1.0067909841921902e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39492,104,1.54 [1.10-2.16],0.0120492342804405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,40218,105,1.27 [0.98-1.65],0.0687205656956186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,46337,124,2.57 [1.72-3.83],3.508334351756273e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,46626,123,2.12 [1.65-2.74],5.449781783784434e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,46593,124,1.25 [1.08-1.45],0.0026488365227836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL10,C-X-C motif chemokine 10,46900,124,1.22 [0.98-1.50],0.0724725015652128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,47117,128,1.22 [1.03-1.45],0.0219780367815877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL12,Stromal cell-derived factor 1,45833,124,1.14 [0.76-1.70],0.5327349173890771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,47117,128,1.43 [1.26-1.62],1.12647912013591e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,45833,124,1.33 [1.14-1.56],0.0003581406261063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,47187,128,5.52 [3.11-9.79],5.241807859855444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,47210,127,1.81 [1.37-2.39],2.864072856153764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL3,C-X-C motif chemokine 3,46668,124,1.01 [0.85-1.20],0.9153796075393376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL5,C-X-C motif chemokine 5,46538,124,1.06 [0.92-1.21],0.4327711304613303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,47210,127,1.36 [1.11-1.66],0.0028474645215297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,46351,127,1.42 [1.22-1.65],5.8742196440592975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,46900,124,1.72 [1.42-2.08],2.9047197352962734e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5A,Cytochrome b5,39172,104,0.95 [0.72-1.26],0.731068434699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5R2,NADH-cytochrome b5 reductase 2,39998,106,1.23 [0.89-1.68],0.2068675066626949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39283,102,0.75 [0.56-1.01],0.0561175199768093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTH3,Cytohesin-3,39172,104,1.03 [0.80-1.31],0.8282326438515641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTL1,Cytokine-like protein 1,40614,105,1.36 [0.64-2.90],0.4222113500427612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAAM1,Disheveled-associated activator of morphogenesis 1,39729,105,1.20 [0.97-1.49],0.0949335128054532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAB2,Disabled homolog 2,47097,128,1.07 [0.93-1.23],0.3407198751020179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,46900,124,2.24 [1.62-3.08],8.225219372546324e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,39446,103,1.22 [0.94-1.57],0.1283162174222883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPK2,Death-associated protein kinase 2,39446,103,1.14 [0.82-1.58],0.4282614914505315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,46626,123,0.99 [0.87-1.13],0.8826397162911174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",46261,123,0.94 [0.75-1.17],0.5553287580850357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBH,Dopamine beta-hydroxylase,40567,105,0.94 [0.80-1.09],0.4124512877880758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,46482,126,1.33 [1.08-1.62],0.0065399247157835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,39446,103,1.44 [1.02-2.04],0.0372729726180485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBNL,Drebrin-like protein,46900,124,1.11 [0.93-1.31],0.2498270453184126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",46850,129,4.91 [3.77-6.38],1.6195553156956123e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCC,Netrin receptor DCC,39492,104,0.63 [0.38-1.04],0.0703526575582188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCDC2C,Doublecortin domain-containing protein 2C,39172,104,1.05 [0.77-1.43],0.7811626399023051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCLRE1C,Protein artemis,39172,104,1.12 [0.62-2.01],0.7142294132039206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,45838,124,7.10 [4.19-12.01],2.902738371362885e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTD,Deoxycytidylate deaminase,39729,105,1.07 [0.88-1.30],0.5045566943987958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN1,Dynactin subunit 1,47097,128,1.04 [0.82-1.33],0.7300998407262133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN2,Dynactin subunit 2,46483,124,0.94 [0.79-1.12],0.4752941382902326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN6,Dynactin subunit 6,45638,124,0.89 [0.70-1.13],0.3579672088144011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTPP1,dCTP pyrophosphatase 1,46694,125,1.12 [0.67-1.86],0.6679728676465264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D1,DCN1-like protein 1,39312,102,0.76 [0.55-1.06],0.1079325700210736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,39172,104,1.22 [0.99-1.50],0.0564835063396475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCXR,L-xylulose reductase,46850,129,0.93 [0.70-1.24],0.6171683334871423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDA1,DET1- and DDB1-associated protein 1,39283,102,1.02 [0.63-1.63],0.9484405969654446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",46483,124,2.49 [1.89-3.28],6.968257776629859e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDC,Aromatic-L-amino-acid decarboxylase,46621,125,1.18 [0.85-1.63],0.3145438006258058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDHD2,Phospholipase DDHD2,40550,105,1.20 [0.91-1.59],0.2018672611637726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,39729,105,0.76 [0.59-0.97],0.0272143214743535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,47117,128,7.07 [4.37-11.42],1.4436410723199405e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDT,D-dopachrome decarboxylase,40614,105,0.91 [0.58-1.42],0.6818692797047228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX1,ATP-dependent RNA helicase DDX1,40451,106,1.17 [0.85-1.60],0.3381873397098596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX25,ATP-dependent RNA helicase DDX25,39492,104,0.93 [0.54-1.60],0.7931418826721247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX39A,ATP-dependent RNA helicase DDX39A,39446,103,1.11 [0.49-2.52],0.7962837571464014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX4,Probable ATP-dependent RNA helicase DDX4,39446,103,0.88 [0.60-1.31],0.5346490327892229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,39492,104,0.85 [0.49-1.49],0.5775730121951138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX58,Antiviral innate immune response receptor RIG-I,45615,120,0.95 [0.71-1.27],0.7195013676138386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",46626,123,1.21 [1.03-1.43],0.0202387736129564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,45757,124,1.88 [1.56-2.28],4.5846437157642285e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,39143,103,1.80 [1.46-2.23],6.370993903058932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,39312,102,0.65 [0.43-0.98],0.0416267079704163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB116,Beta-defensin 116,39312,102,0.80 [0.59-1.09],0.1566209984330445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB118,Beta-defensin 118,39312,102,0.83 [0.54-1.28],0.404221288540081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,46025,124,1.26 [1.13-1.41],2.467111424714752e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENND2B,DENN domain-containing protein 2B,39283,102,1.21 [0.88-1.65],0.246512305542127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENR,Density-regulated protein,39446,103,1.00 [0.71-1.40],0.9966470214191596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DFFA,DNA fragmentation factor subunit alpha,47210,127,1.04 [0.83-1.31],0.7384044226016855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGCR6,Protein DGCR6,39312,102,1.15 [0.76-1.75],0.5162439459647938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,39446,103,1.33 [0.96-1.84],0.089002161423443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKZ,Diacylglycerol kinase zeta,45833,124,1.02 [0.65-1.60],0.9234758708598674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHODH,Dihydroorotate dehydrogenase,39283,102,1.02 [0.68-1.55],0.9106379354935248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,40433,105,1.41 [1.04-1.90],0.0255924829222769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40529,106,1.45 [1.08-1.96],0.0148438986831454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIABLO,"Diablo homolog, mitochondrial",46538,125,1.00 [0.87-1.15],0.983410014891501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,39492,104,1.07 [0.69-1.66],0.7557621937897105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK2B,Divergent protein kinase domain 2B,39729,105,0.75 [0.37-1.51],0.4200711874851149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,47117,128,1.30 [1.00-1.68],0.04931260035814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,47267,128,3.08 [1.85-5.14],1.5500901011962692e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,46259,124,3.03 [2.48-3.69],1.1599970697212506e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,46483,124,1.24 [1.01-1.53],0.0404037822572515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLG4,Disks large homolog 4,40529,106,1.21 [0.95-1.56],0.1268371959580045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLGAP5,Disks large-associated protein 5,40550,105,1.16 [0.85-1.58],0.3401970912520329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,47267,128,1.22 [0.94-1.60],0.135536731876075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,46850,129,9.16 [6.62-12.69],1.1863497610489595e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL4,Delta-like protein 4,39538,103,0.82 [0.59-1.15],0.2476114495287564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,39538,103,1.81 [1.46-2.25],5.269600050693437e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,39538,103,0.38 [0.32-0.46],6.234596605412658e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA1,DnaJ homolog subfamily A member 1,39172,104,0.86 [0.56-1.32],0.4950423028232771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA2,DnaJ homolog subfamily A member 2,47055,127,1.08 [0.89-1.31],0.4215379330148256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA4,DnaJ homolog subfamily A member 4,40529,106,0.84 [0.64-1.09],0.1805367276367026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,46483,124,1.10 [0.91-1.32],0.3220232038251976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,40451,106,1.42 [1.09-1.85],0.0092209555260537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB2,DnaJ homolog subfamily B member 2,39729,105,0.76 [0.54-1.09],0.1337423587425506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB6,DnaJ homolog subfamily B member 6,39359,104,1.19 [0.96-1.48],0.1108801163585433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB8,DnaJ homolog subfamily B member 8,45838,124,1.01 [0.75-1.35],0.9668880358016424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC21,DnaJ homolog subfamily C member 21,40529,106,1.37 [0.88-2.15],0.1674633803439683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39538,103,1.10 [0.89-1.37],0.3748758911837961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC9,DnaJ homolog subfamily C member 9,40451,106,0.91 [0.72-1.16],0.4503752984416894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,46594,123,0.53 [0.37-0.75],0.0003492226273078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNLZ,DNL-type zinc finger protein,39312,102,0.87 [0.67-1.13],0.296221194435648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM1,Dynamin-1,40451,106,1.07 [0.91-1.25],0.4143305640506788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,40550,105,1.80 [1.45-2.25],1.504469415186715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,46337,124,1.46 [1.15-1.85],0.0017858825644827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPEP,Aspartyl aminopeptidase,40529,106,1.05 [0.75-1.47],0.7577527881605427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,46824,124,0.66 [0.48-0.89],0.0078133327373227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOC2B,Double C2-like domain-containing protein beta,39492,104,0.89 [0.51-1.55],0.6855152381731977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOCK9,Dedicator of cytokinesis protein 9,39312,102,0.89 [0.74-1.08],0.2400700176837684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK1,Docking protein 1,40529,106,1.06 [0.92-1.22],0.4149041253746327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK2,Docking protein 2,46694,125,1.09 [0.96-1.24],0.1679861456094972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP1,Dipeptidase 1,46261,123,0.82 [0.59-1.12],0.2140437016346394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP2,Dipeptidase 2,46483,124,1.58 [0.94-2.66],0.0828797673086387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,46626,123,2.15 [1.53-3.03],1.1313840610548432e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,45823,125,0.41 [0.24-0.70],0.0010174932226048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,46483,124,4.17 [2.74-6.33],2.1999416480375448e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,46316,125,1.45 [1.13-1.84],0.0029220140709789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,47267,128,9.11 [4.60-18.03],2.302075941057673e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,46950,128,1.98 [1.66-2.37],5.3084968916000754e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,46337,124,2.38 [1.76-3.20],1.255302568253083e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRG2,Developmentally-regulated GTP-binding protein 2,46483,124,1.08 [0.82-1.43],0.5614187211797923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,46177,126,5.16 [4.03-6.61],1.9011427311598511e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,40550,105,3.69 [2.27-5.99],1.2569681915031634e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,46698,127,2.32 [1.37-3.92],0.0016318191685509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG3,Desmoglein-3,46943,128,1.30 [0.84-2.01],0.2451411004037051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,46338,123,0.46 [0.34-0.62],5.611265690941601e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTD1,D-aminoacyl-tRNA deacylase 1,39729,105,1.06 [0.86-1.31],0.5674509225376853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,40358,105,3.37 [2.64-4.29],8.657627561977511e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39492,104,0.66 [0.45-0.97],0.0359876959844946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,46483,124,2.58 [1.66-3.99],2.3353922973983464e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTYMK,Thymidylate kinase,40628,107,1.02 [0.79-1.33],0.8558764334295924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUOX2,Dual oxidase 2,45838,124,0.78 [0.59-1.03],0.0822159729444596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,40433,105,1.04 [0.68-1.58],0.8624803166761865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP29,Dual specificity phosphatase 29,39492,104,0.99 [0.75-1.31],0.93684841200984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP3,Dual specificity protein phosphatase 3,45638,124,0.87 [0.70-1.07],0.1762601356936191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40451,106,1.28 [1.08-1.51],0.0037707371310222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DXO,Decapping and exoribonuclease protein,40529,106,1.05 [0.71-1.57],0.8001631235521206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40433,105,1.06 [0.74-1.53],0.7373474553792025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,39492,104,1.34 [1.09-1.65],0.0047438816197906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT3,Dynein light chain Tctex-type 3,40433,105,1.03 [0.68-1.56],0.8922180755839305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,46337,124,1.12 [0.95-1.32],0.1783179722458598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,47029,128,4.81 [3.20-7.21],3.383264456026217e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,45638,124,0.79 [0.51-1.24],0.3064416550073195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40628,107,1.41 [1.14-1.75],0.0014823648677718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39538,103,1.40 [1.17-1.69],0.0002928024158804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECI2,Enoyl-CoA delta isomerase 2,39283,102,1.26 [0.96-1.65],0.0964720382234313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECM1,Extracellular matrix protein 1,39569,104,1.04 [0.62-1.76],0.873655365018473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECSCR,Endothelial cell-specific chemotaxis regulator,39312,102,1.18 [0.85-1.64],0.3300429657409051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,47097,128,5.38 [4.36-6.64],3.353465051538588e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,46626,123,0.99 [0.83-1.18],0.9410595984583564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDDM3B,Epididymal secretory protein E3-beta,40433,105,0.73 [0.52-1.04],0.0817172590993126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39283,102,0.80 [0.44-1.43],0.4446700699444867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDF1,Endothelial differentiation-related factor 1,40550,105,1.15 [0.90-1.48],0.2590247525819017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,45838,124,2.55 [1.77-3.68],5.40646538256138e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,39538,103,5.84 [3.66-9.30],1.1133002878520469e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDNRB,Endothelin receptor type B,39446,103,1.15 [0.76-1.72],0.5154959728332449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,40628,107,1.29 [1.06-1.57],0.0095995801660145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40451,106,2.01 [1.57-2.57],3.495096030187229e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB2,Dynein regulatory complex protein 8,39882,107,1.44 [0.89-2.35],0.1387900245992996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,46809,125,7.70 [5.25-11.30],1.6151961705734324e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,40550,105,1.84 [1.28-2.66],0.0010781166467366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,46618,126,6.47 [4.83-8.67],4.816016223349088e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,46258,124,0.63 [0.35-1.16],0.1376508497129027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,39492,104,1.33 [1.04-1.70],0.0234723820209249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGF,Pro-epidermal growth factor,46595,124,1.08 [0.93-1.26],0.3190911365853966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,45615,120,2.04 [1.53-2.71],1.1319027505273188e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,40451,106,2.11 [1.33-3.35],0.0015156374979189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,47267,128,0.45 [0.17-1.20],0.1107188355360004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,46626,123,1.25 [1.00-1.55],0.0461946538388833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,40628,107,1.28 [1.01-1.62],0.039344575070377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHD3,EH domain-containing protein 3,39538,103,1.04 [0.89-1.22],0.616192411673977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40529,106,1.00 [0.71-1.41],0.9955497324677494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40306,105,1.17 [0.99-1.38],0.0577917249806972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39283,102,1.15 [0.88-1.51],0.3044206890056753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39538,103,0.91 [0.57-1.46],0.6955578735210934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4B,Eukaryotic translation initiation factor 4B,46337,124,0.88 [0.67-1.15],0.341350778497906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4E,Eukaryotic translation initiation factor 4E,39446,103,1.03 [0.84-1.27],0.7763092789111181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,46694,125,1.10 [0.87-1.39],0.4154997529019627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,47210,127,1.19 [1.01-1.41],0.0344934970227622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40550,105,1.22 [0.94-1.58],0.1343968648897134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,39283,102,1.18 [0.78-1.78],0.4418584767852603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5A,Eukaryotic translation initiation factor 5A-1,45833,124,0.80 [0.46-1.39],0.4274885474815864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,40550,105,1.13 [0.91-1.40],0.2831879008153016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAVL4,ELAV-like protein 4,39312,102,1.15 [0.93-1.42],0.1924978938099347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,40628,107,3.52 [2.14-5.81],8.036172000956755e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOA,Elongin-A,46483,124,1.06 [0.80-1.40],0.693950695134006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,39283,102,1.45 [1.00-2.11],0.0499792926944321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,45833,124,1.91 [1.46-2.48],1.682283958211763e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,37501,103,1.58 [1.16-2.17],0.0042439155805406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,47267,128,4.56 [2.17-9.59],6.247989444037537e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO1,Alpha-enolase,46644,125,0.99 [0.81-1.21],0.9487591894982282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO2,Gamma-enolase,47117,128,0.97 [0.77-1.23],0.8242643321125823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,39538,103,0.70 [0.50-0.98],0.0376480942485129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOPH1,Enolase-phosphatase E1,40433,105,0.81 [0.52-1.24],0.329505997878977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39283,102,1.80 [1.01-3.18],0.0446257528693996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPEP,Glutamyl aminopeptidase,39283,102,1.06 [0.73-1.55],0.7454766626628229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,47267,128,3.62 [2.20-5.96],3.825850274913776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,46900,124,0.78 [0.57-1.07],0.1246296131081024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39538,103,1.06 [0.62-1.81],0.8387854088228095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,45272,120,1.37 [1.14-1.65],0.0009864295740406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENSA,Alpha-endosulfine,40433,105,0.89 [0.62-1.28],0.5284883498313273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,45615,120,1.35 [0.97-1.88],0.0715727635469781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,45838,124,0.31 [0.16-0.60],0.0006043780363328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,45838,124,2.27 [1.16-4.43],0.0164821947694199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTR1,Endosome-associated-trafficking regulator 1,39538,103,1.07 [0.79-1.45],0.6763002250777342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,39446,103,1.96 [1.43-2.69],3.124879852829229e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPB41L5,Band 4.1-like protein 5,39492,104,1.01 [0.76-1.35],0.947100156020154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPCAM,Epithelial cell adhesion molecule,46669,122,0.88 [0.74-1.05],0.1526802509722057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPGN,Epigen,40433,105,0.83 [0.52-1.31],0.4179634469422204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,46824,124,3.69 [2.24-6.10],3.231605676157862e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA10,Ephrin type-A receptor 10,45638,124,0.98 [0.76-1.25],0.8640071567706206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,45016,122,4.08 [3.41-4.87],4.04223627185639e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,39729,105,2.65 [1.40-5.00],0.0026816522114562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,47267,128,8.27 [5.66-12.08],9.55664045346816e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,46261,123,4.09 [2.77-6.05],1.639854020347238e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHX2,Bifunctional epoxide hydrolase 2,45838,124,0.99 [0.76-1.29],0.9490620567142544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPN1,Epsin-1,39882,107,0.93 [0.59-1.48],0.7568533978549365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,46626,123,1.41 [1.24-1.61],3.005082337152044e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,39538,103,1.17 [0.91-1.51],0.2200636241398085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,47018,128,3.57 [2.63-4.84],3.279609508516541e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,46850,129,1.89 [1.02-3.48],0.0423611425106476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,46514,123,3.85 [1.87-7.94],0.000260191352868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,46850,129,3.63 [1.95-6.74],4.534805020860058e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBIN,Erbin,46483,124,1.08 [0.93-1.27],0.30777794476711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERC2,ERC protein 2,39492,104,0.89 [0.67-1.18],0.4208240296978852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERCC1,DNA excision repair protein ERCC-1,39172,104,1.04 [0.58-1.88],0.8853265159442967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EREG,Proepiregulin,46261,123,1.00 [0.82-1.21],0.989192182007156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERI1,3'-5' exoribonuclease 1,39882,107,1.11 [0.66-1.87],0.6983440548837756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,39446,103,3.10 [2.13-4.50],2.915355300318571e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40433,105,1.17 [0.72-1.92],0.5213141525307229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP29,Endoplasmic reticulum resident protein 29,39729,105,1.12 [0.96-1.31],0.1390347396673515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP44,Endoplasmic reticulum resident protein 44,46405,124,1.24 [0.67-2.29],0.4844723010136758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,39283,102,1.04 [0.67-1.61],0.8690315271772783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,47267,128,4.41 [3.02-6.42],1.2404178264276988e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESM1,Endothelial cell-specific molecule 1,46670,123,0.91 [0.57-1.46],0.7062034748461681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESPL1,Separin,39172,104,1.21 [0.92-1.60],0.1792245421844844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESR1,Estrogen receptor,39446,103,1.25 [0.94-1.66],0.1197022963481479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,40529,106,1.41 [1.14-1.74],0.0015998031671432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI2B,Protein EVI2B,39172,104,1.04 [0.68-1.59],0.8450050100118571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,39446,103,1.31 [1.07-1.61],0.0097586313171827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVPL,Envoplakin,39882,107,1.19 [0.69-2.05],0.5247760990331487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXOSC10,Exosome component 10,39283,102,0.78 [0.53-1.15],0.2135039647203596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXTL1,Exostosin-like 1,39283,102,0.67 [0.41-1.10],0.1148473341791183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,47117,128,1.58 [0.88-2.84],0.1285746362404189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F10,Coagulation factor X,40646,105,0.71 [0.38-1.30],0.2665255269767609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,40083,105,1.60 [1.09-2.36],0.0167632113292204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,46698,127,1.70 [1.31-2.19],4.9523820472249535e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F12,Coagulation factor XII,40679,105,1.03 [0.65-1.63],0.8914070009660786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F13B,Coagulation factor XIII B chain,40456,105,0.76 [0.37-1.60],0.4737559580377902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2,Prothrombin,40679,105,0.40 [0.12-1.30],0.1282981676357037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,46823,124,2.01 [1.53-2.63],5.357236478239403e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,46811,128,2.44 [1.41-4.23],0.0015103927238041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F7,Coagulation factor VII,46811,125,1.39 [0.84-2.32],0.2038199758999034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,46810,125,6.74 [3.06-14.83],2.160827923465456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",46670,123,1.91 [1.68-2.19],8.28393426644526e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",46694,125,1.31 [1.10-1.57],0.0029560484786612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",40628,107,0.47 [0.28-0.80],0.004667076332186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",47267,128,3.43 [2.81-4.18],5.5696437797208245e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,46961,128,1.46 [1.17-1.81],0.0006958108608406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,45766,123,1.20 [0.94-1.54],0.1402937085534232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP9,Fatty acid-binding protein 9,46626,123,1.04 [0.79-1.36],0.772540047209495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FADD,FAS-associated death domain protein,46694,125,0.96 [0.78-1.18],0.6690818347841695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM13A,Protein FAM13A,40451,106,1.15 [0.88-1.50],0.30607110846219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171A2,Protein FAM171A2,40550,105,0.93 [0.81-1.05],0.234298447297601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171B,Protein FAM171B,40433,105,1.37 [0.77-2.44],0.2864526404403502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM172A,Cotranscriptional regulator FAM172A,39538,103,0.94 [0.69-1.28],0.6962488064170377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,40628,107,3.16 [2.13-4.68],9.882275801289668e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,46483,124,10.31 [6.42-16.54],4.039749814517349e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,46621,125,13.03 [9.31-18.24],1.1151368828277048e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,40451,106,2.80 [2.23-3.51],4.897826220948484e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAP,Prolyl endopeptidase FAP,47267,128,1.10 [0.63-1.92],0.7426623826762047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,39492,104,1.17 [0.92-1.49],0.2077318833955053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,47110,128,1.99 [1.60-2.48],9.50953347696179e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FASLG,Tumor necrosis factor ligand superfamily member 6,47210,127,0.70 [0.46-1.07],0.1031880939959243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,40614,105,4.77 [3.08-7.38],2.351024510606341e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBN2,Fibrillin-2,39492,104,1.20 [0.88-1.65],0.2452638633630682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBP1,"Fructose-1,6-bisphosphatase 1",46694,125,1.06 [0.86-1.31],0.597171129910996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40628,107,1.92 [1.52-2.43],5.1971014210549144e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,46626,123,2.30 [1.66-3.18],4.7252472944070134e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40550,105,1.90 [0.91-3.99],0.0883646064042256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,46698,127,1.58 [1.28-1.95],2.1564037187582107e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,46498,125,2.11 [1.51-2.94],1.0603914949821903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,45615,120,1.14 [0.86-1.50],0.3575036158115792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,46733,125,1.21 [0.88-1.66],0.2456693137240925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,40567,105,3.26 [2.21-4.82],2.576245219663293e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,46506,124,0.60 [0.44-0.82],0.0014501644111173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,46694,125,1.45 [1.06-1.97],0.0185950579195995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,46985,125,1.80 [1.42-2.27],9.02294880538632e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL3,Fc receptor-like protein 3,45833,124,1.05 [0.78-1.41],0.7436255091293322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,46698,127,1.36 [1.06-1.76],0.017493480325065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,46626,123,1.61 [1.28-2.02],3.989901634857977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,45615,120,1.53 [1.32-1.76],6.1552446999983165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",39283,102,1.54 [1.28-1.87],8.440197061145587e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",39283,102,1.36 [1.02-1.81],0.0347789309839048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FEN1,Flap endonuclease 1,45615,120,0.81 [0.60-1.09],0.1695039660156652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FES,Tyrosine-protein kinase Fes/Fps,45615,120,0.85 [0.58-1.25],0.4025740835795341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,46810,125,1.73 [1.01-2.95],0.0447242671498109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,39727,105,2.48 [1.38-4.44],0.0022995847429892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40550,105,1.11 [0.88-1.39],0.3826600327519012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF12,Fibroblast growth factor 12,39446,103,0.90 [0.56-1.44],0.6477563091945462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF16,Fibroblast growth factor 16,39446,103,1.02 [0.67-1.54],0.9411230276224278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF19,Fibroblast growth factor 19,46900,124,1.12 [0.91-1.37],0.2768326109532215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,46626,123,1.36 [1.10-1.68],0.0044898935474757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF20,Fibroblast growth factor 20,39446,103,1.00 [0.65-1.55],0.993850400305187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,47029,128,1.53 [1.37-1.71],2.0502937522158635e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,47027,128,1.83 [1.59-2.11],1.2630344419693324e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF3,Fibroblast growth factor 3,39446,103,1.13 [0.66-1.93],0.6495702082341555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,45833,124,3.60 [2.82-4.59],4.865669484999655e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF6,Fibroblast growth factor 6,39446,103,1.19 [0.82-1.72],0.3667018904087035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF7,Fibroblast growth factor 7,39172,104,1.14 [0.93-1.39],0.2096645689563974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF9,Fibroblast growth factor 9,39102,104,0.73 [0.46-1.15],0.1688129596563521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,46850,129,0.32 [0.24-0.41],2.3336349173797866e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,40614,105,0.38 [0.26-0.55],2.152147976100701e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,40529,106,0.49 [0.30-0.81],0.0058935703260992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,46850,129,11.48 [7.53-17.49],6.409192563999904e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR4,Fibroblast growth factor receptor 4,39729,105,0.87 [0.61-1.24],0.446450764612356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,40646,105,2.37 [1.86-3.02],2.2705365979490087e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGR,Tyrosine-protein kinase Fgr,45638,124,1.06 [0.82-1.37],0.6537569582370297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FH,"Fumarate hydratase, mitochondrial",39312,102,0.95 [0.74-1.23],0.7172161719865813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39283,102,0.85 [0.55-1.30],0.447744409514763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIT,Bis(5'-adenosyl)-triphosphatase,45638,124,0.86 [0.69-1.06],0.1604378633815161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FIS1,Mitochondrial fission 1 protein,46669,124,1.13 [0.93-1.37],0.21962179335722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40550,105,1.19 [0.99-1.43],0.0697360607906869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,46839,125,0.98 [0.85-1.13],0.7663002265900256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,46337,124,1.57 [1.08-2.29],0.0176997574110853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,46337,124,1.15 [0.96-1.36],0.1244647280244085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,45562,123,1.13 [0.83-1.54],0.4300628612275359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBPL,FK506-binding protein-like,40451,106,1.13 [0.84-1.52],0.4307632077208316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLI1,Friend leukemia integration 1 transcription factor,45615,120,1.12 [0.97-1.28],0.1175812098427149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,46337,124,4.63 [3.06-7.01],4.724316508374363e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,46403,124,2.05 [1.35-3.12],0.0007600642894931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,45615,120,0.98 [0.58-1.66],0.935377909173288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,47210,127,2.07 [1.33-3.23],0.001338113946452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT4,Vascular endothelial growth factor receptor 3,46850,129,1.04 [0.65-1.66],0.8632177363851825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMNL1,Formin-like protein 1,45638,124,1.02 [0.80-1.31],0.8678939677692146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMR1,Synaptic functional regulator FMR1,45615,120,0.92 [0.58-1.47],0.7363424551349955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FN1,Fibronectin,40679,105,0.57 [0.29-1.14],0.1111419589177087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNDC1,Fibronectin type III domain-containing protein 1,40529,106,1.37 [0.92-2.02],0.1179693516059687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40433,105,1.33 [0.84-2.09],0.2255843151190835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,39446,103,1.13 [0.97-1.32],0.12103675558637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,46635,129,3.48 [2.60-4.65],5.1507313180801507e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,47117,128,2.24 [1.35-3.73],0.0018557598402963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,46702,129,1.09 [1.02-1.17],0.0111425607682165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOS,Proto-oncogene c-Fos,39102,104,1.11 [0.67-1.86],0.6794407554572028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOSB,Protein fosB,45638,124,1.35 [0.97-1.90],0.0783553204272483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXJ3,Forkhead box protein J3,39446,103,1.34 [0.91-1.97],0.1398030651944558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO1,Forkhead box protein O1,46626,123,1.17 [0.97-1.41],0.0985473990185636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO3,Forkhead box protein O3,45615,120,1.13 [0.96-1.34],0.1328384429536428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD4B,FERM domain-containing protein 4B,39283,102,1.17 [0.90-1.52],0.2407192655470683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD7,FERM domain-containing protein 7,39492,104,0.85 [0.48-1.49],0.5693342960710048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRZB,Secreted frizzled-related protein 3,46179,124,1.05 [0.55-1.99],0.8905767453844836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,39538,103,1.51 [1.07-2.11],0.0175937876154207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FST,Follistatin,46823,124,0.97 [0.70-1.36],0.8775812382843544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,39538,103,6.09 [3.79-9.78],8.464311526324213e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,46592,123,8.04 [5.99-10.78],7.272451841167429e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,40454,106,1.34 [1.10-1.62],0.0031513483501054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUCA1,Tissue alpha-L-fucosidase,46966,128,1.01 [0.84-1.22],0.8798559106134035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,39729,105,1.33 [1.00-1.75],0.0464854182488724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,46850,129,1.64 [1.02-2.64],0.0400732367253047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,45546,120,1.01 [0.67-1.52],0.9672192491471104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39809,107,0.96 [0.70-1.32],0.814804585977894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,47117,128,1.91 [1.38-2.65],0.0001009895317492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT8,"Alpha-(1,6)-fucosyltransferase",46337,124,1.10 [0.84-1.43],0.5046032954750966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXN,"Frataxin, mitochondrial",47097,128,1.07 [0.87-1.32],0.4995222981259066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXYD5,FXYD domain-containing ion transport regulator 5,45833,124,1.15 [0.91-1.46],0.2458129626373713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FYB1,FYN-binding protein 1,46621,127,1.04 [0.88-1.23],0.6107372881494291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD10,Frizzled-10,39492,104,0.86 [0.59-1.25],0.4332938834811464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,39312,102,1.38 [1.01-1.88],0.0414622416965149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40433,105,1.20 [0.85-1.68],0.3055405540667524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39882,107,0.99 [0.74-1.33],0.949787598517534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39312,102,1.07 [0.82-1.38],0.6367067381306826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD1,Glutamate decarboxylase 1,39172,104,1.39 [0.69-2.81],0.358914385031455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,39446,103,1.34 [1.04-1.74],0.02369105729054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39882,107,0.73 [0.44-1.23],0.241861873327053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39538,103,1.37 [1.01-1.85],0.0438103656927729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAGE2A,G antigen 2A,39172,104,1.18 [0.93-1.51],0.1803369358153985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAL,Galanin peptides,46900,124,0.86 [0.67-1.10],0.2193075293388232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,46483,124,4.96 [3.10-7.96],2.836578799173816e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,47097,128,0.48 [0.27-0.85],0.0122088989426649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,45833,124,1.96 [1.46-2.63],8.482814153444895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40628,107,1.26 [0.68-2.31],0.4644394952697892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,46483,124,4.22 [1.98-9.01],0.0001922724345434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAMT,Guanidinoacetate N-methyltransferase,39283,102,0.79 [0.43-1.46],0.4462179812515339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,38874,102,1.60 [0.79-3.22],0.1890567210792557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GART,Trifunctional purine biosynthetic protein adenosine-3,40550,105,0.86 [0.41-1.82],0.6985335969822601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS2,Growth arrest-specific protein 2,39882,107,1.18 [0.88-1.58],0.2701901354882993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,46958,126,3.08 [1.67-5.68],0.00032593689655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,39283,102,0.48 [0.31-0.74],0.0010033397536353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,40529,106,1.44 [1.30-1.59],1.2693430372206457e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39172,104,1.03 [0.50-2.09],0.9433419256485828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39538,103,1.15 [0.91-1.45],0.24205503222155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBA,Lysosomal acid glucosylceramidase,39492,104,1.28 [0.93-1.78],0.1318017664070239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP1,Guanylate-binding protein 1,40453,105,1.28 [0.96-1.69],0.0929377821643977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP2,Guanylate-binding protein 2,45833,124,1.08 [0.82-1.41],0.5917634099453755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,45638,124,1.05 [0.76-1.45],0.7559585524329899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP6,Guanylate-binding protein 6,39283,102,0.93 [0.59-1.47],0.763986943175694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GC,Vitamin D-binding protein,40679,105,0.89 [0.42-1.87],0.7560169785363361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCC1,GRIP and coiled-coil domain-containing protein 1,40529,106,1.18 [1.00-1.40],0.0557349049065328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,45615,120,1.94 [1.70-2.21],4.6954566036380093e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,38762,102,1.69 [1.27-2.23],0.0002610427901252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCLM,Glutamate--cysteine ligase regulatory subunit,39283,102,0.94 [0.61-1.45],0.7744022672767927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",46483,124,4.17 [2.77-6.28],7.660490352552645e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,47267,128,3.59 [3.19-4.04],5.714762320519955e-98
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,46694,125,1.75 [1.14-2.68],0.0105228600591734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,45638,124,2.47 [1.81-3.36],8.473196902092569e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GET3,ATPase GET3,40628,107,1.19 [0.87-1.64],0.2796452454418571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFAP,Glial fibrillary acidic protein,45540,120,0.87 [0.60-1.24],0.4333170861758432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,45615,120,1.56 [1.23-1.96],0.0002010679566452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,45615,120,0.82 [0.69-0.99],0.0362370325989625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,47029,128,12.25 [8.62-17.39],1.7755157879345446e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,46483,124,3.10 [1.66-5.78],0.0003754700053284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,46191,124,2.19 [1.28-3.74],0.0041305521979465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,39319,102,0.72 [0.53-1.00],0.0469139813449943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGA1,ADP-ribosylation factor-binding protein GGA1,45638,124,0.97 [0.76-1.22],0.7747503316444706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGACT,Gamma-glutamylaminecyclotransferase,40628,107,1.02 [0.79-1.32],0.8636315968223975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGCT,Gamma-glutamylcyclotransferase,40549,107,0.92 [0.63-1.34],0.6579145909757965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGH,Gamma-glutamyl hydrolase,45906,123,1.54 [0.99-2.39],0.0556510761209522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,46618,126,1.92 [1.50-2.45],1.897829930447778e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,46337,124,1.36 [0.71-2.61],0.3607798939686465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,46621,125,1.12 [1.02-1.22],0.0139327537569347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH2,Growth hormone variant,45615,120,0.96 [0.86-1.07],0.4362649555216285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHR,Growth hormone receptor,39729,105,0.54 [0.27-1.06],0.0750605214057281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRHR,Growth hormone-releasing hormone receptor,45638,124,0.99 [0.74-1.32],0.93745972874587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRL,Appetite-regulating hormone,46694,125,1.00 [0.83-1.21],0.9890295563478358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GID8,Glucose-induced degradation protein 8 homolog,40550,105,0.59 [0.28-1.23],0.1609781643682417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,40550,105,1.47 [1.17-1.85],0.0008530314232377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,39729,105,0.33 [0.17-0.66],0.0015750271072533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,39172,104,1.32 [0.96-1.81],0.0864742214658941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,39538,103,1.99 [1.51-2.63],9.131111691468412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,40529,106,4.92 [3.46-7.00],8.29814748907939e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC3,PDZ domain-containing protein GIPC3,40451,106,1.10 [0.91-1.33],0.3441308065257463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPR,Gastric inhibitory polypeptide receptor,39446,103,0.92 [0.60-1.43],0.7201000202528137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,39446,103,1.13 [0.93-1.37],0.2241739675057297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,39172,104,0.68 [0.47-0.99],0.0453453616209566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,44764,122,1.95 [1.21-3.16],0.0060988747046866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,39655,104,2.56 [1.69-3.89],9.958383364151691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,46337,124,1.47 [1.02-2.11],0.0410230973199805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,39446,103,1.69 [1.09-2.62],0.0186152529397169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLO1,Lactoylglutathione lyase,45838,124,0.96 [0.73-1.26],0.7573794328448983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLOD4,Glyoxalase domain-containing protein 4,46592,124,0.84 [0.53-1.32],0.4481882439296499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLP1R,Glucagon-like peptide 1 receptor,39312,102,1.04 [0.64-1.70],0.8753603657755993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX,Glutaredoxin-1,46394,124,0.93 [0.70-1.22],0.5869881171494701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39729,105,1.19 [0.98-1.44],0.0865909629956952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,45638,124,0.97 [0.67-1.39],0.8660778563705578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLYR1,Putative oxidoreductase GLYR1,40433,105,1.00 [0.73-1.36],0.9999465333546804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,39621,104,1.87 [1.56-2.24],1.1170760785765464e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMFG,Glia maturation factor gamma,40628,107,1.06 [0.82-1.36],0.660509555340117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,47210,127,0.63 [0.47-0.84],0.001720498412477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR2,GMP reductase 2,39729,105,0.98 [0.74-1.29],0.8753229699596694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,40550,105,1.26 [1.06-1.51],0.010706865666658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,45615,120,0.94 [0.73-1.20],0.5948148455146541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39492,104,0.77 [0.50-1.20],0.2488704035616174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNLY,Granulysin,46698,127,1.13 [0.85-1.50],0.3904783901852814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,39538,103,0.63 [0.31-1.26],0.1916651262286759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,39729,105,0.47 [0.28-0.79],0.0043744933714997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,40550,105,1.42 [1.14-1.77],0.0016452061130408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,47117,128,6.05 [4.02-9.10],5.78973535016697e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,46626,123,1.07 [0.92-1.25],0.3948343411250292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GORASP2,Golgi reassembly-stacking protein 2,40451,106,1.32 [0.93-1.89],0.1234910655403009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOT1,"Aspartate aminotransferase, cytoplasmic",40614,105,0.86 [0.56-1.32],0.4915950279119975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BA,Platelet glycoprotein Ib alpha chain,46500,124,1.11 [0.69-1.77],0.6688481568955722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BB,Platelet glycoprotein Ib beta chain,39283,102,1.18 [0.90-1.56],0.2270969829355555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,45244,122,1.18 [0.99-1.41],0.0719027942954341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP5,Platelet glycoprotein V,39729,105,1.05 [0.63-1.77],0.8415059738293353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP6,Platelet glycoprotein VI,46621,127,1.10 [0.92-1.32],0.2841674563450015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,46483,124,0.76 [0.67-0.86],7.766173908764032e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,47097,128,2.34 [1.39-3.92],0.0013384678800592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,46337,124,0.57 [0.43-0.75],7.095198573733095e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,40433,105,1.87 [1.41-2.48],1.5702510852487468e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPHA2,Glycoprotein hormone alpha-2,40451,106,0.95 [0.62-1.44],0.7988399160412203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,40646,105,1.33 [0.91-1.92],0.1364897231808217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40451,106,1.31 [0.98-1.75],0.0692044218595255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,45638,124,1.44 [1.01-2.04],0.0436120395346481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,45423,120,7.10 [4.28-11.79],3.550250844072318e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR101,Probable G-protein coupled receptor 101,39312,102,0.67 [0.43-1.05],0.0809735107828136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR158,Probable G-protein coupled receptor 158,40550,105,1.33 [0.84-2.09],0.219924443848331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,40451,106,1.82 [1.39-2.37],1.0386237480346428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,45838,124,3.47 [2.84-4.25],9.423128313888756e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,40433,105,1.75 [1.45-2.11],6.762665049404709e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRAP2,GRB2-related adapter protein 2,46694,125,1.03 [0.91-1.17],0.59601813255045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40628,107,1.12 [0.84-1.50],0.4351941916148791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",40550,105,0.87 [0.53-1.42],0.5786069416640391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39312,102,1.16 [0.87-1.55],0.3228212849808428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRK5,G protein-coupled receptor kinase 5,45838,124,0.92 [0.67-1.27],0.619285788645995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,46467,126,5.76 [3.89-8.53],2.788382635599556e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRP,Gastrin-releasing peptide,39538,103,1.11 [0.78-1.57],0.5599996424852318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",46483,124,2.22 [1.87-2.64],2.437204570708852e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,38962,104,1.27 [1.03-1.56],0.0281988841298516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSAP,Gamma-secretase-activating protein,45615,120,1.06 [0.89-1.27],0.4861944096792788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,40489,104,6.37 [3.84-10.58],8.09802913140458e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSR,"Glutathione reductase, mitochondrial",40413,104,0.98 [0.41-2.30],0.9562895851814508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA1,Glutathione S-transferase A1,46624,125,1.05 [0.87-1.27],0.589623817611356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA3,Glutathione S-transferase A3,45615,120,1.15 [0.94-1.40],0.1660257868437991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTM4,Glutathione S-transferase Mu 4,39283,102,1.10 [0.86-1.39],0.4489068171275905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,45347,124,0.71 [0.55-0.93],0.0118550979302244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTT2B,Glutathione S-transferase theta-2B,40529,106,1.00 [0.92-1.08],0.9414707535174922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39882,107,0.86 [0.63-1.18],0.3412199531205381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTPBP2,GTP-binding protein 2,39492,104,1.10 [0.88-1.38],0.4147721082369696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,46464,127,3.99 [2.97-5.37],5.371784801306187e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCY2C,Heat-stable enterotoxin receptor,39882,107,0.82 [0.62-1.08],0.1620578706208539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUK1,Guanylate kinase,39283,102,1.32 [0.89-1.97],0.1653731430786057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,46891,128,1.36 [1.07-1.73],0.0131074957283103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GYS1,"Glycogen [starch] synthase, muscle",45838,124,0.95 [0.80-1.14],0.5969411416307556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,47210,127,2.09 [1.41-3.08],0.0002181407066631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMB,Granzyme B,46626,123,0.77 [0.59-1.02],0.0645722282231377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMH,Granzyme H,45838,124,1.08 [0.90-1.29],0.3960685319820971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,H2AP,Huntingtin-interacting protein M,39172,104,1.00 [0.68-1.49],0.9891226304498684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39283,102,0.94 [0.68-1.29],0.7025486882937266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",46960,128,0.67 [0.53-0.84],0.0006799834028666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,47097,128,1.33 [1.18-1.50],2.86712865435243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",46698,127,1.06 [0.87-1.30],0.5520907895645648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,47028,128,3.10 [2.67-3.59],1.8492046369270072e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,46698,127,4.69 [3.54-6.23],8.283466973532716e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBEGF,Proheparin-binding EGF-like growth factor,46960,128,0.93 [0.75-1.14],0.4711199316853351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,47097,128,0.55 [0.42-0.73],3.625310709287563e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,40628,107,0.77 [0.64-0.93],0.0072704643611222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCG22,Protein PBMUCL2,39283,102,0.96 [0.65-1.42],0.8377088029370517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCLS1,Hematopoietic lineage cell-specific protein,47210,127,0.96 [0.72-1.29],0.8105675027380377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC8,Histone deacetylase 8,39446,103,1.08 [0.81-1.44],0.6012299437708906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC9,Histone deacetylase 9,39312,102,0.76 [0.53-1.11],0.1568894250535352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDDC2,5'-deoxynucleotidase HDDC2,40451,106,0.72 [0.46-1.11],0.1394160478536584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGF,Hepatoma-derived growth factor,47029,128,1.03 [0.87-1.22],0.715445956174033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,40529,106,1.20 [0.91-1.59],0.2010362955798689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEBP1,Heme-binding protein 1,45838,124,0.87 [0.63-1.21],0.4118555380316933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,39729,105,4.69 [2.52-8.71],1.0210512640758506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPACAM2,HEPACAM family member 2,40529,106,1.11 [0.72-1.72],0.6321998655171019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,40628,107,8.87 [4.40-17.88],1.0333608272139887e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,46626,123,1.24 [1.02-1.51],0.0287266106897042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,47210,127,3.71 [2.67-5.16],6.353486026355903e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGFAC,Hepatocyte growth factor activator,40261,105,2.02 [0.99-4.11],0.0521070598139014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,45615,120,1.01 [0.83-1.24],0.9003234122859445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,40529,106,1.48 [1.17-1.88],0.0010331546489665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIF1A,Hypoxia-inducible factor 1-alpha,39446,103,1.23 [0.97-1.55],0.0930580669767632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1,Huntingtin-interacting protein 1,39283,102,0.88 [0.48-1.61],0.6686196663306733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,40450,105,2.10 [1.74-2.52],3.032722759640179e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,40550,105,1.74 [1.37-2.21],4.494629434392948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HK2,Hexokinase-2,45838,124,0.92 [0.52-1.63],0.7769991522853021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",40550,105,3.00 [1.69-5.33],0.000184559534736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",46482,122,1.82 [1.21-2.74],0.00423063302656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",46626,123,5.39 [3.83-7.59],5.689537772302103e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,47097,128,0.49 [0.34-0.70],0.000101776045561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,39657,105,1.79 [1.29-2.50],0.0005533776267846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39538,103,1.16 [0.80-1.67],0.432431699651011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39283,102,0.70 [0.44-1.13],0.1467648754041627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMMR,Hyaluronan mediated motility receptor,39098,104,0.90 [0.58-1.38],0.6174749536519177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,46162,125,0.60 [0.42-0.85],0.004262283183986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,45638,124,1.39 [1.05-1.84],0.0223179172655256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNF1A,Hepatocyte nuclear factor 1-alpha,39492,104,0.94 [0.71-1.25],0.681889792131553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,46113,123,2.18 [1.65-2.88],4.9534938278377444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,45687,124,1.04 [0.85-1.27],0.7286994080587768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40550,105,1.27 [0.91-1.77],0.162227519307089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPCAL1,Hippocalcin-like protein 1,47210,127,1.13 [0.91-1.41],0.2731146095780371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,45615,120,0.34 [0.22-0.53],1.1209086651893044e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,40073,104,1.29 [1.05-1.58],0.0137242079528025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,39810,106,1.14 [0.98-1.33],0.0897127347098573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39538,103,1.76 [1.19-2.60],0.0042410472083853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,40456,105,1.94 [1.08-3.48],0.0272005694714303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,39538,103,1.11 [0.90-1.37],0.3116769383521414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,46483,124,2.19 [1.45-3.32],0.0002076489867805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,47097,128,1.39 [0.92-2.12],0.1188263662197902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39446,103,3.14 [2.09-4.72],3.9173648206096296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSBP1,Heat shock factor-binding protein 1,39538,103,1.19 [0.97-1.45],0.0953331127800947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,46626,123,0.58 [0.40-0.86],0.0057368300514986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40529,106,1.47 [1.11-1.96],0.0076943377695363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39283,102,0.96 [0.65-1.42],0.8481483233083776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39538,103,1.34 [0.93-1.93],0.1172578041202132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSP90B1,Endoplasmin,45409,123,0.88 [0.66-1.17],0.3640876081395319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA1A,Heat shock 70 kDa protein 1A,46824,124,1.16 [0.94-1.44],0.1756392149455777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,40433,105,1.92 [1.54-2.39],4.917534404138909e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB1,Heat shock protein beta-1,45954,124,1.21 [0.94-1.55],0.1397772287615103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,47097,128,5.35 [4.02-7.12],1.8535197606309707e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,46350,123,5.02 [3.66-6.89],1.6471229660808524e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1A,5-hydroxytryptamine receptor 1A,39312,102,0.94 [0.71-1.25],0.682350845952735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1B,5-hydroxytryptamine receptor 1B,39312,102,0.93 [0.58-1.49],0.76281126013541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTRA2,"Serine protease HTRA2, mitochondrial",46850,129,1.21 [0.95-1.54],0.1203811675908444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,46447,121,6.73 [3.98-11.40],1.2297430359097288e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,47267,128,8.23 [4.51-15.01],5.994096859188196e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICA1,Islet cell autoantigen 1,45833,124,1.03 [0.84-1.26],0.7784886594022223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,46502,124,3.84 [2.41-6.12],1.3607588009785804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,47267,128,3.35 [2.02-5.53],2.448186712842006e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,47267,128,3.34 [2.01-5.53],2.8805990912552616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,46626,123,0.58 [0.43-0.78],0.0002803951692644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,46694,125,1.69 [1.21-2.37],0.0022748184020844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,46483,124,3.73 [1.67-8.33],0.0013084252135034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ID4,DNA-binding protein inhibitor ID-4,39882,107,1.10 [0.73-1.66],0.6458083336752346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,45638,124,1.27 [0.94-1.71],0.1146368563963761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDO1,"Indoleamine 2,3-dioxygenase 1",39538,103,1.08 [0.80-1.47],0.601982981970526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDS,Iduronate 2-sulfatase,47210,127,0.45 [0.16-1.24],0.1210346361044776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,47097,128,3.38 [2.35-4.87],6.51123318769257e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39482,103,2.96 [2.07-4.22],2.152190164641403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39882,107,0.98 [0.68-1.42],0.9219991750841184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39882,107,1.38 [0.89-2.12],0.1481069299468242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNAR1,Interferon alpha/beta receptor 1,40451,106,1.28 [0.63-2.63],0.4943676780916564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,45833,124,1.19 [1.03-1.38],0.0151333286006551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,46900,124,3.41 [2.47-4.72],1.1151456651787217e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,46337,124,1.94 [1.47-2.55],2.301968799313929e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,45638,124,1.59 [1.18-2.14],0.0020382826835053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL2,Interferon lambda-2,39312,102,0.87 [0.60-1.25],0.4403804810660077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,46626,123,1.78 [1.30-2.44],0.000309854601046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNW1,Interferon omega-1,39283,102,0.58 [0.29-1.16],0.1213914353061836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,39492,104,1.21 [0.82-1.79],0.3447603818126346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,40550,105,0.94 [0.69-1.26],0.6625738923708495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39312,102,0.77 [0.48-1.23],0.275909284084563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40614,105,0.47 [0.25-0.90],0.022150449189258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,46483,124,3.00 [2.28-3.94],3.511070987897551e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39283,102,0.86 [0.54-1.38],0.5386796530198908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,46698,127,7.49 [4.45-12.60],3.5178696480590784e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP1,Insulin-like growth factor-binding protein 1,47189,127,1.03 [0.91-1.17],0.6732963272652828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,47191,127,1.86 [1.45-2.40],1.1781827846044243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,46888,125,0.32 [0.23-0.44],7.057651631277951e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,46101,125,3.65 [3.06-4.35],3.0888051256546073e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,46496,124,3.64 [2.68-4.96],2.0096438396038562e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,47267,128,2.29 [1.88-2.78],1.3240413682330566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,46694,125,5.02 [3.67-6.87],7.340394001634939e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFL4,Insulin growth factor-like family member 4,39446,103,1.11 [0.88-1.39],0.3875052438938651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGHMBP2,DNA-binding protein SMUBP-2,39283,102,1.04 [0.74-1.46],0.8418598408591684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,40613,105,2.42 [1.81-3.25],3.66875493539735e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLON5,IgLON family member 5,39172,104,1.03 [0.86-1.24],0.7478316007662037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF21,Immunoglobulin superfamily member 21,39538,103,0.64 [0.37-1.08],0.096366195786577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,46483,124,2.91 [2.38-3.55],7.41690856952447e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,46694,125,4.76 [3.61-6.27],1.429332837889519e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,40628,107,1.76 [1.45-2.15],1.5087229220067817e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKBKG,NF-kappa-B essential modulator,46626,123,1.15 [0.96-1.38],0.1224136168793263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKZF2,Zinc finger protein Helios,45615,120,0.95 [0.77-1.17],0.6305638038921701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,45833,124,1.40 [1.22-1.61],2.981996772981469e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RA,Interleukin-10 receptor subunit alpha,45833,124,1.11 [0.88-1.41],0.3844002795870144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,46900,124,3.76 [3.03-4.67],2.8062559670483655e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL11,Interleukin-11,45833,124,0.99 [0.78-1.27],0.9654943557929224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,46483,124,2.14 [1.81-2.52],9.863784639451492e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,47210,127,2.62 [2.01-3.42],1.327069365549323e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,45833,124,2.97 [2.45-3.61],5.331553165014272e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,39446,103,2.07 [1.48-2.89],2.013323199709141e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13,Interleukin-13,45833,124,1.01 [0.73-1.41],0.9462069054904504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,46124,128,0.95 [0.48-1.88],0.8934922442144497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,39312,102,0.99 [0.51-1.92],0.9825331907871078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,46626,123,2.30 [1.49-3.55],0.0001793521899114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,45833,124,3.94 [2.57-6.03],2.9218277413464653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,47210,127,1.54 [1.12-2.13],0.0079082461749065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17A,Interleukin-17A,45763,123,1.25 [0.93-1.68],0.1474286771671727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,45833,124,1.63 [1.41-1.88],3.483136438623354e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,45833,124,1.40 [1.01-1.93],0.0445628275052456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17F,Interleukin-17F,45833,124,1.06 [0.87-1.30],0.5698746435536941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RA,Interleukin-17 receptor A,46698,127,1.29 [0.90-1.84],0.1682863480243209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RB,Interleukin-17 receptor B,46034,123,1.14 [0.84-1.53],0.401451495697236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,46512,123,2.59 [1.99-3.38],2.181058537376309e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,46888,125,7.58 [5.41-10.63],7.151796456966101e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,47210,127,8.36 [5.62-12.44],1.0183214637801551e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,46044,122,0.93 [0.84-1.03],0.1611576699135586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,45516,120,1.75 [1.51-2.04],2.8438899316854725e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1A,Interleukin-1 alpha,45833,124,0.99 [0.76-1.29],0.9644978277278752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1B,Interleukin-1 beta,45617,123,1.14 [0.88-1.47],0.3295231358788282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,46618,126,3.11 [2.28-4.24],7.969439431386168e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,46593,123,8.97 [4.06-19.83],5.921194146932245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RAP,Interleukin-1 receptor accessory protein,46698,127,1.37 [0.98-1.91],0.0635985376106218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,47110,128,3.14 [2.25-4.38],1.87057636718224e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL2,Interleukin-1 receptor-like 2,45833,124,0.87 [0.58-1.32],0.5170555012794245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,46595,124,2.12 [1.76-2.56],5.390352380578192e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2,Interleukin-2,45833,124,1.08 [0.65-1.81],0.7569327535428809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20,Interleukin-20,45833,124,1.03 [0.75-1.43],0.8355140185881716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RA,Interleukin-20 receptor subunit alpha,45833,124,1.11 [0.79-1.54],0.5535797033186428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RB,Interleukin-20 receptor subunit beta,39446,103,0.96 [0.61-1.50],0.8637452266168398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL21R,Interleukin-21 receptor,39446,103,1.04 [0.78-1.37],0.8102562368202046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,40433,105,1.58 [1.28-1.96],2.838528844991103e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,45833,124,1.09 [0.76-1.55],0.641247557297844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL24,Interleukin-24,45833,124,0.84 [0.59-1.21],0.3537837096421937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL25,Interleukin-25,39034,104,1.13 [0.65-1.97],0.6697394296343443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,46359,127,2.78 [2.30-3.37],4.515125221800066e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RB,Interleukin-2 receptor subunit beta,45833,124,1.29 [0.90-1.86],0.1713436242040644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RG,Cytokine receptor common subunit gamma,40433,105,1.41 [0.97-2.04],0.0713184585465691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3,Interleukin-3,39172,104,1.19 [0.86-1.66],0.2954489540372314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31,Interleukin-31,39446,103,1.11 [0.80-1.54],0.5434589617322408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31RA,Interleukin-31 receptor subunit alpha,39297,102,1.41 [0.87-2.29],0.1658818709088163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,46626,123,1.48 [1.07-2.05],0.0186194211467894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,45833,124,1.71 [1.16-2.51],0.006941044727526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL34,Interleukin-34,45560,124,1.00 [0.64-1.54],0.9840071515366904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,39446,103,1.07 [0.78-1.47],0.666171284443646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,39286,103,1.28 [1.04-1.57],0.02123874567566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3RA,Interleukin-3 receptor subunit alpha,45833,124,1.53 [0.96-2.45],0.0750062408718238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4,Interleukin-4,45833,124,1.19 [0.96-1.46],0.1067002493628737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,46626,123,3.15 [2.36-4.22],8.381342863670866e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5,Interleukin-5,45833,124,0.92 [0.81-1.04],0.1951493385332026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,46626,123,1.57 [1.24-1.99],0.0002050494158203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,46483,124,1.54 [1.35-1.76],2.1201436350957887e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,46424,124,1.93 [1.21-3.08],0.0058310043341675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,46694,125,5.04 [3.32-7.67],4.0954261138912285e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7,Interleukin-7,46626,123,0.92 [0.71-1.17],0.4879376454406732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,46698,127,0.72 [0.53-0.96],0.0246796641116814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL9,Interleukin-9,39882,107,1.12 [0.84-1.49],0.4284410076596123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,45567,124,1.16 [0.89-1.49],0.2678974591435233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,40433,105,2.58 [2.09-3.20],2.958613510840329e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPA1,Inositol monophosphatase 1,46337,124,0.92 [0.71-1.20],0.5477090120591859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPACT,Protein IMPACT,40529,106,0.88 [0.63-1.23],0.4639197978901824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,39312,102,0.43 [0.20-0.91],0.0266757643650271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ING1,Inhibitor of growth protein 1,45562,123,1.05 [0.76-1.45],0.7631236189629171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,39729,105,2.43 [1.79-3.29],1.0370368112263794e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,46698,127,4.43 [2.87-6.85],2.0752023664622624e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP1,Inositol polyphosphate 1-phosphatase,46483,124,1.08 [0.80-1.46],0.603218106070842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39538,103,1.33 [0.98-1.82],0.0699479369749587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40550,105,0.90 [0.56-1.44],0.6489166783965441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",46483,124,1.19 [1.01-1.41],0.0340142102693073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,40529,106,0.75 [0.61-0.93],0.0071626501749524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,40433,105,1.60 [1.31-1.96],4.492692672624798e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,40451,106,1.50 [1.27-1.79],3.1379350426730434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,39446,103,7.21 [3.94-13.20],1.4789200979239114e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,46258,124,1.12 [0.94-1.34],0.213313663791376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,46483,124,1.61 [1.23-2.12],0.000571135694634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",45838,124,1.21 [1.02-1.42],0.025931174579137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK1,Interleukin-1 receptor-associated kinase 1,45833,124,1.22 [0.97-1.53],0.0900864724825654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK4,Interleukin-1 receptor-associated kinase 4,46626,123,1.07 [0.91-1.25],0.4294120899289647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,44991,121,0.91 [0.60-1.38],0.6665211811943583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM1,Isthmin-1,46626,123,1.17 [0.77-1.78],0.4543513085048386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM2,Isthmin-2,40614,105,0.88 [0.55-1.39],0.5711118743496862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IST1,IST1 homolog,40157,104,1.07 [0.88-1.29],0.4917712046989086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,46626,123,0.39 [0.25-0.61],2.993286186919369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,39729,105,0.57 [0.34-0.97],0.0374159777373375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,46698,127,8.52 [4.89-14.82],3.5647431110741184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA6,Integrin alpha-6,46626,123,0.81 [0.59-1.13],0.2189048094156371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,39446,103,2.19 [1.37-3.51],0.0011271674825847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,46698,127,2.10 [1.31-3.39],0.00223777219203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,47097,128,0.41 [0.24-0.69],0.0007979257903275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAX,Integrin alpha-X,39882,107,1.16 [0.85-1.58],0.3501331699126384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,46655,125,2.48 [1.25-4.90],0.00930925838543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP1,Integrin beta-1-binding protein 1,45615,120,1.18 [0.80-1.77],0.4046887130010623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP2,Integrin beta-1-binding protein 2,45838,124,1.05 [0.91-1.21],0.5052857477111283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,46408,124,3.69 [2.38-5.72],5.050806067219787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB5,Integrin beta-5,46850,129,1.20 [0.83-1.74],0.3377260127062112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,45833,124,3.21 [1.91-5.38],9.983676047927613e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,47097,128,2.45 [1.85-3.25],4.6867034634147e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,40614,105,3.88 [3.05-4.95],5.689997570588507e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40679,105,1.45 [0.54-3.90],0.456672497925646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,46888,125,4.41 [2.92-6.65],1.5844623309257632e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40679,105,1.69 [0.84-3.38],0.1411459830470977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40433,105,1.42 [1.05-1.92],0.0231205863012862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITM2A,Integral membrane protein 2A,46626,123,0.96 [0.74-1.24],0.7338226346351426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPA,Inosine triphosphate pyrophosphatase,39283,102,1.07 [0.82-1.39],0.6328050501761993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39538,103,1.21 [0.96-1.53],0.1072642692903752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39312,102,1.02 [0.69-1.52],0.915147842548438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",45638,124,0.80 [0.57-1.13],0.2094209941466802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IZUMO1,Izumo sperm-egg fusion protein 1,39172,104,1.14 [0.80-1.62],0.4609329387822442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,47117,128,4.87 [3.38-7.02],2.3234309133590158e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,39729,105,1.97 [1.47-2.64],5.504178546005905e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,45833,124,1.41 [1.09-1.82],0.0082451766953306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39172,104,0.98 [0.72-1.35],0.9203491139217924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,40451,106,1.17 [0.94-1.45],0.1517174691114805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,45833,124,1.39 [1.08-1.79],0.0097980044679302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,46483,124,2.30 [1.59-3.33],9.500990331929708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,40451,106,1.21 [1.01-1.44],0.0382955786528473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,39312,102,1.33 [1.01-1.74],0.0392893307522992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,39492,104,1.16 [0.94-1.45],0.1721941290046289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,45638,124,0.76 [0.52-1.13],0.1735708905233563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,39762,105,1.69 [1.23-2.32],0.0010806749934471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDM3A,Lysine-specific demethylase 3A,39446,103,1.10 [0.91-1.34],0.3165781880315362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDR,Vascular endothelial growth factor receptor 2,46850,129,0.71 [0.38-1.32],0.2731834826546737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KEL,Kell blood group glycoprotein,45638,124,1.27 [0.82-1.97],0.280563141367203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHDC3L,KH domain-containing protein 3,39172,104,1.01 [0.77-1.33],0.9510357500229448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHK,Ketohexokinase,39538,103,1.35 [0.99-1.83],0.0554386345730424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA0319,Dyslexia-associated protein KIAA0319,40529,106,1.37 [0.81-2.31],0.2369499848586559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549,UPF0606 protein KIAA1549,39882,107,1.06 [0.80-1.40],0.6682170868988324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549L,UPF0606 protein KIAA1549L,39882,107,1.08 [0.59-1.99],0.8042805363339065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA2013,Uncharacterized protein KIAA2013,40433,105,0.87 [0.58-1.29],0.489047935582526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,39283,102,1.99 [1.53-2.61],4.403994206363277e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,39312,102,1.04 [0.82-1.33],0.7241180840444492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,39283,102,1.21 [1.03-1.43],0.0201479209494355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIFBP,KIF-binding protein,46483,124,1.17 [0.96-1.42],0.1253934642296393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40433,105,1.41 [1.15-1.73],0.0010660359810204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,45615,120,1.35 [1.11-1.64],0.0027644936763497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40451,106,1.02 [0.92-1.14],0.6874039329562811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,45615,120,1.02 [0.90-1.16],0.7648693362386125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39172,104,0.98 [0.77-1.24],0.8512222927860356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL1,Kin of IRRE-like protein 1,39312,102,0.91 [0.63-1.32],0.6126411119343789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL2,Kin of IRRE-like protein 2,45638,124,1.03 [0.70-1.52],0.867020374181125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,46810,125,0.38 [0.22-0.64],0.0003123285325915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KITLG,Kit ligand,46694,125,0.73 [0.49-1.09],0.1212870858206898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLB,Beta-klotho,45638,124,1.02 [0.82-1.27],0.851861324997122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLF4,Krueppel-like factor 4,39312,102,1.18 [0.76-1.84],0.4687665351669131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,40550,105,1.15 [0.86-1.55],0.3474658588976435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK1,Kallikrein-1,46250,128,0.94 [0.83-1.06],0.3073985496482714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK10,Kallikrein-10,46706,129,1.13 [0.78-1.62],0.52528211919661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,46410,129,2.08 [1.67-2.60],1.0818495473322295e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK12,Kallikrein-12,45615,120,1.03 [0.91-1.16],0.6663127948527909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK13,Kallikrein-13,45669,123,0.84 [0.60-1.19],0.3241295813852575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK14,Kallikrein-14,47097,128,1.02 [0.73-1.42],0.9219832355245096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK15,Kallikrein-15,40360,105,1.03 [0.72-1.49],0.8643258634965081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,40614,105,0.73 [0.61-0.88],0.0010812183266867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,47097,128,2.22 [1.95-2.52],1.7932568250431868e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,46771,128,2.01 [1.21-3.31],0.0065268338734012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,38710,102,0.46 [0.28-0.78],0.0037318909242251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,45148,128,1.68 [1.13-2.50],0.0101898902422214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLKB1,Plasma kallikrein,39852,104,1.06 [0.50-2.24],0.8845766662877721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,47210,127,8.20 [5.97-11.26],1.333153994354782e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39312,102,0.89 [0.62-1.28],0.5311391968484237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,47210,127,2.81 [2.05-3.86],1.8245395411013847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39446,103,1.78 [1.43-2.21],2.2793559660749097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,40529,106,2.39 [1.91-3.00],4.838729028422266e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT14,"Keratin, type I cytoskeletal 14",44197,119,0.70 [0.38-1.29],0.2532869615029851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT17,"Keratin, type I cytoskeletal 17",39283,102,0.75 [0.44-1.27],0.2871691909398559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",46483,124,1.70 [1.47-1.96],4.065430982241014e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",46552,123,2.54 [2.14-3.01],9.005060082654295e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT5,"Keratin, type II cytoskeletal 5",45638,124,0.85 [0.62-1.17],0.3277732353699184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",39283,102,1.11 [0.67-1.84],0.6768663898280196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",39312,102,1.51 [1.36-1.67],1.697950432653306e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,46614,125,0.93 [0.70-1.23],0.6088079644139651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYNU,Kynureninase,47210,127,1.23 [0.89-1.71],0.2139133284964733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L1CAM,Neural cell adhesion molecule L1,46850,129,1.20 [0.70-2.04],0.5034230525493726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40628,107,1.17 [0.96-1.43],0.1109080152864831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,40364,105,0.49 [0.27-0.89],0.0182113003023524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACTB2,Endoribonuclease LACTB2,46694,125,1.06 [0.84-1.34],0.638813505363685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,46483,124,2.81 [2.30-3.42],1.9097916026379423e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,46670,123,3.60 [2.89-4.48],1.4764278011396181e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,46337,124,1.34 [1.13-1.57],0.0005408379135202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA1,Laminin subunit alpha-1,39283,102,1.16 [0.84-1.60],0.376292634339918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,46900,124,1.86 [1.21-2.85],0.0043897248126899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,39538,103,4.51 [2.43-8.39],1.872216215588384e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,39474,103,1.46 [1.06-2.00],0.0189137355577174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP2,Lysosome-associated membrane glycoprotein 2,45272,121,1.37 [0.63-3.00],0.4275192731568838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,47133,127,1.85 [1.39-2.45],2.18873494218772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMTOR5,Ragulator complex protein LAMTOR5,40433,105,0.85 [0.52-1.39],0.5159600701192526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAP3,Cytosol aminopeptidase,45833,124,1.14 [0.82-1.57],0.4380169002324677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LARP1,La-related protein 1,40433,105,1.16 [0.89-1.52],0.2723071227274871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT,Linker for activation of T-cells family member 1,47210,127,1.18 [0.95-1.46],0.1394808244137965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,46483,124,1.15 [1.01-1.30],0.0309219567532504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,39446,103,1.20 [0.97-1.49],0.0972934346492097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,46261,123,5.59 [4.37-7.16],9.43308298551583e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,46888,125,1.68 [1.30-2.16],5.923536707955925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,47117,128,1.29 [1.07-1.56],0.0075472261894057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCAT,Phosphatidylcholine-sterol acyltransferase,40646,105,1.00 [0.41-2.43],0.9987620607036892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,40550,105,1.72 [1.46-2.02],5.3630626284823164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,45294,121,2.92 [2.21-3.87],7.363061974734869e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCP1,Plastin-2,40614,105,0.81 [0.54-1.22],0.3179295270374221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLR,Low-density lipoprotein receptor,46815,126,1.03 [0.76-1.40],0.8364704364656053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40550,105,1.18 [0.98-1.42],0.0750747111984612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,40628,107,1.57 [1.23-2.01],0.0003505172934162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,47029,128,1.82 [1.35-2.44],6.98258627702112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEG1,Protein LEG1 homolog,38377,101,1.09 [0.84-1.41],0.5233099981862072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LELP1,Late cornified envelope-like proline-rich protein 1,39312,102,1.03 [0.81-1.31],0.8142473237990834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,40550,105,1.63 [1.12-2.38],0.0112730750699491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,46694,125,1.45 [1.13-1.87],0.0040689431023983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,46694,125,1.78 [1.20-2.66],0.0044654219708884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,40550,105,1.96 [1.52-2.53],1.6767892865142157e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,46694,125,2.54 [1.76-3.67],6.630224375846387e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,46818,125,3.47 [2.22-5.41],4.144504199110501e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,40679,105,2.82 [2.04-3.92],4.758489755043605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,46670,123,4.38 [3.61-5.31],1.6875209928092685e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,46566,127,1.58 [1.18-2.11],0.0020793984463517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS8,Galectin-8,47117,128,1.17 [0.91-1.49],0.2191947496186075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,46668,124,7.16 [4.90-10.44],1.8008150991506418e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,46900,124,2.02 [1.33-3.05],0.0008887383632515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHB,Lutropin subunit beta,45615,120,1.07 [0.90-1.27],0.4576788793268438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,46750,124,0.62 [0.48-0.79],0.0001322714423546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIF,Leukemia inhibitory factor,45638,124,1.02 [0.75-1.39],0.8898746876419126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,46626,123,8.06 [5.85-11.11],2.7601124697648205e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,46698,127,1.90 [1.20-3.00],0.0060231342914079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40614,105,0.95 [0.84-1.07],0.4018407643374675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39283,102,0.99 [0.67-1.47],0.9688917862693752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,46621,125,3.70 [2.37-5.78],9.482802841449777e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40628,107,1.55 [1.19-2.01],0.001103704240829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,47267,128,3.96 [2.32-6.74],4.121643581136295e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,47034,127,3.12 [1.91-5.08],4.984976529411619e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,45833,124,3.20 [2.38-4.31],1.3397167183981604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,47267,128,1.11 [0.88-1.40],0.3671622036333641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,39538,103,1.01 [0.75-1.37],0.9404985199018718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB1,Lamin-B1,40376,106,0.93 [0.68-1.28],0.6692991789694978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,40529,106,3.53 [2.26-5.52],3.1798657078532937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,40550,105,2.34 [1.82-3.01],4.421817056667995e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD2,Leiomodin-2,39312,102,0.83 [0.58-1.18],0.2968811919026434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",39538,103,1.36 [1.13-1.65],0.0015409982797453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPA,Apolipoprotein(a),39723,104,1.04 [0.94-1.15],0.489241455085334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,46483,124,1.18 [0.88-1.60],0.2711773332745457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,46694,125,0.58 [0.44-0.77],0.0001057060603217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,45152,122,2.21 [1.74-2.81],6.562643186904156e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPP,Lipoma-preferred partner,39283,102,1.06 [0.80-1.41],0.6901235137169125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39283,102,1.42 [1.11-1.81],0.0052755448374034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39492,104,0.66 [0.39-1.11],0.1148166735157498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,40679,105,3.00 [1.58-5.68],0.0007856558657893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,46960,128,3.11 [2.08-4.67],3.908206071579104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39306,103,2.25 [1.44-3.50],0.0003467511280603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,46483,124,1.44 [0.83-2.51],0.1989734761768185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,46694,125,4.86 [3.42-6.91],1.477465073253425e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2,Low-density lipoprotein receptor-related protein 2,39492,104,0.98 [0.60-1.61],0.9386483169916184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,39492,104,1.22 [1.02-1.45],0.03231798443815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,47117,128,1.17 [0.92-1.48],0.2105175094900891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,46483,124,2.63 [1.93-3.58],7.810760870272344e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40451,106,2.15 [1.42-3.26],0.0003109725376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC38,Leucine-rich repeat-containing protein 38,39492,104,1.23 [0.86-1.75],0.2578533696896545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC59,Leucine-rich repeat-containing protein 59,40628,107,1.36 [0.99-1.88],0.0606081202396666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40433,105,1.48 [1.05-2.09],0.0252621661472762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,45833,124,0.43 [0.29-0.63],1.562825438402015e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39492,104,1.02 [0.65-1.61],0.926915251518222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40550,105,0.37 [0.17-0.81],0.0128454455269323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,45615,120,1.01 [0.76-1.35],0.929131291393642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,39882,107,0.91 [0.71-1.17],0.473658164213562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,46626,123,1.50 [1.03-2.20],0.0347316866921486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,46626,123,1.60 [1.13-2.27],0.0087781650995097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,47097,128,0.56 [0.42-0.76],0.0001693966910689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTB,Lymphotoxin-beta,40433,105,1.05 [0.62-1.77],0.8501909807531587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,47267,128,6.37 [4.60-8.82],7.557919395575054e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,45615,120,1.81 [1.50-2.19],6.230826844570272e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,46439,123,6.07 [4.29-8.60],3.1873365732052422e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTO1,Protein LTO1 homolog,45833,124,1.13 [0.81-1.58],0.4670582799363796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,40433,105,1.59 [1.17-2.18],0.0033070432206804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,46126,124,0.61 [0.47-0.80],0.0003379704707782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,46445,124,2.23 [1.66-2.98],7.48009411387674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,46626,123,1.94 [1.26-2.98],0.0026753501992715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,46157,123,5.04 [3.32-7.65],2.852848339387423e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,46337,124,2.76 [2.04-3.73],4.757164642434757e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYAR,Cell growth-regulating nucleolar protein,45615,120,0.81 [0.56-1.17],0.2620515844268464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYN,Tyrosine-protein kinase Lyn,46483,124,1.11 [0.91-1.34],0.2977996334759549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD1,Ly6/PLAUR domain-containing protein 1,45638,124,0.89 [0.66-1.19],0.4303217642805377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,46488,129,1.53 [0.97-2.43],0.0700708801601763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,45615,120,1.62 [1.27-2.07],9.166390127819078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPLA2,Acyl-protein thioesterase 2,39312,102,0.99 [0.83-1.19],0.947150097221672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39492,104,0.91 [0.75-1.11],0.3645619004201302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40679,105,4.90 [2.02-11.90],0.0004458075146732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYZL2,Lysozyme-like protein 2,39172,104,1.08 [0.67-1.76],0.7439801046820971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LZTFL1,Leucine zipper transcription factor-like protein 1,39729,105,1.10 [0.85-1.42],0.4534010346055029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,M6PR,Cation-dependent mannose-6-phosphate receptor,39538,103,0.86 [0.50-1.47],0.5735049745809051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,46186,123,1.56 [1.29-1.89],4.4604036023599024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAEA,E3 ubiquitin-protein transferase MAEA,45615,120,1.04 [0.69-1.59],0.838368709875007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAG,Myelin-associated glycoprotein,39492,104,0.80 [0.55-1.18],0.2650178633098545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGEA3,Melanoma-associated antigen 3,39882,107,0.95 [0.77-1.17],0.6056698265191369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGED1,Melanoma-associated antigen D1,45615,120,1.29 [0.94-1.77],0.1087052817205769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,40628,107,3.19 [2.13-4.77],1.8931574788160138e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,40433,105,1.52 [1.12-2.05],0.0068039899313351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39538,103,1.64 [0.78-3.44],0.1892637900882634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN2B2,Epididymis-specific alpha-mannosidase,40628,107,1.31 [0.96-1.79],0.0869418049610813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39172,104,1.13 [0.79-1.60],0.5073218169216369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,46900,124,1.09 [0.95-1.26],0.2064049557527588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,46850,129,5.22 [3.36-8.10],1.6465092179083913e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC4,MANSC domain-containing protein 4,39283,102,1.15 [0.88-1.49],0.3115314252839408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39312,102,0.95 [0.52-1.73],0.8581657491643686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39283,102,0.81 [0.55-1.20],0.2969388000197421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,40529,106,1.83 [1.41-2.38],5.479085057652952e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40451,106,1.32 [1.00-1.74],0.051697402735727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,46626,123,1.04 [0.88-1.22],0.6730869335168188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,45615,120,1.15 [0.98-1.35],0.0810593731344873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,46261,123,1.07 [0.93-1.23],0.3602602159890847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,39172,104,1.41 [0.97-2.06],0.0704295010426793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK9,Mitogen-activated protein kinase 9,46626,123,1.21 [0.82-1.77],0.3357153532563416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPKAPK2,MAP kinase-activated protein kinase 2,39882,107,1.07 [0.83-1.37],0.6096243471469533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,39172,104,1.07 [0.94-1.20],0.3016331944326357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPT,Microtubule-associated protein tau,45638,124,1.17 [0.85-1.62],0.3321229184265722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,46694,125,2.58 [1.40-4.77],0.0024948058812159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",39655,104,1.17 [0.94-1.46],0.1488144223489167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,46261,123,2.49 [1.28-4.86],0.0072080911074943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,46745,123,2.98 [1.78-4.96],2.887666304977801e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,46258,124,0.55 [0.34-0.91],0.0188568169629068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,45615,120,1.20 [1.01-1.42],0.0435445461762378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAX,Protein max,45638,124,1.09 [0.94-1.26],0.2469636128904788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,47267,128,1.84 [1.48-2.29],3.899854205509765e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MBL2,Mannose-binding protein C,40103,105,1.17 [0.98-1.39],0.0798968708244803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,46888,125,1.62 [1.01-2.58],0.0440697822914011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40550,105,1.23 [0.84-1.81],0.2899913788277965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,39446,103,1.29 [1.06-1.56],0.0100255567917386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,46482,125,2.08 [1.49-2.90],1.6868942402871308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCTS1,Malignant T-cell-amplified sequence 1,40451,106,1.43 [0.88-2.33],0.1504085451344453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,46337,124,1.62 [1.28-2.05],5.23766998161078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",40420,105,0.91 [0.57-1.46],0.701399145239453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,46705,129,2.04 [1.73-2.40],2.1448822630394817e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDM1,Nuclear protein MDM1,39492,104,1.01 [0.56-1.82],0.9807434706022732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39538,103,1.26 [1.05-1.52],0.0153797446116352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED18,Mediator of RNA polymerase II transcription subunit 18,45615,120,1.09 [0.88-1.34],0.4480615629119133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED21,Mediator of RNA polymerase II transcription subunit 21,39283,102,0.97 [0.64-1.49],0.8958311785849086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,46670,123,2.14 [1.43-3.19],0.0001976149853115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,39283,102,1.08 [0.61-1.92],0.7828241297540228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,47110,128,2.10 [1.18-3.71],0.0110729705928729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MELTF,Melanotransferrin,40628,107,1.42 [0.79-2.55],0.235021297687632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,39729,105,0.40 [0.28-0.57],4.425826563143482e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,40451,106,1.22 [0.96-1.55],0.1028089054429006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,46694,125,0.89 [0.78-1.01],0.0651939125465956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,46670,123,0.39 [0.22-0.66],0.0005753558082976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,47210,127,2.17 [1.20-3.93],0.0106375212199273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MESD,LRP chaperone MESD,46698,127,1.07 [0.94-1.21],0.3135263672465928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,46813,124,0.37 [0.16-0.84],0.0167011264715284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1,Methionine aminopeptidase 1,45638,124,1.06 [0.61-1.82],0.8436450597419072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",46626,123,1.21 [1.01-1.45],0.0440452022780124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP2,Methionine aminopeptidase 2,47029,128,1.16 [0.87-1.53],0.3070660790576811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3,Microfibril-associated glycoprotein 3,45838,124,1.09 [0.79-1.50],0.616402898561139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3L,Microfibrillar-associated protein 3-like,39492,104,0.75 [0.52-1.09],0.1264474753983377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,39729,105,7.77 [4.52-13.34],1.111225821039832e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,47267,128,1.77 [1.21-2.59],0.0031892792147414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,46698,127,4.22 [3.18-5.59],1.2408352672624493e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGLL,Monoglyceride lipase,46823,124,1.07 [0.89-1.29],0.4662057608108112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,46626,123,1.05 [0.92-1.20],0.460803571942963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIA,Melanoma-derived growth regulatory protein,46850,129,0.84 [0.55-1.30],0.4333744567876577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICALL2,MICAL-like protein 2,39492,104,1.21 [0.94-1.56],0.1328705668186818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,46626,123,1.26 [1.07-1.48],0.0046224629101558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIF,Macrophage migration inhibitory factor,46623,127,0.95 [0.75-1.19],0.6541058001456288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,45833,124,2.52 [1.95-3.25],1.5541127470319698e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40433,105,1.12 [0.94-1.33],0.2190308416863944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINK1,Misshapen-like kinase 1,40529,106,1.13 [0.92-1.37],0.2466602274820809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MITD1,MIT domain-containing protein 1,46337,124,1.05 [0.89-1.24],0.5854965986342924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MKI67,Proliferation marker protein Ki-67,39446,103,1.29 [0.85-1.96],0.2245006382186979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,39172,104,1.22 [0.97-1.52],0.0837563449536854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,46626,123,1.78 [1.47-2.15],2.370913943551512e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,46483,124,1.68 [1.40-2.01],1.5409273603367248e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,44988,120,1.30 [1.08-1.57],0.0066068291735946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,46591,123,1.95 [1.56-2.43],3.5289959543589127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,46734,128,2.65 [2.10-3.35],2.382023630483881e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP13,Collagenase 3,45638,124,1.17 [0.72-1.92],0.522208909004507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,40628,107,1.14 [0.83-1.56],0.4252544833313635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,46698,127,1.58 [1.20-2.09],0.0012597530962312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,45765,124,3.97 [2.92-5.40],1.7665986157359942e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,47039,128,1.27 [1.04-1.56],0.0220076185057917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,46620,127,1.31 [1.01-1.71],0.0422022416910229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39283,102,1.27 [0.91-1.78],0.1582607434590044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,39492,104,1.16 [0.87-1.55],0.3029835762779128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNAT1,CDK-activating kinase assembly factor MAT1,39882,107,0.84 [0.53-1.33],0.4685482936861773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNDA,Myeloid cell nuclear differentiation antigen,46624,125,0.95 [0.80-1.12],0.535000735632928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,39729,105,1.40 [1.08-1.83],0.0125050611981918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOG,Myelin-oligodendrocyte glycoprotein,47097,128,1.38 [0.88-2.17],0.1600795978623982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORC3,MORC family CW-type zinc finger protein 3,40529,106,1.38 [0.75-2.55],0.3016429505247047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L1,Mortality factor 4-like protein 1,39882,107,1.05 [0.66-1.68],0.8391208691174843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L2,Mortality factor 4-like protein 2,39172,104,1.15 [0.71-1.86],0.581864041177085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORN4,MORN repeat-containing protein 4,39172,104,0.97 [0.76-1.25],0.826392159703218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPHOSPH8,M-phase phosphoprotein 8,45838,124,1.09 [0.89-1.34],0.4125769744953641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPI,Mannose-6-phosphate isomerase,46483,124,1.13 [0.95-1.36],0.1768157546417361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,46823,124,1.15 [0.92-1.43],0.2346319293813897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPO,Myeloperoxidase,46698,127,1.34 [0.98-1.84],0.064741979201021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPRIP,Myosin phosphatase Rho-interacting protein,40360,105,0.87 [0.56-1.35],0.5337694344352711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,40646,105,8.51 [5.20-13.91],1.5012434242488386e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRI1,Methylthioribose-1-phosphate isomerase,39492,104,0.77 [0.59-1.01],0.0630487459758561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL24,"39S ribosomal protein L24, mitochondrial",39283,102,1.13 [0.73-1.77],0.576255263051532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL28,"39S ribosomal protein L28, mitochondrial",40550,105,1.04 [0.62-1.73],0.8953480050721061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL46,"39S ribosomal protein L46, mitochondrial",45638,124,1.20 [0.72-2.01],0.4862566910800213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",39098,104,1.40 [0.88-2.21],0.1516986567590375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40550,105,1.13 [0.90-1.42],0.2903987115253176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPS16,"28S ribosomal protein S16, mitochondrial",39446,103,0.75 [0.35-1.60],0.4573559036652763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,46414,124,1.83 [1.45-2.31],3.139049217136411e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLNL,Mesothelin-like protein,39492,104,0.82 [0.50-1.35],0.4257780273183442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,46576,125,1.42 [1.16-1.74],0.000790777941506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,47117,128,3.89 [2.96-5.11],2.4734007375807435e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,46850,129,1.04 [0.84-1.29],0.7017091901732815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,40031,104,1.54 [1.01-2.37],0.0469813896207818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSTN,Growth/differentiation factor 8,45838,124,0.75 [0.56-1.01],0.0555240069652239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,39446,103,1.28 [1.06-1.55],0.0103820510426617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40529,106,1.59 [0.90-2.79],0.1069542192120032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39882,107,1.12 [0.95-1.31],0.1737251536448698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",40451,106,1.20 [0.99-1.46],0.0691927425019743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTPN,Myotrophin,45838,124,0.69 [0.40-1.17],0.1652061618255501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTR,Methionine synthase,39283,102,1.09 [0.81-1.45],0.575156030832165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,40451,106,1.22 [1.04-1.44],0.0174353958337224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS2,Protein MTSS 2,40433,105,1.20 [1.00-1.43],0.0523532883039431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,39882,107,1.46 [1.10-1.93],0.0085686452177602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,45638,124,4.74 [3.97-5.65],7.662676569544941e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC16,Mucin-16,46483,124,1.05 [0.96-1.14],0.3195270310460136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,40614,105,1.15 [0.95-1.40],0.1616486860018559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,39172,104,1.50 [1.15-1.96],0.0026157993545649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,45833,124,1.66 [1.41-1.96],2.200507223254608e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,39729,105,0.54 [0.39-0.75],0.0002184898387171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",40628,107,2.04 [1.69-2.46],1.1259627322780797e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",39538,103,1.36 [1.16-1.60],0.0001441732589441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40550,105,1.19 [0.92-1.53],0.1844317172524076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,40628,107,1.29 [1.08-1.55],0.0058452146968784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH4,Myosin-4,39283,102,0.69 [0.44-1.11],0.1248378052958005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH7B,Myosin-7B,39172,104,0.99 [0.65-1.53],0.9740183125728058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH9,Myosin-9,40614,105,1.17 [1.00-1.38],0.0501953802993708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39283,102,1.48 [1.18-1.87],0.000824085520518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,39538,103,1.93 [1.54-2.41],1.1944829726510464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL4,Myosin light chain 4,39538,103,1.13 [0.83-1.53],0.4385502262007901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL6B,Myosin light chain 6B,39492,104,0.96 [0.78-1.20],0.7450658025992709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39492,104,1.72 [1.40-2.12],4.00249739313813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO6,Unconventional myosin-VI,40550,105,1.39 [0.94-2.04],0.0951764666491885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO9B,Unconventional myosin-IXb,45833,124,1.06 [0.83-1.35],0.6499698327100794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOC,Myocilin,46698,127,0.86 [0.61-1.22],0.3910686647120909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM1,Myomesin-1,39312,102,1.10 [0.75-1.62],0.6190602501850011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,39283,102,1.56 [1.17-2.08],0.0022934135498438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,39729,105,1.47 [1.22-1.77],5.523230931151873e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,46822,123,1.92 [1.47-2.51],1.6273409584575738e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZT1,Mitotic-spindle organizing protein 1,45615,120,1.14 [0.84-1.55],0.4128387598635766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA10,N-alpha-acetyltransferase 10,39283,102,0.87 [0.61-1.24],0.4447066565122703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA80,N-alpha-acetyltransferase 80,39492,104,1.16 [0.99-1.34],0.0595330640832163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,46116,123,0.86 [0.65-1.14],0.3012435172110987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,40433,105,1.33 [1.00-1.77],0.0497745539184322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NADK,NAD kinase,46694,125,1.09 [0.83-1.44],0.5283866262756738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,39374,102,1.34 [1.04-1.73],0.0254026386766147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,39467,103,0.62 [0.44-0.89],0.0086928661295153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39729,105,4.21 [1.86-9.55],0.0005762571037824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAMPT,Nicotinamide phosphoribosyltransferase,45615,120,1.01 [0.74-1.36],0.9627159436057708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAP1L4,Nucleosome assembly protein 1-like 4,40376,106,0.89 [0.57-1.39],0.6083769542992663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAPRT,Nicotinate phosphoribosyltransferase,40529,106,0.75 [0.42-1.33],0.3244987493108767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40550,105,1.30 [0.86-1.97],0.2089216006621085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,46850,129,10.15 [6.69-15.40],1.169631019766775e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBN,Nibrin,45833,124,0.87 [0.62-1.22],0.4051874932050645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM1,Neural cell adhesion molecule 1,46888,125,1.02 [0.62-1.69],0.933666667690526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM2,Neural cell adhesion molecule 2,46698,127,0.83 [0.46-1.50],0.5321539556284701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,47117,128,0.47 [0.37-0.58],1.2255267771891388e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCF2,Neutrophil cytosol factor 2,46548,122,0.93 [0.76-1.13],0.4559253668271009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCK2,Cytoplasmic protein NCK2,46900,124,1.08 [0.93-1.25],0.30678846574347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCLN,Nicalin,45833,124,1.14 [0.84-1.53],0.4018323913920404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,46558,123,4.78 [3.39-6.74],4.705123588882262e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40451,106,4.82 [3.37-6.90],7.527272500378581e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,47097,128,6.18 [3.83-9.98],9.454176606149446e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDRG1,Protein NDRG1,45638,124,0.87 [0.65-1.15],0.3312387495596389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40433,105,0.89 [0.64-1.25],0.5051808820066293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39381,103,2.01 [1.26-3.22],0.0034890909086273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40451,106,1.23 [1.01-1.49],0.039967227084887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",45615,120,1.28 [1.11-1.49],0.0008908172235805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,39283,102,1.49 [1.00-2.21],0.0511885780459864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECAP2,Adaptin ear-binding coat-associated protein 2,39283,102,1.10 [0.84-1.44],0.481557685495926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN1,Nectin-1,39446,103,0.96 [0.52-1.77],0.8963212499773809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,46621,125,8.44 [6.19-11.51],1.9410246338582188e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,46850,129,3.46 [2.69-4.45],4.254428976381277e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39446,103,0.92 [0.62-1.35],0.6659777505906124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD9,Enhancer of filamentation 1,39446,103,1.17 [0.69-2.00],0.5611256904653751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,45494,123,2.61 [2.13-3.19],7.809790174621492e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEK7,Serine/threonine-protein kinase Nek7,39882,107,0.99 [0.76-1.28],0.9283157843514264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,46850,129,0.55 [0.44-0.68],9.850110182301224e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL2,Protein kinase C-binding protein NELL2,46900,124,1.47 [0.85-2.54],0.1684980683431557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NENF,Neudesin,40433,105,1.02 [0.86-1.20],0.8578713222009022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,40550,105,1.97 [1.09-3.54],0.0238819703582406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEXN,Nexilin,40646,105,1.16 [0.90-1.50],0.2439059982769245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,47210,127,25.61 [16.93-38.73],2.9832670430990063e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFAT5,Nuclear factor of activated T-cells 5,39446,103,1.20 [0.98-1.47],0.0846589184946425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",46626,123,1.17 [1.00-1.37],0.0571566681549833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",45833,124,1.78 [1.45-2.17],1.6332500418234033e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFE2,Transcription factor NF-E2 45 kDa subunit,39538,103,1.20 [0.94-1.54],0.1470964433806356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFIC,Nuclear factor 1 C-type,40550,105,1.02 [0.69-1.50],0.934690082523796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39283,102,1.22 [0.95-1.57],0.1149429027387385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39882,107,1.05 [0.76-1.47],0.7605941259580934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,45615,120,1.35 [1.01-1.81],0.0423041512491351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40451,106,1.20 [1.01-1.43],0.0394958955943491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFX1,Transcriptional repressor NF-X1,39283,102,1.22 [0.93-1.60],0.1591382557374684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFYA,Nuclear transcription factor Y subunit alpha,39283,102,1.16 [0.76-1.79],0.4885188667554385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGF,Beta-nerve growth factor,46337,124,2.68 [0.90-7.99],0.0776830504502777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,40628,107,2.32 [1.76-3.06],2.556767388195904e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,40529,106,3.32 [2.25-4.90],1.619517154812514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,38778,103,7.02 [3.97-12.42],2.150596893142325e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID1,Nidogen-1,46731,125,1.43 [0.94-2.17],0.0936175137072514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID2,Nidogen-2,46698,127,1.06 [0.86-1.31],0.5640217006930383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,45615,120,1.32 [1.05-1.66],0.018093603710344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT1,Deaminated glutathione amidase,39538,103,0.70 [0.47-1.05],0.0812275010658851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT2,Omega-amidase NIT2,40478,107,1.24 [0.96-1.59],0.098188364100895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN1,Neuroligin-1,39492,104,1.04 [0.78-1.38],0.7917240659179148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN2,Neuroligin-2,39312,102,0.72 [0.45-1.17],0.1902590272370168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME1,Nucleoside diphosphate kinase A,39446,103,2.05 [0.90-4.67],0.0882994846383875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME3,Nucleoside diphosphate kinase 3,46745,123,0.89 [0.45-1.78],0.744870881739129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMI,N-myc-interactor,40281,104,1.07 [0.83-1.37],0.602700120489218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,46337,124,0.94 [0.75-1.18],0.5978935842140204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMRK2,Nicotinamide riboside kinase 2,39172,104,1.03 [0.64-1.64],0.9169584622677884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40550,105,0.95 [0.72-1.27],0.7365933304815703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,46698,127,4.31 [2.60-7.16],1.6437781760884774e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,39283,102,1.14 [0.99-1.32],0.0666547751525606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",45638,124,2.10 [1.74-2.53],1.448433993583731e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS2,"Nitric oxide synthase, inducible",39283,102,0.82 [0.49-1.37],0.4529151627479358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",45638,124,1.74 [1.49-2.02],1.1695994720114137e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,47267,128,13.25 [5.66-31.05],2.7114133204385742e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,40614,105,3.96 [1.99-7.88],8.60126146540607e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,47267,128,1.60 [1.02-2.50],0.0389633381635017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,39923,105,2.25 [0.69-7.36],0.180897518141485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,46694,125,3.76 [2.96-4.78],2.038934283043845e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS1,Nephrin,39446,103,0.93 [0.52-1.68],0.8204756314582833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS2,Podocin,39446,103,1.07 [0.90-1.27],0.4598344110142541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,40628,107,1.64 [1.13-2.38],0.0088956754301202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,45838,124,1.43 [1.28-1.59],3.074249078671678e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,46626,123,1.38 [1.07-1.78],0.0145456072547295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPR1,Atrial natriuretic peptide receptor 1,39283,102,0.57 [0.31-1.05],0.0693318556962535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,45615,120,1.18 [1.00-1.39],0.0443867248053499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,46698,127,1.60 [1.13-2.26],0.0078735863726632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,40614,105,1.68 [0.96-2.95],0.0694829357530947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTXR,Neuronal pentraxin receptor,46694,125,0.63 [0.39-1.04],0.071118283502362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,47097,128,3.98 [3.02-5.26],1.5981024235940212e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,46694,125,5.02 [3.57-7.06],1.920443284657624e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRGN,Neurogranin,40646,105,1.14 [0.93-1.39],0.2030003024108557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRN1,Neuritin,40550,105,1.19 [0.75-1.90],0.4517491472508185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,46966,125,6.21 [3.72-10.35],2.806570860222499e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP2,Neuropilin-2,46698,127,1.54 [0.92-2.59],0.099118557908037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRTN,Neurturin,45833,124,1.24 [0.93-1.64],0.1414544159209529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRXN3,Neurexin-3,39492,104,0.95 [0.55-1.64],0.8530508237838517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NSFL1C,NSFL1 cofactor p47,47117,128,0.82 [0.64-1.04],0.098877344128025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40628,107,1.05 [0.82-1.35],0.671733520124113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,40529,106,2.43 [1.97-2.98],3.9427948887399867e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,46551,123,0.89 [0.74-1.06],0.1936216955983918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,46850,129,1.36 [1.05-1.78],0.0209940747989919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,46626,123,2.62 [1.90-3.61],4.549337059385802e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF4,Neurotrophin-4,45615,120,0.86 [0.57-1.31],0.4900016920066131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK2,BDNF/NT-3 growth factors receptor,46694,125,1.51 [0.81-2.83],0.1966383910434083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,47117,128,0.51 [0.34-0.75],0.0007973027764639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,46694,125,1.62 [1.45-1.80],1.3036765448612988e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUB1,NEDD8 ultimate buster 1,46626,123,1.08 [0.90-1.30],0.4002543821066301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40433,105,1.13 [0.94-1.35],0.1909650215173185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,47019,128,2.77 [1.92-4.00],5.3172782408920864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,47210,127,1.33 [1.03-1.72],0.0286106365412189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39538,103,0.56 [0.23-1.41],0.2217819230016571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39283,102,0.79 [0.51-1.23],0.3044985545989705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,40381,106,1.27 [1.03-1.55],0.0225471105647915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],46483,124,0.69 [0.51-0.94],0.0177892673590369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT5,ADP-sugar pyrophosphatase,46698,127,1.26 [0.94-1.70],0.1213793410338422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,39446,103,1.23 [0.98-1.54],0.0796468184417645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUP50,Nuclear pore complex protein Nup50,39283,102,1.24 [0.75-2.05],0.4070570281381355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPE4,NXPE family member 4,39283,102,0.77 [0.40-1.51],0.4488678016304774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH1,Neurexophilin-1,45638,124,1.10 [0.76-1.60],0.6132778115344977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,39446,103,1.50 [0.79-2.84],0.2109991593840014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OBP2B,Odorant-binding protein 2b,46180,124,0.83 [0.63-1.07],0.1545716109694156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,40550,105,3.16 [2.45-4.06],4.0887552657398e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,45560,124,0.71 [0.51-0.98],0.0399321161664622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OFD1,Oral-facial-digital syndrome 1 protein,39882,107,0.97 [0.72-1.31],0.8547703696793353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGA,Protein O-GlcNAcase,40451,106,1.25 [0.96-1.61],0.0921057071466858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,46483,124,1.49 [0.93-2.39],0.0982454115755382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,46698,127,3.23 [2.44-4.27],3.209577984436487e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39882,107,0.88 [0.63-1.23],0.4686230226756024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,38252,100,1.40 [1.18-1.66],8.7875656724896e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLR1,Oxidized low-density lipoprotein receptor 1,46234,124,1.21 [0.95-1.55],0.1254620709697686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,46900,124,0.33 [0.24-0.46],3.475106015837533e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,46483,124,0.61 [0.49-0.77],2.3624936981213944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMP,Olfactory marker protein,39312,102,0.80 [0.52-1.23],0.313226531678171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPHN1,Oligophrenin-1,40529,106,1.14 [0.96-1.36],0.1304797320456782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,39538,103,1.38 [1.05-1.80],0.0195679788495748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPTC,Opticin,46483,124,1.03 [0.73-1.45],0.8829156895335535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,40533,105,2.51 [1.05-5.99],0.0374957751375061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSBPL2,Oxysterol-binding protein-related protein 2,40529,106,0.91 [0.55-1.50],0.7167161632836576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,46745,123,4.22 [2.67-6.65],6.428464506786882e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,46402,122,1.34 [1.07-1.68],0.0110005789419887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,46966,125,6.69 [3.14-14.28],8.605179274467746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSTN,Osteocrin,39492,104,0.89 [0.54-1.45],0.6398987000650649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTOA,Otoancorin,39312,102,1.02 [0.71-1.46],0.919910134809383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD6B,Deubiquitinase OTUD6B,40451,106,1.08 [0.79-1.47],0.6278220369413505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,40550,105,1.50 [1.13-1.98],0.0046172592934163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39538,103,1.21 [0.95-1.55],0.1240548116960135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,47117,128,1.27 [1.14-1.42],3.092508997215965e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,46480,129,2.08 [1.42-3.05],0.0001733461168584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,39283,102,1.36 [1.02-1.81],0.0375641432302418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,45833,124,1.27 [1.01-1.59],0.0412092655090262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI4,Protein-arginine deiminase type-4,45560,124,0.80 [0.63-1.02],0.0750598944495013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAEP,Glycodelin,46337,124,1.09 [0.95-1.25],0.2353729359334392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40550,105,1.12 [0.97-1.29],0.1330977051427239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39882,107,1.14 [0.80-1.63],0.4654140930983587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,45838,124,1.63 [1.28-2.08],6.536673121842532e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,39538,103,1.01 [0.65-1.58],0.955843637968062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39102,104,1.33 [0.94-1.87],0.1048278804417673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAK4,Serine/threonine-protein kinase PAK 4,45638,124,1.09 [0.85-1.40],0.4875157621503527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALLD,Palladin,39446,103,1.26 [0.82-1.93],0.2972880550556659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,40232,106,3.23 [2.43-4.31],1.112932897504835e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,40529,106,3.83 [3.02-4.85],1.1012008313622098e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM3,Paralemmin-3,39283,102,1.08 [0.84-1.39],0.5644460685293506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,47036,126,1.39 [0.77-2.53],0.2759491175857506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,46698,127,1.80 [1.00-3.24],0.0498909885217946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAPPA,Pappalysin-1,45833,124,0.73 [0.52-1.02],0.0670643741867613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARD3,Partitioning defective 3 homolog,39882,107,1.06 [0.84-1.34],0.6205445109296446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARK7,Parkinson disease protein 7,46698,127,0.92 [0.68-1.23],0.5651727631569201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARP1,Poly [ADP-ribose] polymerase 1,46626,123,1.16 [0.93-1.45],0.1979178240213819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,39729,105,1.36 [0.93-1.99],0.1086466611242924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39172,104,0.97 [0.54-1.73],0.9058338109928278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBLD,Phenazine biosynthesis-like domain-containing protein,45638,124,0.78 [0.57-1.06],0.1140449916313892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40451,106,1.95 [1.30-2.93],0.0012627252704805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,39312,102,1.08 [0.88-1.33],0.4401209112123001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39653,105,1.44 [1.01-2.04],0.0419228023573049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBP2,Poly(rC)-binding protein 2,40550,105,1.11 [0.86-1.42],0.4282877521879407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,47063,127,2.65 [1.57-4.47],0.0002761543909348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH12,Protocadherin-12,40550,105,1.76 [0.87-3.54],0.1151220655241568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,46694,125,3.25 [2.56-4.12],3.3879589405428123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,40451,106,1.84 [1.36-2.50],7.992055748947328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,40451,106,2.62 [1.53-4.47],0.0004178566452305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,40433,105,1.65 [1.12-2.43],0.0120795187338716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCNA,Proliferating cell nuclear antigen,39172,104,1.13 [0.88-1.46],0.341458109738004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,40433,105,1.02 [0.71-1.46],0.9205821942496742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,47267,128,2.70 [1.86-3.90],1.3800088631941462e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40451,106,1.12 [0.88-1.44],0.3501332893140745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40628,107,1.15 [0.95-1.38],0.1498371888968556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,47019,128,2.60 [2.03-3.33],3.3502466102499134e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,46483,124,3.14 [2.42-4.07],6.234650481751248e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,47117,128,1.05 [0.81-1.37],0.699247270017977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,46694,125,1.54 [1.14-2.06],0.0045307820749166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCL2,Phosducin-like protein 2,39172,104,1.05 [0.74-1.48],0.7919922247380218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39172,104,1.11 [0.82-1.50],0.4915293383426746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39283,102,0.90 [0.63-1.31],0.5959803721008589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39729,105,1.12 [0.93-1.35],0.2241394951519901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFA,Platelet-derived growth factor subunit A,47267,128,1.08 [0.87-1.33],0.504612636151541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,46900,124,1.08 [0.90-1.30],0.4066531585308874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,45615,120,1.74 [1.02-2.97],0.0434766130218286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,46694,125,5.58 [3.66-8.51],1.3589371465681433e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRB,Platelet-derived growth factor receptor beta,47267,128,1.19 [0.76-1.87],0.4517956850624758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA2,Protein disulfide-isomerase A2,39172,104,0.97 [0.61-1.55],0.9130645810171588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,39729,105,2.71 [1.93-3.80],9.872371620775025e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,40614,105,1.33 [1.01-1.76],0.0446330949316383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA5,Protein disulfide-isomerase A5,39172,104,1.10 [0.81-1.48],0.551569268009774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM5,PDZ and LIM domain protein 5,40550,105,1.05 [0.90-1.24],0.5135635332722918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM7,PDZ and LIM domain protein 7,46900,124,1.09 [0.96-1.24],0.1683014694803156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",45615,120,1.09 [0.79-1.50],0.6160719131416359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDRG1,p53 and DNA damage-regulated protein 1,39492,104,0.79 [0.51-1.21],0.2731677544301261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39172,104,0.59 [0.33-1.05],0.0740057228815061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,39283,102,1.35 [1.02-1.79],0.0348546568032058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39446,103,2.56 [1.97-3.33],1.637539076953943e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,47267,128,3.67 [1.87-7.21],0.0001600914982282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEBP1,Phosphatidylethanolamine-binding protein 1,46698,127,0.96 [0.73-1.26],0.7696402559796542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,46698,127,1.76 [1.09-2.85],0.0207292571245734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39538,103,0.65 [0.31-1.35],0.2447509250354019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,39729,105,2.54 [1.88-3.43],1.3719889496753174e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,40646,105,0.33 [0.16-0.66],0.001711232536899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PER3,Period circadian protein homolog 3,39446,103,1.12 [0.96-1.30],0.1589511686174485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PF4,Platelet factor 4,40371,104,1.20 [0.99-1.46],0.0614956402690833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN2,Prefoldin subunit 2,45638,124,1.02 [0.76-1.37],0.8963819656625132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN4,Prefoldin subunit 4,39172,104,1.16 [0.83-1.61],0.3894340054939879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN6,Prefoldin subunit 6,39492,104,0.98 [0.72-1.34],0.9079131970994152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",46405,124,0.99 [0.81-1.22],0.9509847251560996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,40646,105,1.47 [1.16-1.86],0.0013390206488245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40628,107,1.15 [0.81-1.63],0.4491357050120713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,47210,127,4.24 [3.38-5.33],2.0610349743641127e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,47034,127,2.31 [1.75-3.05],4.091365854942395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40159,105,2.14 [1.10-4.16],0.0251931730579578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP4,Peptidoglycan recognition protein 4,39283,102,1.27 [0.98-1.64],0.0755742250077312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGM2,Phosphoglucomutase-2,39492,104,1.11 [0.84-1.47],0.4685695164579917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,39446,103,1.14 [0.97-1.33],0.1182079122596341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHACTR2,Phosphatase and actin regulator 2,40550,105,1.11 [0.95-1.30],0.2011785798715328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,40451,106,2.14 [1.57-2.92],1.722906179143217e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB2,Pleckstrin homology-like domain family B member 2,39172,104,1.11 [0.93-1.33],0.2431293823393523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,46337,124,4.09 [3.03-5.51],2.6600874170044602e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39729,105,1.33 [0.86-2.07],0.1986548412265893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,40646,105,1.70 [0.80-3.63],0.170488649479534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,46066,125,2.03 [1.69-2.45],1.087587187688356e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40550,105,1.12 [0.89-1.42],0.336740250308568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,46097,126,6.08 [4.61-8.03],2.346642962301514e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,46626,123,0.85 [0.66-1.11],0.2376570104249125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,46698,127,0.37 [0.20-0.70],0.002320466020693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39446,103,1.14 [0.83-1.57],0.4144192325690482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,46698,127,4.79 [3.49-6.58],3.750341508821386e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,46694,125,3.36 [2.43-4.64],1.8254712391792565e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39729,105,0.62 [0.49-0.79],0.0001046480915152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PITHD1,PITH domain-containing protein 1,39102,104,1.09 [0.86-1.37],0.4838823600489218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,40628,107,12.81 [6.92-23.73],5.157439945907432e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,39283,102,1.68 [1.31-2.14],3.1870423389560144e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,46747,124,0.69 [0.53-0.89],0.0044569155093657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKN3,Serine/threonine-protein kinase N3,39882,107,1.24 [0.99-1.55],0.0645365322854295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,46337,124,1.83 [1.39-2.39],1.1512217911358087e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,46850,129,5.51 [3.41-8.92],3.402351349935612e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,47189,128,0.67 [0.47-0.95],0.0233634964298027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",46598,125,1.40 [1.17-1.68],0.000318483534341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G4A,Cytosolic phospholipase A2,46900,124,1.13 [0.95-1.35],0.1766093326881326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,46698,127,0.54 [0.41-0.71],8.869605985752493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAT,Tissue-type plasminogen activator,47110,128,1.03 [0.76-1.39],0.8716164604750929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,46698,127,1.51 [1.02-2.22],0.0387537795275614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,46358,123,12.99 [8.83-19.11],8.283974976239528e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",40529,106,0.55 [0.41-0.75],0.0001031928720213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39446,103,1.34 [0.93-1.93],0.1122879525958325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40529,106,1.19 [0.99-1.44],0.0666653475183903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40529,106,1.49 [1.17-1.91],0.0012284843598342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLG,Plasminogen,39649,104,1.87 [0.79-4.43],0.1527797958752124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,45638,124,1.77 [1.29-2.42],0.0003409008174765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,46694,125,1.98 [1.43-2.74],3.634793459222728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLPBP,Pyridoxal phosphate homeostasis protein,46694,125,0.92 [0.73-1.16],0.4878094703872255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,40457,106,1.79 [1.32-2.43],0.0001973277372347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLTP,Phospholipid transfer protein,47115,126,0.73 [0.48-1.10],0.1314282464729058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC1,Plexin domain-containing protein 1,45615,120,1.26 [0.81-1.96],0.3117692868452504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,40529,106,2.17 [1.53-3.07],1.3225798694898374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNA4,Plexin-A4,46626,123,1.19 [0.98-1.44],0.0877322503982735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,47037,127,33.26 [22.94-48.23],2.6459956311575407e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB3,Plexin-B3,46545,125,1.18 [0.86-1.62],0.3138816977288214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,46466,124,1.02 [0.94-1.11],0.5978683649384648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMCH,Pro-MCH,39283,102,0.93 [0.72-1.21],0.6073110111118922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMM2,Phosphomannomutase 2,39283,102,1.23 [0.91-1.66],0.1837203690685738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMS1,PMS1 protein homolog 1,39492,104,1.23 [0.88-1.74],0.2275894008005435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMVK,Phosphomevalonate kinase,45561,124,0.97 [0.84-1.12],0.7129564307354435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,40646,105,1.16 [0.88-1.54],0.2902941565315219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40529,106,1.37 [1.11-1.71],0.0041477602818206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP2,Pancreatic lipase-related protein 2,46670,123,1.04 [0.98-1.10],0.2428511191406808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA1,Paraneoplastic antigen Ma1,39538,103,0.97 [0.70-1.35],0.8546817576067315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA2,Paraneoplastic antigen Ma2,39312,102,0.92 [0.58-1.45],0.7250344233488639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",45833,124,1.01 [0.89-1.16],0.8429223176075272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL,Podocalyxin,46483,124,1.04 [0.37-2.98],0.9344300154685956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL2,Podocalyxin-like protein 2,46850,129,1.50 [0.89-2.52],0.1297409070049299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,39446,103,2.23 [1.84-2.70],3.210635065608566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39446,103,1.42 [0.79-2.57],0.2415782160564316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",46483,124,1.75 [1.33-2.31],6.881510057414334e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POMC,Pro-opiomelanocortin,39538,103,1.01 [0.78-1.31],0.9279188326945657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,40646,105,0.38 [0.27-0.54],6.18547047045955e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,45838,124,1.57 [1.01-2.43],0.0430943531362621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,46900,124,0.39 [0.33-0.45],3.935704482505396e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POSTN,Periostin,40614,105,0.73 [0.45-1.19],0.2061291274820551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,40376,104,1.19 [0.95-1.49],0.1252994334993085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,47117,128,0.86 [0.62-1.21],0.3888105444937016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,46729,125,1.13 [0.95-1.33],0.1644394302761799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,39882,107,0.85 [0.61-1.18],0.3431585205845449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40614,105,1.14 [0.87-1.49],0.3317023405927766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,39446,103,1.90 [1.26-2.87],0.0021636723992986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,45615,120,0.48 [0.26-0.88],0.0171632445485259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1B,Protein phosphatase 1B,39446,103,1.24 [0.97-1.58],0.0868691691951816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1F,Protein phosphatase 1F,40628,107,1.18 [0.85-1.65],0.3199576316393782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,46483,124,0.76 [0.59-0.99],0.0445600687829272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40433,105,1.09 [0.87-1.35],0.4579210934463185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,46850,129,1.09 [0.94-1.28],0.2634439196988176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39882,107,1.34 [1.11-1.62],0.001983322549975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40550,105,1.17 [0.94-1.46],0.1533874997051472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40550,105,2.02 [1.48-2.75],8.174491625066359e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R2,Protein phosphatase inhibitor 2,46694,125,1.13 [0.93-1.37],0.2146162198717586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R9B,Neurabin-2,47210,127,1.15 [0.98-1.36],0.0873563274578468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40451,106,1.17 [1.01-1.35],0.0364074146936332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP3R1,Calcineurin subunit B type 1,46337,124,1.31 [0.88-1.94],0.1826524369947327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPT1,Palmitoyl-protein thioesterase 1,39492,104,1.20 [0.98-1.47],0.0815836883001938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,46639,129,1.58 [1.37-1.82],2.9379385686829343e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PQBP1,Polyglutamine-binding protein 1,45615,120,0.87 [0.63-1.20],0.3959566709017764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAME,Melanoma antigen preferentially expressed in tumors,39172,104,1.19 [0.59-2.42],0.6296333439716488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,40614,105,23.78 [14.52-38.93],2.197352500718132e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRC1,Protein regulator of cytokinesis 1,40433,105,0.82 [0.48-1.40],0.4741058259721017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,46970,128,4.48 [3.57-5.63],3.415543350207201e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX1,Peroxiredoxin-1,45381,120,0.91 [0.76-1.10],0.3528922734966768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,39951,102,0.51 [0.37-0.72],9.656732210725592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",45833,124,1.32 [1.07-1.63],0.0087190701704181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX5,"Peroxiredoxin-5, mitochondrial",47210,127,0.86 [0.68-1.08],0.1985207125042659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,47097,128,0.54 [0.41-0.71],8.645088326219319e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,45833,124,2.34 [1.73-3.18],4.909774762509049e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,46670,123,4.45 [2.87-6.89],2.310431770484852e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,40614,105,2.39 [1.73-3.29],1.1447375710924136e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG3,Proteoglycan 3,40614,105,0.97 [0.66-1.41],0.8604108416693765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,45833,124,1.43 [1.09-1.87],0.0094459049634645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39492,104,1.24 [0.69-2.23],0.4683805348204659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,46694,125,1.17 [0.96-1.41],0.1176823874714418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40453,106,1.29 [1.01-1.64],0.0406416150758812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKCQ,Protein kinase C theta type,45833,124,1.14 [0.80-1.63],0.4588876229594723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKD2,Serine/threonine-protein kinase D2,39283,102,1.05 [0.70-1.57],0.811897992222392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKG1,cGMP-dependent protein kinase 1,39729,105,1.07 [0.92-1.23],0.4011827245467114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,45615,120,1.35 [1.09-1.68],0.0067258457841725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRL,Prolactin,47117,128,1.15 [0.94-1.40],0.1848205424570472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,40529,106,1.40 [1.03-1.91],0.0308658012730384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROC,Vitamin K-dependent protein C,46810,125,0.72 [0.39-1.31],0.2797035644679663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROCR,Endothelial protein C receptor,39283,102,1.29 [0.80-2.09],0.3014308898393483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROK1,Prokineticin-1,46626,123,1.17 [0.88-1.56],0.2909036720999686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,40679,105,0.54 [0.27-1.05],0.0701246560301192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,39442,105,1.43 [1.13-1.81],0.0029418318875895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR5,Proline-rich protein 5,39446,103,1.12 [0.77-1.64],0.5498596622405161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,39538,103,2.57 [1.64-4.03],4.2137373593053344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,46888,125,1.51 [1.17-1.94],0.0012885801232859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,39446,103,2.09 [1.71-2.54],3.287217135643275e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,46538,125,1.96 [1.33-2.89],0.0006553136325496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS53,Serine protease 53,40529,106,0.78 [0.48-1.27],0.3147606368961247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,46516,124,6.77 [5.06-9.06],7.698250702119092e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,45638,124,1.02 [0.88-1.17],0.814106820245462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,47097,128,3.46 [2.35-5.09],2.7012711116691747e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,45519,125,1.54 [1.21-1.98],0.0005445788975355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,39882,107,2.07 [1.32-3.23],0.0014125021891256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,40226,105,2.99 [2.28-3.92],3.258637106559498e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAPL1,Proactivator polypeptide-like 1,40451,106,1.13 [0.79-1.63],0.4936161936235226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSCA,Prostate stem cell antigen,40451,106,1.06 [0.98-1.14],0.1540027250445853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,46337,124,1.87 [1.56-2.25],2.132103798382457e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,46626,123,1.18 [0.96-1.47],0.1186033105539997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMA1,Proteasome subunit alpha type-1,45615,120,1.00 [0.72-1.40],0.984932437718928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMC3,26S proteasome regulatory subunit 6A,39172,104,0.79 [0.42-1.50],0.473670777148097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40550,105,0.89 [0.61-1.30],0.5552483827359805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39492,104,1.10 [0.79-1.53],0.586891493782916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,46483,124,0.61 [0.44-0.84],0.0026056103770844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME1,Proteasome activator complex subunit 1,46257,124,0.87 [0.57-1.34],0.5363912405219987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,46125,122,0.90 [0.58-1.41],0.6548171625036203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,46626,123,0.68 [0.50-0.94],0.0211867119176321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG4,Proteasome assembly chaperone 4,39446,103,0.78 [0.55-1.11],0.1636203627173773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSPN,Persephin,46626,123,1.09 [0.92-1.29],0.2986019604506539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,45615,120,1.33 [1.06-1.66],0.0130232049432669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,38301,101,1.02 [0.85-1.22],0.8211646462622606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",45638,124,0.72 [0.42-1.23],0.2285581700595059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,46354,124,5.02 [3.77-6.67],1.9530126776726422e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,39147,101,1.55 [1.15-2.10],0.0041109515936577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,40628,107,1.26 [1.03-1.54],0.027998123902881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH,Parathyroid hormone,39492,104,1.00 [0.80-1.24],0.9658706931437564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,46626,123,1.71 [1.34-2.18],1.4397577518201584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,45638,124,2.62 [1.86-3.71],4.216303098127329e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,45838,124,1.25 [0.93-1.68],0.1311321651281759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,39446,103,1.42 [1.06-1.89],0.0170366507664747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,46337,124,1.19 [0.99-1.44],0.0666059389525802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,46823,124,1.02 [0.86-1.23],0.7944030724497125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39370,103,1.55 [1.10-2.20],0.013416420800479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40628,107,3.03 [1.84-4.99],1.248362498751418e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,40614,105,3.94 [2.38-6.50],8.946986800472503e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,47267,128,1.16 [0.67-1.98],0.5985814951006836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,40451,106,1.87 [1.32-2.67],0.0004885869748103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40451,106,2.17 [1.45-3.27],0.0001861916090696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,46552,122,2.01 [1.04-3.86],0.0370235652652343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,46183,123,2.79 [1.92-4.06],8.435887706500926e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,40529,106,1.13 [0.70-1.85],0.6121829891239197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,47267,128,1.01 [0.55-1.86],0.9777353718006556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40628,107,0.90 [0.49-1.64],0.727089418140858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39729,105,0.86 [0.63-1.18],0.3518079572081289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,45422,123,1.50 [1.18-1.90],0.0010600294847865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTTG1,Securin,39882,107,0.82 [0.50-1.35],0.4418980690513989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,46626,123,2.15 [1.42-3.25],0.0002895524048296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVALB,Parvalbumin alpha,46883,128,1.00 [0.87-1.15],0.990115116129926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,47117,128,4.02 [2.96-5.44],2.640282292755113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXDNL,Peroxidasin-like protein,40433,105,0.78 [0.52-1.17],0.2308282239127947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXN,Paxillin,45638,124,1.29 [1.00-1.68],0.0542234593587614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYDC1,Pyrin domain-containing protein 1,39538,103,0.80 [0.49-1.32],0.3829716641353667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,39283,102,2.33 [2.00-2.71],2.0756580599744118e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,40679,105,0.51 [0.32-0.81],0.0045295636081144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QDPR,Dihydropteridine reductase,46467,125,1.08 [0.75-1.55],0.6976898831691376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,46737,127,5.88 [3.93-8.80],6.270546323108205e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,39866,103,1.72 [1.39-2.12],4.852408209210949e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB10,Ras-related protein Rab-10,40628,107,1.14 [0.83-1.56],0.4292747930102968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB11FIP3,Rab11 family-interacting protein 3,40628,107,1.14 [0.97-1.35],0.1183584853343361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB27B,Ras-related protein Rab-27B,40628,107,1.24 [0.98-1.57],0.0765192392327066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB2B,Ras-related protein Rab-2B,40433,105,1.09 [0.80-1.46],0.591057782353088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB33A,Ras-related protein Rab-33A,39283,102,1.11 [0.85-1.44],0.4442456429552898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,45833,124,1.04 [0.87-1.25],0.6622020447206229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB39B,Ras-related protein Rab-39B,39283,102,0.94 [0.75-1.18],0.605289474494557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39312,102,0.94 [0.67-1.30],0.6914854166950217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB44,Ras-related protein Rab-44,40433,105,1.16 [0.81-1.66],0.4181623103408279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,46626,123,0.42 [0.30-0.59],3.480096856123412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6B,Ras-related protein Rab-6B,45638,124,1.05 [0.76-1.46],0.7500943594489518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEP1,Rab GTPase-binding effector protein 1,39729,105,1.14 [0.91-1.45],0.2591359162894961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEPK,Rab9 effector protein with kelch motifs,45615,120,0.99 [0.75-1.31],0.956462516202238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABGAP1L,Rab GTPase-activating protein 1-like,45833,124,0.82 [0.63-1.08],0.1673273531466264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAC3,Ras-related C3 botulinum toxin substrate 3,39492,104,0.94 [0.69-1.26],0.6610845369312591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD23B,UV excision repair protein RAD23 homolog B,45615,120,0.97 [0.68-1.37],0.8532374998810124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD51,DNA repair protein RAD51 homolog 1,39882,107,1.26 [0.98-1.61],0.0675849279562028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALB,Ras-related protein Ral-B,39446,103,1.72 [0.92-3.21],0.0876595064197495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALY,RNA-binding protein Raly,40433,105,1.11 [0.77-1.60],0.5736095168943292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,39538,103,0.74 [0.51-1.06],0.098469150252301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP2,E3 SUMO-protein ligase RanBP2,39312,102,0.76 [0.41-1.40],0.3828405981605858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,45615,120,1.10 [0.78-1.56],0.5758028510981408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAP1A,Ras-related protein Rap-1A,39446,103,1.18 [0.96-1.46],0.1201538902413359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,39882,107,1.22 [0.89-1.66],0.2118875086585584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,45615,120,1.60 [1.23-2.10],0.000589674019955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,46966,125,2.05 [1.66-2.53],2.339478526779312e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASA1,Ras GTPase-activating protein 1,45638,124,1.09 [0.67-1.77],0.7356251923437636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39172,104,1.30 [0.87-1.94],0.2074748948275563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASSF2,Ras association domain-containing protein 2,45615,120,1.20 [0.96-1.51],0.1098291719985831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,40550,105,3.71 [2.23-6.18],4.667376473672385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,45597,120,0.67 [0.51-0.88],0.0046657058177756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM17,Splicing factor 45,40550,105,1.17 [0.93-1.47],0.1896233234858514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM19,Probable RNA-binding protein 19,39283,102,0.83 [0.52-1.31],0.4242623710965875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM25,RNA-binding protein 25,39172,104,1.17 [0.78-1.73],0.4468351300678022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP1,Retinol-binding protein 1,39492,104,1.13 [0.89-1.44],0.3098255453699441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,46483,124,1.74 [1.45-2.10],5.4070991007311294e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,46483,124,2.52 [2.01-3.14],4.530359704704054e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,40451,106,1.68 [1.34-2.10],6.0291581813159954e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS,RNA-binding protein with multiple splicing,39446,103,1.06 [0.79-1.41],0.7081032697354592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS2,RNA-binding protein with multiple splicing 2,39538,103,1.17 [0.98-1.40],0.0820112839693864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCC1,Regulator of chromosome condensation,40433,105,1.07 [0.74-1.53],0.7322026258801166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCOR1,REST corepressor 1,45838,124,0.98 [0.69-1.41],0.9304987026879412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39538,103,1.46 [0.58-3.69],0.4236481682750852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REEP4,Receptor expression-enhancing protein 4,40550,105,1.28 [0.98-1.66],0.0661391089960211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,46424,123,3.24 [2.71-3.86],1.2542035115122932e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,47267,128,2.40 [2.00-2.87],1.305863987806327e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,47267,128,2.27 [1.88-2.73],6.030473426372343e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3G,Regenerating islet-derived protein 3-gamma,40433,105,1.28 [0.84-1.96],0.2506832456941325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,46745,123,5.17 [4.10-6.53],9.533572665580473e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELB,Transcription factor RelB,39446,103,0.90 [0.61-1.33],0.5974076337519254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,46698,127,4.52 [3.26-6.28],2.1611219962627825e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,46694,125,2.56 [2.27-2.89],3.242012573840291e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REPS1,RalBP1-associated Eps domain-containing protein 1,39446,103,1.06 [0.66-1.71],0.7952171585192239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REST,RE1-silencing transcription factor,39172,104,0.92 [0.53-1.58],0.7538155108773711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,46483,124,2.03 [1.36-3.05],0.000576901807774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,46576,124,2.45 [1.89-3.17],1.234957625944916e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REXO2,"Oligoribonuclease, mitochondrial",39283,102,0.91 [0.59-1.40],0.6554340532098135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,40433,105,2.10 [1.06-4.14],0.0324369319414594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGCC,Regulator of cell cycle RGCC,40550,105,1.07 [0.84-1.37],0.5820632282724607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39882,107,1.27 [1.02-1.60],0.0349011271683714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,47117,128,1.48 [0.90-2.43],0.118906995950348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,47117,128,2.81 [1.69-4.68],7.08646649783495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS10,Regulator of G-protein signaling 10,40550,105,1.07 [0.79-1.46],0.6446573925300678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS8,Regulator of G-protein signaling 8,45833,124,0.95 [0.73-1.23],0.6917701504034521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RHOC,Rho-related GTP-binding protein RhoC,46052,123,1.12 [0.97-1.29],0.1083815797852541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RICTOR,Rapamycin-insensitive companion of mTOR,39446,103,0.81 [0.53-1.25],0.345321417381772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39729,105,1.48 [1.07-2.05],0.0169514146408897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILP,Rab-interacting lysosomal protein,46960,128,0.91 [0.71-1.18],0.4814926754922728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILPL2,RILP-like protein 2,40628,107,1.08 [0.90-1.31],0.3944767811754921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39283,102,0.94 [0.69-1.28],0.7015445853694322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN1,Prorelaxin H1,40550,105,1.10 [0.81-1.51],0.5359267045249531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN2,Prorelaxin H2,39658,105,1.16 [0.92-1.45],0.2136480005367677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,40646,105,4.30 [3.44-5.39],4.364440245035702e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,39538,103,1.98 [1.60-2.44],2.0703583510240167e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE3,Eosinophil cationic protein,46468,125,1.02 [0.89-1.17],0.7981580237595014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,39311,100,4.27 [3.05-5.99],4.119576095427857e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,40361,104,2.52 [2.13-2.98],1.337804849510304e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASEH2A,Ribonuclease H2 subunit A,40550,105,1.24 [0.87-1.78],0.2277262544692861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,47038,128,7.01 [5.26-9.34],2.5467189201114833e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,39538,103,3.73 [2.99-4.64],9.96932658908504e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF168,E3 ubiquitin-protein ligase RNF168,39446,103,1.13 [0.73-1.77],0.5821479873060693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF31,E3 ubiquitin-protein ligase RNF31,39446,103,1.13 [0.68-1.89],0.6412107126421202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF4,E3 ubiquitin-protein ligase RNF4,39882,107,0.93 [0.69-1.25],0.6154238613321101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF41,E3 ubiquitin-protein ligase NRDP1,45615,120,1.13 [0.88-1.44],0.334127790634097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF43,E3 ubiquitin-protein ligase RNF43,39882,107,1.24 [0.98-1.57],0.0754065808194831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF5,E3 ubiquitin-protein ligase RNF5,39538,103,0.92 [0.71-1.19],0.5039210472107714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,46745,123,5.02 [3.33-7.58],1.5794433258351718e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,47117,128,1.45 [0.76-2.77],0.2600078367102313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO4,Roundabout homolog 4,39538,103,2.00 [0.68-5.89],0.2078670326028101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,46694,125,2.62 [1.65-4.17],4.3597202602580176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RP2,Protein XRP2,46483,124,0.97 [0.67-1.39],0.8622012614998246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPA2,Replication protein A 32 kDa subunit,39446,103,1.03 [0.56-1.91],0.9133592600118436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPE,Ribulose-phosphate 3-epimerase,39882,107,0.96 [0.73-1.25],0.737749158948863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,39492,104,0.77 [0.47-1.26],0.2924299339875715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,39538,103,1.07 [0.70-1.63],0.766777065445831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPS10,40S ribosomal protein S10,39283,102,1.07 [0.68-1.66],0.7730722148138895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRAS,Ras-related protein R-Ras,39492,104,1.09 [0.95-1.25],0.2249834308533858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,45615,120,1.45 [1.16-1.82],0.0012391623690522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,45615,120,1.19 [0.94-1.51],0.1555562531502922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRP15,RRP15-like protein,39312,102,1.08 [0.87-1.34],0.4891565315762611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,46337,124,1.76 [1.18-2.63],0.0054022649675541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,47097,128,3.57 [2.38-5.35],7.211360887369362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,46483,124,1.77 [1.20-2.62],0.003879991900733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTKN2,Rhotekin-2,39283,102,1.10 [0.78-1.54],0.5971285880494808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40550,105,1.10 [0.90-1.33],0.3480002122239332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,47097,128,3.75 [3.14-4.47],3.855917092859859e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RUVBL1,RuvB-like 1,45615,120,0.91 [0.77-1.09],0.3169506670716148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RWDD1,RWD domain-containing protein 1,47117,128,0.99 [0.77-1.26],0.9246972099130608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RYR1,Ryanodine receptor 1,39283,102,1.24 [0.79-1.96],0.3516633204043409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A11,Protein S100-A11,46338,125,1.17 [0.87-1.59],0.3014092992076241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A12,Protein S100-A12,46045,123,0.94 [0.75-1.18],0.5945292321026027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,39446,103,1.61 [1.06-2.45],0.0246421261820243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,40550,105,0.56 [0.37-0.85],0.0062300637065855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A16,Protein S100-A16,45560,124,0.93 [0.70-1.23],0.605877687960173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,40433,105,1.38 [1.06-1.79],0.0163735426883638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A4,Protein S100-A4,46850,129,0.90 [0.68-1.18],0.428069329668595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100G,Protein S100-G,40550,105,0.72 [0.48-1.08],0.1157063134972117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,45838,124,1.53 [1.23-1.91],0.0001208417144319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAA4,Serum amyloid A-4 protein,40679,105,0.90 [0.48-1.70],0.7452990802234359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAFB2,Scaffold attachment factor B2,40550,105,1.14 [0.58-2.26],0.705911535819632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAG,S-arrestin,39312,102,1.11 [0.77-1.60],0.5708757145142377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,46626,123,1.20 [0.97-1.48],0.1003385115842419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAP18,Histone deacetylase complex subunit SAP18,39882,107,1.10 [0.88-1.38],0.4176107215094277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,40470,107,1.22 [1.03-1.45],0.0206269259665712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39283,102,1.34 [0.94-1.92],0.1050664094635723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT1,Diamine acetyltransferase 1,39283,102,0.94 [0.63-1.38],0.7364680275522361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,39882,107,1.30 [1.04-1.64],0.0229204561640437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SATB1,DNA-binding protein SATB1,40550,105,1.32 [0.76-2.27],0.3216891577627106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SBSN,Suprabasin,40541,105,0.81 [0.47-1.37],0.4282517980709581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,46483,124,1.40 [1.17-1.67],0.0002685508036199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,47117,128,7.55 [5.27-10.83],4.065330474664746e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,45638,124,1.37 [1.12-1.67],0.0022373504660953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,45454,123,4.56 [3.69-5.63],8.540377277955587e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,47267,128,2.50 [1.78-3.51],1.055665103406582e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,47117,128,7.11 [4.75-10.63],1.3350024715809618e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,46882,128,9.81 [6.70-14.36],7.321161813845182e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG3,Secretogranin-3,46745,123,1.00 [0.62-1.60],0.9951588109953288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,46746,124,1.51 [1.13-2.03],0.0059876380028719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB2A2,Mammaglobin-A,39283,102,0.71 [0.36-1.43],0.3404796331258611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,39729,105,2.13 [1.03-4.39],0.0417009530794003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,46823,124,1.30 [1.14-1.50],0.0001546082741941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,45833,124,3.09 [2.39-3.99],8.49178609553001e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,39312,102,1.13 [0.88-1.44],0.3406039685015067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,46960,128,1.62 [1.19-2.21],0.0021194997397346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2A,Sodium channel protein type 2 subunit alpha,39312,102,0.84 [0.54-1.31],0.4416663761502075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2B,Sodium channel subunit beta-2,39492,104,0.50 [0.24-1.06],0.0692908785819936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3A,Sodium channel protein type 3 subunit alpha,39492,104,0.68 [0.36-1.27],0.2252183470940745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3B,Sodium channel subunit beta-3,39312,102,0.60 [0.36-1.00],0.0514883774731325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,39538,103,2.25 [1.50-3.37],9.01265157559116e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCP2,Non-specific lipid-transfer protein,45615,120,1.00 [0.81-1.24],0.9890733384385216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,39389,103,1.80 [1.29-2.50],0.0005326254476137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,40628,107,2.61 [1.80-3.80],4.973485072495251e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRIB,Protein scribble homolog,39538,103,1.13 [0.94-1.35],0.2101011219057141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRN1,Secernin-1,46626,123,0.84 [0.62-1.13],0.2459126343240692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCT,Secretin,39492,104,1.20 [0.82-1.75],0.3453620732190126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,46694,125,2.70 [2.03-3.60],8.833211217222106e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,46694,125,0.56 [0.41-0.77],0.0003773413046766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,40433,105,1.19 [1.01-1.40],0.0356123705756457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,40451,106,1.29 [1.01-1.64],0.0406932938924411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDK2,Protein sidekick-2,39729,105,1.13 [0.70-1.82],0.6202767193195055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEC31A,Protein transport protein Sec31A,39538,103,1.01 [0.79-1.29],0.950924925396036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,39538,103,1.74 [1.41-2.15],2.9085804246192935e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,47267,128,2.56 [1.88-3.49],2.073318206846169e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELENOP,Selenoprotein P,40679,105,1.44 [0.63-3.25],0.3851150846378777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELL,L-selectin,40679,105,0.64 [0.29-1.42],0.2752974673700675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,46888,125,1.34 [1.03-1.75],0.0317998350994025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,46626,123,2.67 [1.52-4.69],0.0006648442561344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,46694,125,5.81 [3.36-10.05],2.859834838809696e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,39729,105,1.47 [0.98-2.20],0.0627689757831857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4C,Semaphorin-4C,46483,124,1.00 [0.55-1.79],0.9898748912650032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4D,Semaphorin-4D,47117,128,1.19 [0.70-2.02],0.5192238249443712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,39446,103,2.17 [1.38-3.42],0.0008402742546994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,47110,128,3.70 [2.90-4.73],8.999516508095154e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN3,Neuronal-specific septin-3,40550,105,1.16 [0.93-1.45],0.195629083457058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN7,Septin-7,39882,107,1.16 [0.86-1.56],0.3286355243990415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,40452,106,3.25 [2.41-4.38],9.473812572847786e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN9,Septin-9,46483,124,0.98 [0.56-1.73],0.9518298923827758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,39907,103,9.36 [3.01-29.08],0.0001105971536456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,47267,128,1.94 [1.33-2.83],0.0005791670340983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA12,Serpin A12,45332,120,1.14 [0.99-1.31],0.0590202886809229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,40534,105,2.74 [1.14-6.59],0.0246043521323004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,39950,105,2.43 [1.10-5.37],0.0289028727925319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,40093,105,1.67 [1.06-2.62],0.0260428492019248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,40679,105,7.79 [2.78-21.86],9.597233954250966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,40679,105,1.44 [0.53-3.93],0.4753761527172795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,46259,123,1.68 [1.39-2.03],6.232356515053253e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB1,Leukocyte elastase inhibitor,46545,127,1.05 [0.88-1.25],0.5720358415939457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB5,Serpin B5,45838,124,1.08 [0.77-1.50],0.66714047761147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB6,Serpin B6,46963,127,1.21 [0.93-1.56],0.1596088362308479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,47210,127,1.23 [0.99-1.53],0.0672199273330121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB9,Serpin B9,46337,124,1.33 [0.81-2.21],0.2636287582935855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINC1,Antithrombin-III,40604,105,2.09 [0.60-7.31],0.2492962507292065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,40604,105,3.26 [1.73-6.15],0.0002667791115296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE1,Plasminogen activator inhibitor 1,47267,128,1.18 [0.92-1.50],0.1857563757931085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE2,Glia-derived nexin,40628,107,1.00 [0.76-1.32],0.9777327806286706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,40063,103,5.78 [3.65-9.16],8.420729300534589e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF2,Alpha-2-antiplasmin,39919,103,1.81 [0.43-7.58],0.416336717446012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPING1,Plasma protease C1 inhibitor,40604,105,1.77 [0.66-4.75],0.2549909586233185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,39882,107,1.17 [1.02-1.35],0.0279149315147691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI1,Neuroserpin,39655,104,0.75 [0.39-1.45],0.3925217159125523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI2,Serpin I2,40451,106,1.13 [0.84-1.54],0.4215769713723115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,45638,124,0.97 [0.75-1.24],0.7941921472722531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,46184,124,0.57 [0.36-0.90],0.0152165502569419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6,Seizure protein 6 homolog,39492,104,1.21 [0.67-2.17],0.5269238982945572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,46850,129,2.79 [1.67-4.66],8.454350165430061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,46483,124,2.59 [1.51-4.45],0.0005465461603266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,46483,124,0.76 [0.60-0.95],0.0166905077368139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,46180,124,1.87 [1.48-2.36],1.5351754518474834e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,39729,105,1.80 [1.14-2.85],0.0116590309366434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA1,Pulmonary surfactant-associated protein A1,45615,120,1.12 [0.86-1.45],0.3965385112377725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA2,Pulmonary surfactant-associated protein A2,45615,120,1.00 [0.74-1.35],0.9925658801941296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,46694,125,1.47 [1.16-1.85],0.0012603195328954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,39937,106,1.55 [1.14-2.09],0.0045894069415996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2B3,SH2B adapter protein 3,45615,120,1.11 [0.94-1.32],0.2026285231363339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,46626,123,1.18 [0.93-1.50],0.1701949989672788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39312,102,1.34 [1.08-1.66],0.0082574257915704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,40451,106,1.39 [1.02-1.91],0.0386913147018693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GL3,Endophilin-A3,39659,106,1.20 [0.96-1.49],0.1087652041125155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GLB2,Endophilin-B2,40529,106,0.97 [0.74-1.27],0.8168744816187754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,40646,105,0.51 [0.37-0.70],4.210784042476123e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHC1,SHC-transforming protein 1,39172,104,0.97 [0.82-1.14],0.6960387655788594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHD,SH2 domain-containing adapter protein D,39210,101,1.06 [0.88-1.28],0.5267945922922951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHH,Sonic hedgehog protein,39446,103,1.23 [0.82-1.83],0.3194316911449141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,40614,105,3.94 [3.22-4.83],2.45532145891206e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",46823,124,1.02 [0.85-1.23],0.8159753247183346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHPK,Sedoheptulokinase,39882,107,0.96 [0.61-1.52],0.8573577502843155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,46769,129,1.77 [1.29-2.42],0.0003679018443167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,46900,124,3.93 [3.06-5.05],9.265345432444366e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,46626,123,3.18 [2.62-3.84],1.6775734302987308e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,45638,124,0.87 [0.68-1.11],0.2660193670260121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,46698,127,1.49 [1.23-1.79],3.226013850059104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,47097,128,3.82 [2.86-5.11],1.4904591030689765e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,46694,125,5.04 [3.20-7.95],3.0353804411212e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39538,103,2.86 [1.95-4.20],8.6546452179432e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,47028,128,2.80 [1.68-4.66],7.824375972750171e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIL1,Nucleotide exchange factor SIL1,39538,103,1.25 [0.74-2.12],0.4043454311912423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,46815,125,2.26 [1.61-3.19],2.773733248043433e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,46594,123,3.72 [2.82-4.90],9.458379489028583e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39446,103,1.09 [0.89-1.34],0.3880714662939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,46483,124,1.00 [0.83-1.20],0.96617685122899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",45638,124,0.71 [0.50-1.01],0.0544538274662899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,45833,124,1.93 [1.47-2.54],2.250879379663376e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,46261,123,1.04 [0.84-1.30],0.7014772795968955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP2,Src kinase-associated phosphoprotein 2,46900,124,1.09 [0.93-1.26],0.2798800049355364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKIV2L,Helicase SKI2W,39283,102,0.97 [0.61-1.54],0.901972883436935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLA2,Src-like-adapter 2,40550,105,1.14 [0.96-1.36],0.1365826101771318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,45833,124,2.30 [1.84-2.87],2.58029978789988e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,45615,120,2.73 [2.08-3.57],3.837177810321533e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,46626,123,2.05 [1.65-2.54],8.770887553536166e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,45615,120,3.47 [2.67-4.51],1.3778953044383376e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC12A2,Solute carrier family 12 member 2,39283,102,1.24 [0.70-2.20],0.4630803762030188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC13A1,Solute carrier family 13 member 1,40433,105,1.06 [0.78-1.45],0.6925583275196225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,45638,124,1.42 [1.17-1.73],0.0004628067609054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,39492,104,1.22 [0.89-1.68],0.2183021179039291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC27A4,Long-chain fatty acid transport protein 4,45638,124,1.14 [0.92-1.41],0.2428779789625679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC28A1,Sodium/nucleoside cotransporter 1,39172,104,1.15 [0.86-1.52],0.3444288248174473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,39172,104,1.04 [0.71-1.53],0.8384412299966928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,45638,124,1.86 [1.35-2.57],0.0001744758246428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,46626,123,1.60 [1.29-1.98],1.609685383820824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC44A4,Choline transporter-like protein 4,39492,104,1.11 [0.87-1.41],0.3926477723700741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC4A1,Band 3 anion transport protein,40614,105,0.76 [0.51-1.14],0.1801395595491723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC51B,Organic solute transporter subunit beta,39283,102,0.99 [0.76-1.28],0.9144499424161916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39729,105,1.15 [0.93-1.42],0.1882790531680647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40451,106,1.51 [1.21-1.90],0.0002953286878751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39172,104,1.05 [0.77-1.43],0.777189508241632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,45638,124,1.33 [1.04-1.70],0.0242960445722933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,39446,103,0.64 [0.36-1.16],0.1400625821747845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,47097,128,2.30 [1.58-3.35],1.316483582391399e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,45838,124,1.80 [1.23-2.63],0.0023452998993539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLK,STE20-like serine/threonine-protein kinase,39882,107,1.07 [0.86-1.34],0.5527626116583354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,40451,106,1.59 [1.31-1.92],2.7193004811268007e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,40321,104,1.56 [1.16-2.10],0.0036229912474968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD1,Mothers against decapentaplegic homolog 1,45615,120,1.17 [0.97-1.41],0.092223648893375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,40433,105,1.19 [0.92-1.52],0.1792179277945382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD3,Mothers against decapentaplegic homolog 3,40433,105,1.07 [0.75-1.53],0.7029499091419338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD5,Mothers against decapentaplegic homolog 5,46483,124,0.58 [0.27-1.27],0.1749870506928092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMARCA2,Probable global transcription activator SNF2L2,45638,124,0.95 [0.76-1.18],0.6252616208802426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMC3,Structural maintenance of chromosomes protein 3,39172,104,1.07 [0.77-1.47],0.6921161125320251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,40451,106,1.09 [0.82-1.46],0.5560354854605998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,47097,128,3.34 [2.52-4.41],2.855080423844269e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,46900,124,3.08 [2.26-4.21],1.471680073946873e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,46888,125,2.14 [1.61-2.83],1.3889552480577066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,39446,103,1.28 [0.99-1.66],0.0585966042204963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,46824,124,0.92 [0.72-1.16],0.4747667896059114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40433,105,0.77 [0.56-1.08],0.1303104037482063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMS,Spermine synthase,39312,102,1.03 [0.77-1.37],0.8329163875138506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,40451,106,1.43 [1.21-1.70],3.770338334231046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP23,Synaptosomal-associated protein 23,46694,125,1.13 [0.94-1.36],0.2056193342244012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP25,Synaptosomal-associated protein 25,39312,102,1.08 [0.73-1.59],0.6961033317730245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP29,Synaptosomal-associated protein 29,46850,129,1.12 [0.95-1.33],0.1810289892329292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAPIN,SNARE-associated protein Snapin,40550,105,0.79 [0.57-1.10],0.1638152336040621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCA,Alpha-synuclein,39729,105,0.95 [0.81-1.11],0.485357718568023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,46337,124,2.38 [1.90-2.97],2.325327866973604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39538,103,2.10 [1.45-3.06],9.359452893474512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',40529,106,1.45 [1.13-1.86],0.003473209810023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNU13,NHP2-like protein 1,39283,102,0.77 [0.53-1.12],0.175679531166744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX15,Sorting nexin-15,39729,105,0.80 [0.56-1.13],0.2111029825616822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX18,Sorting nexin-18,40451,106,1.13 [0.77-1.66],0.5250910507998203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,40433,105,1.29 [1.07-1.56],0.0069175578233187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX5,Sorting nexin-5,39538,103,0.95 [0.50-1.81],0.8790920137991438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,46694,125,1.19 [0.95-1.48],0.1278137916195442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD1,Superoxide dismutase [Cu-Zn],45757,121,0.86 [0.61-1.21],0.3929197333458846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",46698,127,1.29 [0.90-1.85],0.1708828561307878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD3,Extracellular superoxide dismutase,40646,105,0.60 [0.36-1.01],0.0566531055564796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,40550,105,1.79 [1.45-2.22],7.278100384144366e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,45615,120,4.58 [3.38-6.20],9.082237553357108e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORD,Sorbitol dehydrogenase,46885,127,0.94 [0.75-1.17],0.577360800891163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,46621,125,1.93 [1.31-2.86],0.0009809772525351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,46621,125,1.68 [1.12-2.52],0.0128783840266049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39492,104,0.86 [0.55-1.32],0.4874907928930128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX2,Transcription factor SOX-2,40476,105,0.77 [0.34-1.73],0.5265218116708987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,39492,104,3.72 [1.90-7.26],0.0001192741656133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40550,105,1.58 [1.00-2.50],0.0491253353520416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPAG1,Sperm-associated antigen 1,40550,105,1.20 [0.91-1.59],0.1935911334009242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARC,SPARC,46850,129,1.07 [0.86-1.35],0.5394977547034432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARCL1,SPARC-like protein 1,46743,125,1.45 [0.88-2.39],0.1441578485189392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPART,Spartin,39729,105,1.20 [0.95-1.53],0.1302306134332127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPESP1,Sperm equatorial segment protein 1,40628,107,1.24 [0.72-2.13],0.4303057890955455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,46698,127,4.06 [3.30-4.99],5.514794649644349e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,39729,105,1.84 [1.16-2.92],0.0099181517033361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,46626,123,2.90 [2.50-3.35],3.477685322027541e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK5,Serine protease inhibitor Kazal-type 5,46698,127,1.29 [0.83-2.01],0.2575429696216391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,47097,128,1.35 [0.99-1.83],0.0557428255178843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK8,Serine protease inhibitor Kazal-type 8,39283,102,1.35 [0.88-2.06],0.1699434500656151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,46543,126,3.96 [2.82-5.55],1.8274676604863285e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,46900,124,3.63 [2.54-5.19],1.492392495198946e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,40451,106,1.01 [0.90-1.13],0.9165253985886352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,46337,124,0.56 [0.39-0.80],0.001538812903426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,46745,123,3.42 [2.83-4.13],5.225857399544051e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,46468,125,6.72 [4.66-9.70],2.3132708986205488e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,47191,127,1.82 [1.33-2.49],0.0001677713218249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39446,103,1.54 [1.06-2.24],0.025095707310617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRING1,SREBP regulating gene protein,39172,104,1.18 [0.89-1.55],0.2431630050517553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR1B,Cornifin-B,39882,107,1.04 [0.84-1.29],0.7128916551140094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,40529,106,1.52 [1.17-1.97],0.0018237986543706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRY2,Protein sprouty homolog 2,45833,124,1.01 [0.85-1.20],0.8883967413999612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39312,102,1.08 [0.59-1.98],0.805907476595018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,40529,106,1.44 [1.03-2.03],0.034641196667978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRC,Proto-oncogene tyrosine-protein kinase Src,46774,129,1.03 [0.91-1.18],0.6000085185114803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,46483,124,1.21 [0.94-1.56],0.131973244812566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,46626,123,1.16 [0.98-1.38],0.0911851827473564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,40628,107,2.81 [1.75-4.52],2.0289404203812512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSB,Lupus La protein,45638,124,0.83 [0.60-1.13],0.2400198082713937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39446,103,1.43 [0.92-2.23],0.1139961692206509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,46621,125,0.90 [0.79-1.02],0.0842742433182885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,46888,125,1.84 [1.28-2.64],0.0009498449961544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSH3,Protein phosphatase Slingshot homolog 3,39172,104,0.95 [0.53-1.74],0.8796824045721012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40451,106,1.27 [0.92-1.75],0.1441875985112364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST13,Hsc70-interacting protein,39729,105,0.83 [0.59-1.16],0.2732809048275301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",46483,124,1.84 [1.42-2.37],2.839229194726575e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",47267,128,2.72 [2.10-3.51],2.0776895015810683e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39446,103,1.25 [0.89-1.74],0.1907382326633386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,40614,105,3.21 [1.78-5.77],9.919924974762224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAM,Signal transducing adapter molecule 1,40433,105,1.28 [0.80-2.05],0.3066254969040599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAMBP,STAM-binding protein,46261,123,0.96 [0.74-1.23],0.7446955132672031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,39446,103,1.31 [1.04-1.66],0.0211168742689812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT5B,Signal transducer and activator of transcription 5B,46483,124,1.04 [0.93-1.17],0.5051664655073798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39172,104,1.12 [0.85-1.48],0.4182893271701368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,47117,128,2.51 [1.93-3.26],4.427475679426792e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,46637,127,4.56 [2.44-8.53],2.00805841578198e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STEAP4,Metalloreductase STEAP4,39312,102,1.06 [0.83-1.36],0.6266790563174605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STIP1,Stress-induced-phosphoprotein 1,46623,127,0.93 [0.74-1.19],0.5722518939099976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,45838,124,1.08 [0.87-1.34],0.4998253267177521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK24,Serine/threonine-protein kinase 24,45638,124,1.16 [0.90-1.49],0.2586335761967088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK4,Serine/threonine-protein kinase 4,46694,125,1.07 [0.90-1.28],0.4466590562986176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STOML2,"Stomatin-like protein 2, mitochondrial",39172,104,0.98 [0.79-1.22],0.8372932130584435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,45615,120,1.41 [1.11-1.78],0.004406046209826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX1B,Syntaxin-1B,39492,104,0.90 [0.55-1.47],0.6714089192644841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX3,Syntaxin-3,40529,106,1.02 [0.63-1.67],0.922140838159856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,46483,124,1.48 [1.22-1.79],5.912184300320737e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX5,Syntaxin-5,39446,103,1.31 [0.91-1.91],0.1492967814364002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,45615,120,1.36 [1.09-1.68],0.0056490305342543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,39446,103,2.02 [1.38-2.95],0.0002954180079424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,46626,123,1.60 [1.19-2.13],0.0016035449404356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP1,Syntaxin-binding protein 1,40550,105,1.13 [0.89-1.44],0.3215776517615449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP3,Syntaxin-binding protein 3,45615,120,1.06 [0.74-1.52],0.7647698505744785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGP1,SURP and G-patch domain-containing protein 1,40451,106,1.23 [0.80-1.89],0.3379661516255349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGT1,Protein SGT1 homolog,45615,120,1.01 [0.83-1.24],0.8922652529660093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT1A1,Sulfotransferase 1A1,47117,128,1.01 [0.90-1.14],0.8362335312672611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,46626,123,1.56 [1.29-1.89],4.885319281883126e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF1,Formylglycine-generating enzyme,39446,103,1.19 [0.94-1.51],0.1423987958199279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,47117,128,1.60 [1.17-2.20],0.0034051410731164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",40550,105,1.56 [1.21-2.01],0.000673067003468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD1,Sushi domain-containing protein 1,45838,124,1.05 [0.75-1.47],0.7616360598508904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,46698,127,2.54 [1.69-3.84],8.512400203088795e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,40433,105,1.76 [1.24-2.51],0.0016260108334264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD5,Sushi domain-containing protein 5,39506,104,0.97 [0.56-1.69],0.9279624004253614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,39492,104,1.35 [1.07-1.72],0.0131374167495804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,40451,106,1.43 [0.90-2.29],0.1298248876280456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYAP1,Synapse-associated protein 1,39729,105,0.97 [0.71-1.33],0.8456560054602011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39312,102,1.26 [0.97-1.64],0.0809442233860955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYT1,Synaptotagmin-1,40529,106,0.98 [0.61-1.58],0.9491395560456152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,40628,107,1.31 [1.05-1.63],0.018023182257116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39882,107,1.11 [0.93-1.33],0.2304812583322459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACC3,Transforming acidic coiled-coil-containing protein 3,46483,124,1.02 [0.89-1.18],0.7267360717365587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,41390,114,2.90 [2.17-3.86],4.1430315943239123e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,40433,105,1.36 [0.89-2.09],0.1590703277549594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,46483,124,3.04 [2.23-4.14],2.3323984530619152e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAGLN3,Transgelin-3,39172,104,1.07 [0.78-1.48],0.6668959882222395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,40457,105,1.38 [0.93-2.04],0.1085398355361354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TANK,TRAF family member-associated NF-kappa-B activator,45833,124,1.20 [0.96-1.51],0.1074029463104047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAP1,Antigen peptide transporter 1,39882,107,0.83 [0.58-1.18],0.2979879076920411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARBP2,RISC-loading complex subunit TARBP2,45638,124,1.17 [0.96-1.42],0.1302329510718426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39492,104,1.09 [0.88-1.35],0.4295235310690357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40433,105,1.18 [0.73-1.90],0.5041055725209725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,40529,106,1.53 [1.18-1.99],0.0014779479966527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D17,TBC1 domain family member 17,45638,124,0.87 [0.60-1.27],0.4697027863607901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D23,TBC1 domain family member 23,46483,124,1.13 [0.95-1.34],0.1792031007103173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D5,TBC1 domain family member 5,46626,123,1.12 [0.92-1.35],0.2648583306160219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,39729,105,1.02 [0.82-1.27],0.8683048778595241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCB,Tubulin-folding cofactor B,46337,124,1.04 [0.88-1.22],0.6356001706782402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCC,Tubulin-specific chaperone C,46337,124,1.10 [0.90-1.34],0.3429325458450281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,45615,120,1.09 [0.90-1.32],0.3795785573078832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBR1,T-box brain protein 1,39492,104,0.82 [0.51-1.32],0.4194760750458111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,46265,124,0.71 [0.61-0.82],6.229891156161402e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1B,T-cell leukemia/lymphoma protein 1B,45838,124,1.02 [0.84-1.24],0.8131508670324126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN1,Transcobalamin-1,39843,101,1.32 [0.90-1.93],0.1561826238905121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,47191,127,3.66 [2.77-4.84],7.227464565882062e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,40628,107,2.16 [1.55-3.00],5.378033023092746e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCP11,T-complex protein 11 homolog,39882,107,0.75 [0.50-1.13],0.1686358028462922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCTN3,Tectonic-3,40628,107,1.66 [0.91-3.01],0.0955891845269992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDGF1,Teratocarcinoma-derived growth factor 1,45638,124,1.06 [0.96-1.18],0.2589929418468673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDO2,"Tryptophan 2,3-dioxygenase",39492,104,0.76 [0.44-1.30],0.3181567456794065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,40433,105,1.00 [0.75-1.32],0.9774739605253522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDRKH,Tudor and KH domain-containing protein,45638,124,1.19 [0.99-1.42],0.0613221681656013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEF,Thyrotroph embryonic factor,39283,102,1.03 [0.66-1.59],0.9109086741056146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,46850,129,4.57 [2.35-8.88],7.345972296872397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TERF1,Telomeric repeat-binding factor 1,39446,103,1.41 [0.78-2.53],0.2518823888381027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TET2,Methylcytosine dioxygenase TET2,39810,106,1.06 [0.89-1.26],0.5080847060699748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX101,Testis-expressed protein 101,39492,104,1.05 [0.76-1.46],0.7516640558706235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX33,Testis-expressed protein 33,39882,107,1.05 [0.66-1.67],0.8320258727705709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,40679,105,2.57 [1.10-6.01],0.0299111950672802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFAP2A,Transcription factor AP-2-alpha,39312,102,0.79 [0.55-1.14],0.2027061288421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,46468,127,2.12 [1.84-2.44],7.730495664436878e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,46823,124,3.61 [2.94-4.42],5.009917292294216e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,46671,125,2.52 [2.21-2.87],2.3504508954560987e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI,Tissue factor pathway inhibitor,46575,125,0.68 [0.40-1.16],0.1578511308860656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,46703,129,1.54 [1.26-1.88],2.2006884551169327e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,46889,125,2.26 [1.61-3.17],2.563347684140013e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TG,Thyroglobulin,40433,105,1.08 [0.91-1.27],0.386257526752593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,46626,123,2.86 [2.24-3.64],2.4360451165269934e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,47133,127,2.66 [2.07-3.41],2.126980561162624e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB2,Transforming growth factor beta-2 proprotein,40433,105,1.16 [0.84-1.58],0.3681591198914009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,46424,124,0.60 [0.33-1.08],0.0888960204024976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,39446,103,2.56 [1.70-3.85],6.047707965862239e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,46850,129,3.97 [3.17-4.96],1.1751895057134752e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,47267,128,1.82 [1.10-3.02],0.0197236484550741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,46622,125,0.78 [0.63-0.95],0.016225629226806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,40646,105,5.08 [2.87-8.99],2.348003664083369e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39102,104,0.91 [0.71-1.17],0.4622908266797103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,46694,125,4.01 [2.87-5.60],3.8303753612966574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,46698,127,4.17 [3.31-5.27],2.204415320635912e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,46731,125,1.71 [1.24-2.37],0.0012103677812787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THOP1,Thimet oligopeptidase,46468,125,0.78 [0.47-1.31],0.3530527773493539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THPO,Thrombopoietin,45838,124,0.95 [0.64-1.43],0.8196567502714134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THRAP3,Thyroid hormone receptor-associated protein 3,39283,102,0.85 [0.68-1.06],0.1597348315916066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THSD1,Thrombospondin type-1 domain-containing protein 1,39148,101,0.79 [0.44-1.42],0.4303785786961961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THTPA,Thiamine-triphosphatase,40356,104,0.93 [0.75-1.15],0.4975780610528364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,47117,128,3.72 [2.39-5.81],6.359265273873605e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIA1,Nucleolysin TIA-1 isoform p40,45325,122,1.05 [0.92-1.19],0.4698396898259754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,47267,128,1.66 [1.04-2.65],0.0325530191796865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",45562,123,1.07 [0.76-1.50],0.7003477317736532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39882,107,2.37 [1.78-3.16],3.4046214648568597e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,46888,125,1.20 [0.84-1.71],0.3236452766840904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40628,107,1.50 [1.00-2.26],0.0498075750214141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40529,106,1.09 [0.88-1.35],0.4375063869412683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,46208,125,5.61 [4.30-7.32],5.40986567741736e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,40628,107,0.78 [0.32-1.87],0.5763124779438482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP3,Metalloproteinase inhibitor 3,46900,124,1.12 [0.99-1.25],0.0645740805146487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,46698,127,1.61 [1.13-2.28],0.0077020780907653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,46544,125,6.52 [3.34-12.75],4.0524498684460537e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJAP1,Tight junction-associated protein 1,46850,129,1.13 [0.93-1.35],0.2124024045842837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJP3,Tight junction protein ZO-3,39312,102,1.06 [0.69-1.62],0.7972043035316732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",39882,107,1.42 [1.03-1.97],0.0329078864195161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,39446,103,4.01 [2.47-6.50],1.9003466710810195e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,39882,107,2.21 [1.05-4.62],0.0359854139305567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,47210,127,1.33 [1.01-1.73],0.0389890032514865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,39446,103,2.34 [1.35-4.06],0.0023840753242849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39492,104,1.17 [0.83-1.63],0.3682929432469304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED1,Transmembrane emp24 domain-containing protein 1,39882,107,1.19 [0.88-1.61],0.2650585468559316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED10,Transmembrane emp24 domain-containing protein 10,39283,102,0.86 [0.54-1.38],0.544788679652787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED4,Transmembrane emp24 domain-containing protein 4,39283,102,0.73 [0.50-1.08],0.1182822148582243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED8,Protein TMED8,40451,106,1.15 [0.96-1.37],0.1358815938703552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM106A,Transmembrane protein 106A,40433,105,1.19 [0.94-1.51],0.157279931369623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM132A,Transmembrane protein 132A,39538,103,1.03 [0.76-1.39],0.8496939676233891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM25,Transmembrane protein 25,40550,105,1.09 [0.77-1.55],0.6330302572036332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,39172,104,1.82 [1.23-2.67],0.0024342869120639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11B,Transmembrane protease serine 11B,39312,102,0.76 [0.55-1.04],0.0851684640897113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,40452,106,2.06 [1.46-2.89],3.173684751702711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,46483,124,1.86 [1.56-2.22],5.405282937865492e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS5,Transmembrane protease serine 5,46111,124,0.77 [0.51-1.15],0.1957899349991765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,46698,127,1.46 [1.19-1.80],0.0003553155040839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,46888,125,1.54 [1.12-2.10],0.0073259026043017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,45764,123,1.91 [1.58-2.31],2.988141429972154e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40451,106,1.58 [1.15-2.17],0.0048355867697312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,45833,124,1.12 [0.73-1.72],0.6065164455297893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39729,105,1.02 [0.77-1.36],0.8844089349359586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,46337,124,3.65 [3.05-4.36],9.306712372430582e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,46337,124,20.80 [8.03-53.90],4.139852312164327e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,46805,126,1.55 [1.10-2.18],0.012228731826079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,47210,127,5.27 [4.16-6.69],7.531153046206237e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,46670,123,6.12 [4.41-8.50],2.31856226664372e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,46850,129,5.59 [4.45-7.04],4.2762470858904015e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,46745,123,2.43 [2.01-2.93],3.6165407800667934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,45833,124,1.47 [1.06-2.05],0.0209870908036482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,46745,123,7.46 [5.49-10.13],7.342215424044746e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39729,105,2.28 [1.48-3.50],0.0001727513937982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,47097,128,3.81 [2.89-5.03],3.846258785461235e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,46698,127,7.07 [5.44-9.20],2.240241999527533e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,46698,127,2.23 [1.95-2.55],6.22432594718474e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,47117,128,4.26 [2.87-6.31],5.222802918406381e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,47133,127,4.14 [3.24-5.29],1.0499865843381182e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,46337,124,2.11 [1.76-2.52],2.875213957396122e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,47117,128,2.47 [1.89-3.22],2.5799913002922328e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,46337,124,2.51 [2.15-2.93],2.2865178929852064e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,47210,127,0.63 [0.45-0.90],0.010657363840231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,46626,123,0.65 [0.50-0.85],0.0016508447668861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,47210,127,0.31 [0.18-0.53],1.5702906441617606e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,46900,124,5.91 [3.73-9.38],4.398274268135295e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,47187,128,2.41 [1.54-3.77],0.0001197772455871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,46337,124,1.23 [0.94-1.60],0.1322395627393297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40614,105,3.52 [2.48-4.99],1.9523878616627986e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNIP1,TNFAIP3-interacting protein 1,40529,106,1.23 [1.00-1.51],0.0533409421194873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,40614,105,2.32 [1.52-3.54],9.096059094364352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",45838,124,1.30 [1.06-1.59],0.013414419412313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNPO1,Transportin-1,39882,107,0.90 [0.52-1.54],0.689618097450474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNR,Tenascin-R,46337,124,1.16 [0.81-1.68],0.4161466997866651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,46698,127,0.36 [0.21-0.61],0.0001517414184437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40628,107,1.46 [1.19-1.80],0.0003125839088833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1,DNA topoisomerase 1,40451,106,1.12 [0.96-1.32],0.1566320560838266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1MT,"DNA topoisomerase I, mitochondrial",39172,104,0.81 [0.52-1.27],0.3551939669226275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,39446,103,1.31 [1.05-1.64],0.0173881457090784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,39538,103,1.18 [0.85-1.64],0.3129457125318874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53,Cellular tumor antigen p53,45615,120,1.14 [0.78-1.65],0.4969188059873877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,39446,103,1.41 [1.14-1.75],0.0015542948510736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,38880,103,1.34 [0.96-1.87],0.0852500837206502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,45838,124,1.09 [0.66-1.80],0.7456162995426772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP73,Tumor protein p73,39492,104,0.76 [0.44-1.32],0.3315800750461222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPBGL,Trophoblast glycoprotein-like,39492,104,0.69 [0.41-1.17],0.1670256223993519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPD52L2,Tumor protein D54,39729,105,1.05 [0.89-1.25],0.5532518684671112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,40628,107,0.50 [0.25-0.98],0.044188976012649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPM3,Tropomyosin alpha-3 chain,39283,102,1.31 [0.91-1.89],0.1462901496791531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,45615,120,0.73 [0.57-0.92],0.0089913593283962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,46359,123,1.97 [1.55-2.52],5.2129115527836016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP2,Tubulin polymerization-promoting protein family member 2,39882,107,0.97 [0.76-1.24],0.7965121342854038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,45638,124,0.53 [0.32-0.87],0.0113472978484476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,39283,102,1.42 [1.08-1.86],0.0109376704387064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPRKB,EKC/KEOPS complex subunit TPRKB,39172,104,0.95 [0.71-1.29],0.7604876356947191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,47133,127,1.43 [1.06-1.94],0.0210948877619797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,40550,105,1.61 [1.17-2.21],0.0032730757727919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSG1,Tryptase gamma,39446,103,1.19 [0.63-2.27],0.5894606056766187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPT1,Translationally-controlled tumor protein,45833,124,1.06 [0.84-1.33],0.6355381499228382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF2,TNF receptor-associated factor 2,46626,123,1.00 [0.80-1.26],0.9973916118434422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39446,103,1.10 [0.67-1.80],0.7204051523465937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39283,102,1.19 [0.85-1.67],0.3188796711935917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39882,107,1.11 [0.91-1.36],0.2876565634975466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,40614,105,1.78 [1.36-2.32],2.8604271792483592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,46670,123,2.30 [1.79-2.96],7.353550209291712e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML1,Trem-like transcript 1 protein,40646,105,1.11 [0.80-1.54],0.5394015313700967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,46698,127,1.70 [1.14-2.55],0.0099245153285242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,47097,128,1.50 [1.19-1.90],0.000714547641492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,46626,123,1.01 [0.82-1.23],0.9561762350021924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM24,Transcription intermediary factor 1-alpha,39808,107,1.10 [0.84-1.45],0.4936748394572615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40451,106,1.18 [0.99-1.40],0.0644114947537152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM26,Tripartite motif-containing protein 26,39172,104,1.01 [0.71-1.43],0.9521712624318732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM40,E3 ubiquitin ligase TRIM40,39492,104,1.27 [0.99-1.63],0.0571219070990083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM5,Tripartite motif-containing protein 5,46626,123,1.07 [0.89-1.29],0.4838854344092831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,40433,105,1.23 [1.00-1.52],0.0481645205816691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,39283,102,0.75 [0.50-1.11],0.1469973519586178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC1,Hamartin,39446,103,1.14 [0.90-1.43],0.2767280659227628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,40550,105,1.32 [1.03-1.69],0.029140228532144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,46694,125,0.76 [0.62-0.94],0.0125175322622049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSLP,Thymic stromal lymphopoietin,45838,124,1.05 [0.81-1.36],0.703532719854401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSNAX,Translin-associated protein X,39283,102,0.82 [0.51-1.33],0.4279804423554545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,45838,124,0.84 [0.66-1.07],0.1618970869214918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN15,Tetraspanin-15,39283,102,1.23 [0.90-1.68],0.2013915451536071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN7,Tetraspanin-7,39312,102,0.78 [0.60-1.03],0.0765592381480119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,40451,106,1.25 [1.03-1.51],0.0214316999165259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPYL1,Testis-specific Y-encoded-like protein 1,39446,103,1.03 [0.65-1.63],0.9095414401843324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TST,Thiosulfate sulfurtransferase,45558,124,1.15 [0.93-1.41],0.1914708740831767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTF2,Transcription termination factor 2,39492,104,1.16 [0.82-1.64],0.4000085078773614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,39283,102,1.40 [1.12-1.75],0.0035163975370406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,40233,105,0.40 [0.20-0.79],0.0087424621781658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TUBB3,Tubulin beta-3 chain,39312,102,1.02 [0.52-2.01],0.9588241981141205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,40614,105,1.17 [0.94-1.45],0.1510259712523416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXK,Tyrosine-protein kinase TXK,39882,107,1.06 [0.82-1.36],0.6550835641624249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,46337,124,1.26 [1.05-1.52],0.012618689704295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXN,Thioredoxin,39980,102,0.81 [0.51-1.28],0.3623027268136145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,46850,129,2.21 [1.30-3.74],0.0034057131577865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,47117,128,1.53 [1.24-1.89],8.078910319589946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC9,Thioredoxin domain-containing protein 9,40529,106,1.22 [0.89-1.67],0.2254387784628231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNL1,Thioredoxin-like protein 1,39234,102,0.95 [0.77-1.18],0.6455619989672324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",46698,127,1.29 [0.94-1.77],0.1189058709802794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYMP,Thymidine phosphorylase,46402,125,1.23 [0.97-1.57],0.0809920510392543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,46694,125,2.16 [1.24-3.75],0.0062890308105598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39446,103,1.73 [1.26-2.37],0.0006126974983476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,46483,124,0.48 [0.30-0.78],0.0027151152856964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,40433,105,0.94 [0.49-1.79],0.8429041535693994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40628,107,1.44 [1.08-1.92],0.0125432115955318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39446,103,1.17 [0.87-1.58],0.298839881666193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBQLN3,Ubiquilin-3,39283,102,1.18 [0.90-1.55],0.2213324154878103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,39729,105,1.04 [0.80-1.36],0.7811620242902199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40451,106,1.08 [0.94-1.23],0.2754752845435163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,39283,102,1.19 [1.02-1.39],0.0307208488293583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,39283,102,0.73 [0.39-1.36],0.3242773090452245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,46337,124,4.26 [3.24-5.59],2.621435036547129e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,47123,127,0.35 [0.28-0.43],1.476468708978806e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,39446,103,2.22 [1.22-4.06],0.0093102165760221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC79,Protein unc-79 homolog,39172,104,1.25 [0.91-1.73],0.1636198491748486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,40433,105,1.46 [0.93-2.28],0.0995659315347349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,40628,107,1.37 [1.14-1.64],0.0005705886054268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3A,Uroplakin-3a,39312,102,0.79 [0.52-1.19],0.2570731839326228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3BL1,Uroplakin-3b-like protein 1,39807,107,1.17 [0.87-1.57],0.2985011465312746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,39729,105,1.02 [0.78-1.32],0.9006884266701725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROS,Uroporphyrinogen-III synthase,39492,104,0.81 [0.59-1.10],0.1763051822705212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USO1,General vesicular transport factor p115,46483,124,1.11 [0.93-1.33],0.2553912714454859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40433,105,1.26 [0.98-1.62],0.0663906155252933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40529,106,1.91 [1.45-2.53],5.462025165110438e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39283,102,1.03 [0.83-1.28],0.7851449328293552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,45838,124,1.11 [0.94-1.31],0.2217601936190067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UXS1,UDP-glucuronic acid decarboxylase 1,45615,120,1.13 [0.85-1.50],0.3840245929672702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,45838,124,1.41 [1.14-1.75],0.0017557677162438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP8,Vesicle-associated membrane protein 8,39446,103,1.19 [0.96-1.46],0.1068647901227203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,46626,123,1.07 [0.89-1.29],0.4586064724962851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,45973,123,2.73 [1.57-4.76],0.000378637428304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASP,Vasodilator-stimulated phosphoprotein,40646,105,1.13 [0.88-1.44],0.3322237464344643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,46483,124,0.68 [0.43-1.09],0.1123898623756217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAV3,Guanine nucleotide exchange factor VAV3,39312,102,1.07 [0.89-1.30],0.4729471669379457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,46810,125,7.47 [5.22-10.69],3.427636042857334e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,47117,128,1.76 [1.04-2.98],0.0339855263640144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCPKMT,Protein-lysine methyltransferase METTL21D,39172,104,1.00 [0.80-1.25],0.9861882728136476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,47060,127,1.81 [1.43-2.30],1.1635837450052776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,39446,103,4.74 [2.78-8.10],1.1841625361248325e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFC,Vascular endothelial growth factor C,46850,129,1.17 [0.89-1.54],0.2470771182212951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,47136,127,4.44 [3.04-6.48],1.1937083294367418e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,40550,105,2.30 [1.37-3.88],0.0017536127118747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIM,Vimentin,45838,124,1.05 [0.90-1.22],0.5465009347652001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,39538,103,0.67 [0.29-1.57],0.3607937691962209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIT,Vitrin,40628,107,1.42 [0.88-2.29],0.1564109463827217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,46483,124,1.97 [1.53-2.53],1.2118257139848126e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN1,Pantetheinase,40646,105,1.06 [0.82-1.37],0.6555281444485221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,46483,124,1.59 [1.09-2.31],0.0148713610317669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39882,107,1.15 [0.88-1.50],0.2990197349314765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS37A,Vacuolar protein sorting-associated protein 37A,46483,124,1.18 [0.97-1.43],0.0920922289231752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS4B,Vacuolar protein sorting-associated protein 4B,40433,105,1.04 [0.86-1.26],0.6661898823631776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,46483,124,1.13 [0.93-1.38],0.2156326491725133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,40433,105,1.57 [1.03-2.42],0.0380257376300949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39283,102,1.71 [1.11-2.63],0.014746149744413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,40433,105,2.72 [2.25-3.30],1.3354440395073432e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,46637,127,4.99 [3.95-6.30],3.023807196905699e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,46624,125,1.39 [1.12-1.73],0.0029042525206393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSNL1,Visinin-like protein 1,40529,106,0.75 [0.45-1.25],0.2665440005024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,45638,124,1.50 [1.16-1.95],0.0018519606945551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,39882,107,0.69 [0.39-1.22],0.2056601453886301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,45838,124,1.45 [1.19-1.75],0.0001693121562339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,47117,128,0.92 [0.74-1.14],0.443101700304917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,45615,120,2.05 [1.38-3.05],0.0004164010223231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39729,105,1.51 [1.12-2.03],0.0061345480026563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,47029,128,1.65 [1.14-2.37],0.0077850859269093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA5A,von Willebrand factor A domain-containing protein 5A,39172,104,1.03 [0.82-1.31],0.777172716182909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,46182,123,3.09 [2.15-4.44],1.2209882404652014e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,40550,105,1.17 [0.82-1.67],0.3940910175824519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,47267,128,1.53 [1.24-1.88],5.7440526913156525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",46698,127,1.25 [0.82-1.90],0.293657935018917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WAS,Wiskott-Aldrich syndrome protein,45833,124,1.05 [0.82-1.33],0.7012977321059728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,45838,124,1.13 [0.95-1.33],0.1661204619923131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,45638,124,1.01 [0.84-1.22],0.9078302864442436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,40529,106,1.39 [1.12-1.72],0.0031039781975392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASL,Neural Wiskott-Aldrich syndrome protein,39446,103,0.94 [0.68-1.32],0.7321014553027392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WDR46,WD repeat-containing protein 46,40433,105,1.04 [0.62-1.72],0.8912665498556434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,39616,104,1.62 [1.35-1.95],1.6061466720632925e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,47019,128,1.49 [1.19-1.88],0.0006122638612391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,44329,123,3.63 [2.98-4.43],2.2493352838036763e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",46184,124,0.35 [0.24-0.52],7.593737239105597e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",46745,123,1.45 [0.90-2.34],0.1292114889138455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,47097,128,0.31 [0.19-0.50],1.3937612455034468e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,45833,124,3.86 [2.93-5.08],6.71364088512291e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,46337,124,0.97 [0.72-1.32],0.8597951219497855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,47097,128,1.71 [1.41-2.08],6.86465977762911e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,47042,128,3.46 [2.57-4.67],3.692390818685171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,39446,103,1.39 [1.03-1.89],0.0331785176550242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,46850,129,0.72 [0.63-0.82],1.481910461976734e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XRCC4,DNA repair protein XRCC4,45638,124,1.05 [0.69-1.60],0.8186187364461573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,40529,106,4.63 [3.55-6.05],2.6852223754858746e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40451,106,1.09 [0.96-1.24],0.1952401100685431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,46483,124,1.19 [1.03-1.37],0.0162776293268094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YJU2,Splicing factor YJU2,40433,105,1.17 [0.69-1.98],0.5523297730267707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,39283,102,0.73 [0.53-0.99],0.0448950952154161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YTHDF3,YTH domain-containing family protein 3,45833,124,1.06 [0.88-1.27],0.5242149454155572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YWHAQ,14-3-3 protein theta,39729,105,1.08 [0.85-1.38],0.5221033473927217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YY1,Transcriptional repressor protein YY1,39446,103,1.73 [0.95-3.14],0.0727739046938085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBP1,Z-DNA-binding protein 1,39446,103,1.18 [0.75-1.85],0.469009086615004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,45615,120,1.34 [1.10-1.64],0.0037575900169624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,45838,124,1.44 [1.12-1.87],0.0051289252392811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39283,102,0.98 [0.71-1.36],0.9150882963627563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,40451,106,1.09 [0.89-1.34],0.3948183497527265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,40529,106,1.52 [1.03-2.26],0.0360255720981998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,39446,103,1.32 [0.87-2.01],0.1849295338002473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF75D,Zinc finger protein 75D,39882,107,0.80 [0.56-1.13],0.2052739520325138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF830,Zinc finger protein 830,40433,105,0.86 [0.65-1.12],0.2679410568308599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,40451,106,1.93 [1.55-2.40],4.610526896263596e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40433,105,1.20 [0.87-1.67],0.2720740803912816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP3,Zona pellucida sperm-binding protein 3,39538,103,1.05 [0.98-1.14],0.1848648504598591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP4,Zona pellucida sperm-binding protein 4,39172,104,0.89 [0.48-1.66],0.7174022848807426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZPR1,Zinc finger protein ZPR1,39312,102,1.06 [0.90-1.25],0.4820275719476297
